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3 V .
SUMMARY
Following a review of the literature on resistance to
Fasciola heoatica, a series of experiments are described,
which were designed to study the protective effect of cur¬
tailed previous infections, implantation with adult flukes
and passive transfer of immune serum in rats and rabbits.
Rats were chosen to represent those mammals which readily
acquire resistance to F, heoatica e.g. cattle, and rabbits to
represent those in which the ability to acquire such resis¬
tance is questionable e.g. sheep.
One mature or two immature infections which had been
eliminated with deacetylated diamphenethide stimulated
similar levels of resistance to challenge with F. hepatica. in
rats, although the latter procedure resulted in more severe
hepatic lesions than the former. In both cases the resistance
was manifested by a significant decrease in the numbers of
flukes recovered from previously infected rats compared with
previously uninfected rats. Following challenge infections,
the resistant rats also showed significantly lower mean peak
eosinophil counts and significantly lower mean peak glutamic
dehydrogenase levels, indicating less liver damage. Higher
antibody titres were also recorded after challenge in the
previously infected animals than in the controls.
On the other hand, in rabbits neither a single mature
or two previous immature infections which had been eliminated
with rafoxanide stimulated a significant resistance to
challenge. - The two previous infections appeared to result in
some decrease in the challenge infection but this was not
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statistically significant and was attributed to structural
changes in the liver acting as a mechanical barrier to the
development of the chairenge infection. Although such
structural changes resulting from previous infections may
also play a role in resistance to F. hepatica in rats, the
involvement of immunological factors in this resistance was
clearly demonstrated by implanting adult flukes subcutaneously
or intraperitoneally thus by-passing the parenchymal intra¬
hepatic migration which is the probable stimulus resulting
in the mechanical barrier. These implantations resulted in
a significant resistance to challenge in rats but not in
rabbits. Once again, the resistance was manifested by both
a significant reduction of the challenge infection and a
significant decrease in the mean peak serum glutamic de¬
hydrogenase levels after challenge.
In rats metabolic products diffusing from mature flukes
which had been encapsulated in diffusion chambers and im¬
planted subcutaneously or intraperitoneally were found to
contain immunogens which stimulated resistance to challenge.
Hence, the fluke tegumental cells or the eggs do not appear
to have an essential role in this resistance. The similar
stimulation of resistance by subcutaneous implantation of
one or two encapsulated adult flukes, which were removed
after two weeks, showed that the continuing presence of the
sensitising flukes was not needed to maintain the resistance,
at least in the short term.
It was also shown that resistance can be transferred
passively by the globulin fraction of serum and therefore
probably by antibody. This protective agent in immune serum
or immune-gamma globulin could be inactivated or absorbed
out by factor(s) present in the metabolic products of
cultured flukes.
The successful transfer of resistance by immune serum
seems to depend on the volume of serum transferred, the time
of transfer in relation to infection and the species of the
recepient and the donor. Thus immune rat serum or gamma¬
globulin precipitated from such serum, transferred at the
time of challenge and again 2 days later, resulted in a
significant level of resistance in terms of both the number
of flukes recovered from the challenge infection and the
serum glutamic dehydrogenase levels. However such re¬
sistance was not obtained in rabbits injected with immune
homologous serum. The ratio of the transferred serum to
recepienfs weight was about 1:50 in rabbits compared to 1:15
in rats. However, using these same ratios immune rat serum
was found to confer protection on rabbits and immune rabbit
serum was protective to rats. This suggests that the immune
rat serum simply has a greater protective capacity. A
similar high protective capacity was also shown by immune
bovine serum and by gamma-globulin precipitated from such serum
but not by ovine serum.
The dissertation ends with a discussion of these results
and of their relevance to the various hypotheses which have





Fascicliasis is "the disease caused by digenetie trematodes
of the genus Fasciola. In domestic livestock there are two
generally recognised species but there are others of
disputed validity (Dinnik and Dinnik, 1959; Sinclair, 1967;
Hammond 1970). The type species F. hepatica (Linnaeus, 1758)
is of very wide distribution mainly in the temperate parts of
the world, Australia and the Americas but also at high
altitudes (over 1670 met) in tropical areas (Dinnik and
Dinnik, 1959; Kendall, 1965).
The life cycle of F, hepatica was first described by
Leuckart (1882) and Thomas (1883). Sinitsin (1914)
elucidated the route of migration from the intestine to the
liver and Schumacher (1938) confirmed that F. hepatica migrates
across the peritoneal cavity into the liver. The second major
species is F. qigantica (Cobbold, 1855), which is widespread
in the tropics and sub-tropics.
Fascioliasis is economically most important in sheep and
cattle, but it occurs in a very wide range of susceptible
mammals including goats, camels, buffalo, swine and equidae.
Wild mammals may also contract the disease and some of these
act as reservoir hosts (Dinnik and Dinnik, 1959; Hammond,
1972). There are also reports of human fascioliasis from
many parts of the world (Dawes and Hughes, 1964; Boray, 1969;
Hammond, 1974).
Dargie (1975) summarised the direct effects of the disease
as a) antigenic stimulation, leading to elevated serum
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globulins and eosinophilic b) liver damage, resulting in
elevated serum enzymes, anaemia and hypoalbuminaemia
c) inappetance, with a consequent less cf weight or poor-
weight gain d) Haemorrhage via the bile due to the blood
sucking activities of adult parasites. The importance of
these effects are mainly influenced by the number of flukes
in the host.
Sewell (1966a) pointed out that F. qiqantica appears to be
better adapted as a parasite of cattle than F. hegatica and
that the fibrosis and calcification caused in the livers of
cattle infected with the former is less marked than in those
infected with the latter, so that the livers appear more like
those of sheep infected with F, hepatica. However, this
author also commented that otherwise there is no great
difference between the two species in the aetiology of either
the subacute form of the disease associated with the
parenchymal migration of large numbers of immature flukes or the
more chronic form due to the adult flukes within the bile ducts.
However, the infectivity of both species and the development
of the disease are influenced by various factors such as the
breed, age, nutritional status and management of the host as
well as the ecological requirements of the different inter¬
mediate hosts, these being the small amphibious Lymnaea
truncatula (Muller) for F. hepatica or the larger aquatic snail
Lm natalensis (Krauss) for F. qiqantica (Sewell and Hammond,
1974).
The economic losses due to fascioliasis may be very serious,
particularly where the local environmental conditions are
favourable to the intermediate hosts, so that the final hosts
are exposed to a high rate of infection which may lead to out¬
breaks of acute fascioliasis with both high morbidity and high
mortality (Sewell, 1974). However, of greater overall
economic importance is the chronic wasting condition. In
sheep the sequelae include poor fleece yields (Roseby, 1970),
as well as low birth weights, low milk production by the ewe
and subsequently poor weight gains by her lambs (Reid, 1973) .
Chronic infections of cattle result in poor food con¬
version ratios (Liddel, 1972) lowered weight gains and poor milk
production in terms of both quantity and quality (Ross, 1970;
Black and Froyd, 1972). In addition, condemnation of infected
bovine and ovine livers at meat inspection results in a
significant loss of revenue.
In the present author's experience, fascioliasis is the
most important helminth disease in the Sudan and undoubtedly
accounts for serious economic losses as a result of mortality,
reduced productivity and the condemnation of infected livers
(Karib, 1962; Haroun and Hussein, 1975). The predominant
parasite is F. qiqantica but it is not known whether -F. hepatica
is present at higher altitudes towards the frontier with
Ethiopia and Jebel Marra area in the western Sudan. The
disease is endemic all along the areas irrigated by the White
Nile and its tributaries from the southern borders of the
country to Khartoum.
It is also reported from the western parts of the country
where permanent swamps and shallow water-bodies exist.
The situation is aggravated by the scarcity of grazing
land during the dry season, particularly in the western
provinces, which have the largest livestock population in
the country. The result is that large populations of animals
are concentrated along the White Nile and its tributary
Bahr El Ghazal where they are exposed to infection (Haroun,
1975).
Significant advances have been made in the control of
fascioliasis by the development of more effective fasciolicides
and molluscicides as well as by improvement of land drainage
and disease forecasting techniques in the more developed parts
of the world. However, control methods need repeated treat¬
ments and are therefore expensive and in general have limited
application in countries such as the Sudan. Hence, the
development of an effective vaccine against this disease would
be of great value.
The objectives of the present investigation were therefore
to extend knowledge of means of immunising experimental animals
against F. heoatica either actively or passively and to monitor
the effects of this resistance using appropriate parameters.
Secondly, to further study the role of soluble metabolic
products in the stimulation of resistance against F. hepatica.
Rats and rabbits were used as models for cattle and sheep
in this work as they offer both logistic and financial
advantages, although it is appreciated that there will be a
need to confirm observations made in laboratory hosts in the
definitive host of commercial importance.
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CHAPTER 2
REVIEW OF THE LITERATURE ON RESISTANCE TO
FASCIOLA HEPATICA
It has been established that many mammalian hosts naturally
possess or can acquire an ability to resist a wide range of
helminthic infections (Soulsby, 1958; Urquhart, Jarrett and
Mulligan, 1962). Immunity is conveniently divided into two
forms: innate immunity and acquired immunity. The former is
an expression of the host's ability to resist infection without
previous contact with the infective agent while the latter
requires such contact. Both types of immunity are involved in
suppressing fascioliasis and may be expressed in a number of
ways e.g. reduction in the number of flukes reaching the liver
parenchyma or bile ducts, retardation or inhibition of
development of flukes in the liver, elimination of the parasites
in the parenchyma during the immature phase or reduction of the
life span of the adult parasites in the bile ducts (Armour and
Dargie, 1973; Ross, 1967a).
2.1. Innate resistance
Almost all mammals are susceptible to Fasciola hepatica
(Kendall, 1967). This susceptibility, however, varies
considerably from species to species depending on a number of
factors including: the histological structure of the host's
liver, the type and severity of the reaction produced by the
parasite in the liver and the level of infection (Ross, 1967a,
Boray 1967a, Nansen, Anderson, Harmer and Riising, .1972).
Ross (1967a) classified mammalian hosts into three groups
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on the basis of their innate resistance to F, hepatica: low,
medium and high resistance groups. Laboratory animals,
sheep and possibly horses and donkeys are included in the
first group, cattle are considered to have medium resistance
whereas pigs are highly resistant.
2.1.1. Rats
Innate resistance to Fasciola hepatica in rats is dependent
on various factors which include age, sex, strain of rat and
the size of the infective dose.
2.1.1.1.
Boray (1964) reported that whereas infections with
F . hepatica developed in 90-93% of young Wistar strain rats,
no adult flukes were recovered following infection of 5 to 6
month old rats with 5-10 metacercariae. Ray (1970) also
noted that male rats weighing 65 to 75 g were more susceptible
to infection with F. hepatica than older animals weighing 160
to 170 g. Similarly, Armour and Dargie (1973) and Dargie
(1973) reported that adult rats are more resistant to
fascioliasis than young animals. They observed that age
resistance was coincident with the formation of hepatic fibrous
tissue, but they did not discount the possibility of immuno¬
logical immaturity acting as a contributory factor in the
greater susceptibility of young animals.
Hayes, Bailer and Mitrovic (1974a)also examined the effect
of age on resistance to F, hepatica in male rats. Eight and
13-month-old rats exposed to 20 cysts were found to yield 58
and 56% less flukes, respectively, than similarly infected 3
or 4-week-old rats. This difference was significant.
Goose and Macgregor (1974) observed that age resistance
only developed after puberty. They found that susceptibility
to infection with F. hepatica in Wistar rats increased with
age from weaning to a peak at puberty. The time at which
age resistance manifests itself was also investigated by
Rajasekariah and Howell (1977a). They encountered a
variation in the degree of resistance in lO-week-old rats,
which led them to suggest that the factors involved in age
resistance in rats develop at about that age. These authors
also observed that age resistance was consistently demonstrated
when worm recoveries from 15 and 25-week-old rats were compared
with those from 5-week-old animals. They also found no
difference in worm recoveries from 15-week and 25-week-old rats
and concluded that once age resistance is fully established it
does not become further enhanced.
Age resistance in the rat may also result in elimination
of the fluke burden. Thus Boray (1964) found that his rats
lost their fluke burden 4 months after infection. However,
Hayes et al. (1974a)reported that some outbred Charles River
strain albino rats only lost their fluke burden 12 months
after infection, while Hughes, Harness and Doy (1976) also
reported that inbred Piebald Virol Glaxo and Sprague Dawley
strains eliminated their fluke burden 7 and 18 months
respectively after challenge.
2.1.1.2 . S^c
Ray (1970) reported that the sex of the rat did not appear
to affect their susceptibility to infection with F. hepatica.
However, female rats were reported to be more resistant to
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F. hgpatica than males by Daxgie (1973) and Armour and Dargie
(1973).
Later Goose and Macgregor (1974) reported that whereas
males are more susceptible to infection than females at
puberty they found no difference in susceptibility in
weanling or mature Wistar strain rats. Furthermore,
according to Hughes, Harness and Doy (1976), whereas sex
difference affected the susceptibility of Piebald Virol Glaxo
strain to infection with F. hepatica. it did not in the
Sprague Dawley strain.
2.1.1.3. Strain
According to Wakelin (1970) the strain of the host can
greatly influence the course of experimental infections with
a particular species of parasite. This effect was reported
with the nematode Trichuris muris to range from the inability
of the parasite to achieve patency in some strains of mice to
normal development in others. A strain difference was also
reported in the response of rats to F. hepatica infection by
Hughes, Harness and Doy (1976), as three or four times as
many flukes develop in Piebald Virol Glaxo rats than in
Sprague Dawley rats. Furthermore, Piebald Virol Glaxo rats
eliminated their fluke burden 7 to 8 months after infection
as compared with the 18 months needed by the Sprague
Dawley rats. These authors considered that this difference
might be a function of the greater number of flukes which
reach the bile ducts in the former strain. Hence, they
postulated the existence of a threshold number of flukes for
each strain which is necessary for the stimulation of
elimination.
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2.1.1.4. Dose of Metacercariag
Thorpe (1965) reported that in rats infected with a
large number of metacercariae of F. hepatica there was some
delay in the flukes entering the bile ducts. He injected
five groups of male Wistar rats with 5, 20, 40, 80 and 16G
metacercariae respectively* Six weeks after infection he
found that only in the group injected with 5 metacercariae
was a greater proportion of flukes recovered from the bile
ducts than from the liver parenchyma although a small number
of flukes was recovered from the bile ducts even in the group
infected with 160 metacercariae. This led him to the
conclusion that some form of crowding effect or competitive
inhibition by flukes takes place in heavy infections.
Conversely when Rajasekariah and Howell (1977a) injected groups
of male Wistar rats aged either 5, 10, 15 or 25 weeks with 1,
5, lO, 15 or 20 metacercariae they found that the proportion of
worms that developed to maturity at a particular age was the
same in all groups. Moreover, they found consistency in
prepatent periods and overlap in worm sices from various groups.
They therefore concluded that, over their narrow range of
rather low doses, neither a crowding effect nor competitive
inhibition occurred and suggested that these phenomena may
only occur in rats infected with large numbers of metacercariae.
2.1.2. Rabbits
The use of rabbits in experimental infections with
£• hepatica was first reported by Lutz (1892). Much later
Urquhart (1954) found that the susceptibility of rabbits to
F. hepatica varies within a wide range. Thus the number of
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flukes recovered from 32 rabbits infected with a total of 160G
metacercariae of F. hepatica ranged from 8% to 70% of the
infecting dose with a mean of 32.2%. These findings were
comparable to those of Montgomerie (1923) in sheep. When this
author infected 32 sheep with a total of 2550 metacercariae, he
observed a mean fluke burden of 37.4% of the infecting dose
with a range between 8% and 76%. Hence, Urquhart (1954)
suggested that the innate resistance of sheep to infection
with F. hepatica is at about the same level and within the same
limits as that of rabbits. He maintained that sex and breed
have no significant effect on the susceptibility of rabbits to
F. hepatica. although he noted that this comparison had been
made between females and castrated males and also that the
numbers of rabbits of the two breeds used (Dutch and Old
English-Chinchilla crosses) were not ideally distributed to
determine their precise importance.
The lack of any age resistance in rabbits was also pointed
out by Kendall, Hebert, Paxfitt and Peirce (1967). As they
recovered a lower proportion of flukes from larger doses of
cysts, this suggested that this might be a manifestation of
competitive inhibition similar to that reported in rats
(Thorpe, 1965).
2.1.3. Mice
The susceptibility of mice to F. hepatica was first
reported by Shirai (1927) and Taylor and Parfitt (1957) found
this host suitable for viability tests of metacercariae.
Infections with 10 to 20 metacercariae were reported by Hughes
(1962a)to be fatal within 3 to 4 weeks. This is caused by
severe damage to the hepatic parenchyma which is greatest
around the 5th week after infection when the parasite exhibits
maximum growth (Dawes and Hughes, 1964). Later, Harness,
Doy and Hughes (1977a) showed that there is no advantage to
be gained by infecting mice with more than 2 metacercariae if
adult infections are required. They infected groups of mice
orally with 2, 3 or 5 metacercariae. Eleven weeks later,
they found the mortality rates to be 40%, 62% and 77%
respectively.
The strain of mouse was shown by Harness, Doy and Hughes
(1973) to affect susceptibility to infection with F. hepatica.
When these authors infected bacteria susceptible, virus
susceptible (BSVS) albino mice and Laboratory Animals Centre
(LAC) grey mice with 20 metacercariae each and examined them
at 24-hour intervals aLfter infection, they found a quicker
migration of flukes across the body cavity and earlier
penetration of the liver in the LAC mice than in the BSVS strain.
2.1.4. Sheep
There is no evidence of natural resistance to F. hepatica
in sheep (Taylor, 1949). According to Durbin (1952) infection
can persist for at least 11 years compared to 3 years in
rabbits (Montgomerie, 1931) and 4 years and 9 months in goats
(Leiper, 1938). Ross (1967a) observed little or no
obstruction to the migration of the immature parasites in the
ovine hepatic parenchyma. Fibrosis was minimal and liver cell
regeneration was found to be characteristic of the ovine liver.
Fibrosis was also found to be minimal after the establishment
of the flukes in the bile ducts, which expand to accommodate
12.
increasing numbers of parasites*
As with mice (Dawes and Hughes, 1964), high level
infections have been reported to be fatal in the critical
phase between the 6th and 8th week during which maximum damage
to the liver occurs (Ross,1967a).
2.1.5. Cattle
The relatively high natural resistance of cattle to
F. hepatica has been recognized for a long time (Hutyra and
Marek, 1926j Taylor, 1949). This resistance is expressed
both during the migratory parenchymal and the adult bile duct
stages of the infection (Ross, 1965 a, b; 1967a; Boxay,
1967a). According to Ross (1967a), the former is related to
the relatively large amount of fibroelastic tissue in rhe bovine
liver, which helps to restrict and inhibit the parasite's
migration in the parenchyma. The bile duct resistance,
characteristic of cattle, is thought to be due to the marked
fibrosis and calcification of the bile ducts resulting in
starvation of the flukes and their eventual elimination 16-30
weeks after infection. This expulsion is preceded by a
period of 4 to 6 weeks of reduced biological activity, resulting
in diminished faecal egg output (Doyle, 1971) .
Ross (1965a) investigated the effect of the size of the
infective dose and reported that a dose of 2500 cysts or more
results in a drastic reduction in the number of flukes
reaching the bile ducts and that at even higher doses of 5GQO -
15000yet more immature flukes are trapped in the liver
parenchyma. Hence, as the level of infection is increased,
this retardation and inhibition reduces the numbers of adult
I
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flukes which develop. The author suggested that this is
caused by a high degree of tissue reaction and intensive
fibrosis, which is specially marked in the ventral lobe of
the liver due to preferential migration by the parasites.
According to Ross (1968) the life span of F. hepatica
in cattle is a function of the level and pattern of infection
becoming shorter with increasing levels of infection. Thus,
whereas from a single infection of about 200 cysts, 60 adult
parasites were established and 75% of these were lost between
the 5th and 21st month after infection and the rest survived
up to the 26th month; with a single infection of 2500 to
15000 cysts, however, the life span of adult parasites in
the bile ducts was reduced to 6-7 months (Ross, 1967b).
Ross (1963) also observed that 14-17-month-old steers were
more resistant to initial heavy infections than younger
animals and that calves in particularly good condition showed
more resistance than those in poor condition.
2.2. Acquired resistance
Several ways of stimulating resistance to F. hepatica
have been tried in various hosts. These include repeated
infections with normal metacercariae, infection with irradiated
metacercariae, inoculation with dead fluke material (somatic
antigens), inoculation with secretions and excretions of living
flukes (metabolic antigens), implantation with living flukes,
passive transfer of immune serum, passive transfer of lymphoid
cells and exposure to other (less pathogenic) parasites.
14.
2.2.1. Stimulation of resistance by repeated
infections with F. hepatica
2.2.1.1. Rats
There is now substantial experimental evidence indicating
that rats are able to develop a singificant degree of
resistance to reinfection with F. hepatica. As in innate
resistance, acquired resistance has been found to be stronger
in the female than in the male host (Goose and Macgregor,
1974).
Ruther (1963) demonstrated that 5 immunising infections
each with 50 metacercariae caused a significant reduction in
mean fluke burden to 0.75% of the infecting dose compared to
17.6% in rats 'with a single infection. The size of flukes
from resistant rats was also reduced to about 50% of those
from control infection. Immunising and challenge infections
were all performed after leaving time for regeneration of
liver tissue.
Hayes, Bailer and Mitrovic (1972) reported a reduction
of 92.5% in the parasitic burden of rats previously infected
with 3 metacercariae each of F. hepatica and challenged with
a similar dose after 7 weeks, when compared with controls.
They distinguished the parasites of the immunising and
challenge infections by size and found no detectable effect on
the primary infection by the challenge infection.
Hayes, Bailer and Mitrovic (1973) confirmed their 1972
findings by reporting a reduction of 76% in the number of
flukes recovered from challenge infections of 10 metacercariae
after a primary infection with only one fluke. Rats with
primary infection of lO metacercariae were reported to have
completely resisted superinfection. Challenge infections
were again found not to affect the primary infections in
terms of parasitic burden, in spite of the profound effect
of the primary infection on challenge.
Further evidence of resistance to superinfection as well
as the presence of this resistance in long standing chronic
infections was reported by Hayes, Bailer and Mitrovic (1974a).
They carried out a study in which rats were challenged with
20 metacercariae of F« hepatica 28 or 48 weeks after initial
exposure to the same dose. Significant differences in the
parasitic burdens recovered from superinfected rats and
controls were found in both occasions.
Hayes et, al# (1972; 1973; 1974a)recovered these
significantly reduced fluke burdens from previously infected
rats 3 or 4 weeks after challenge and concluded that the
esqpression of resistance must have had taken place earlier
than that time. According to Hayes et al. (1972) this
resistance was not a function of the host's age as there was
no difference in the proportion of an initial infective dose
which developed in rats infected at 3.5 or 10.5 weeks of age.
To further determine the time of expression of this resistance,
Hayes and Mitrovic (1977) carried out a study in which they
exposed rats to primary infection with 15 metacercariae of
F» hepatica and superinfected them with 3CO metacercariae 7
to 11 weeks later. When challenge infections were
terminated after 24 or 48 hours, 83,9% to 99% fewer flukes
were recovered from the peritoneal cavities of superinfected
rats than from rats not previously exposed. Hence, they
reported that resistance to F. hepatica in the rat is expressed
within the first 24 hours after challenge. Doy, Hughes and
Harness (1978) also reported that a 3-week-old primary
infection of 30 metacercariae per rat initiated a high degree
of resistance within 48 hours after challenge with 200 cysts.
A mean of 0.8 flukes was recovered from the peritoneal cavities
of the previously infected rats as compared to 39.2 flukes
from control rats.
Removal of the immunising infection by anthelmintic
treatment before challenge did not appear to interfere with
the ability of rats to develop resistance against challenge.
This was demonstrated by Goose said Macgregor (1973a). Rats
infected with 30 metacercariae of F. hepatica each and re¬
infected with the same dose after 9 or 14 weeks harboured
significantly fewer flukes from the challenge infection than
the previously uninfected controls. Autopsy was carried out
3 weeks after challenge. A similar level of resistance was
found whether or not the rats were treated with rafoxanide to
remove the initial infection 4 and 6 days before challenge.
This resistance was not only directed against immature flukes
derived from oral infection but also against adult flukes
transferred into the peritoneal cavities of immunised rats.
Thus rats implanted intraperitoneally with 5 or 6 adult flukes
9 or lO weeks after an immunising oral infection of 30 cysts
of F. hepatica harboured significantly fewer implanted flukes
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than controls when they were killed a week after implantation.
Comparable results were obtained by Hughes, Anderson and
Harness (1976), They implanted 3 flukes in the peritoneal
cavities of each of 16 rats which had been infected orally
with 30 metacercariae of F. hepatica 10 weeks previously.
Of these 34 were found to be dead at necropsy one week after
implantation, whereas only 3 of the 48 flukes implanted in
previously uninfected controls were dead. In contrast ,
when lO flukes were implanted subcutaneously into another 10
rats, which had been orally infected with 30 metacercariae
lO weeks previously, 9 were found alive at necropsy 7 weeks
later, although they were all encysted and degenerative
changes were found in their testes. These results led
Hughes, Anderson and Harness (1976) to the conclusion that
oral infection causes sensitization of the host with all
stages of the flukes, that this is necessary for the develop¬
ment of protection against adult fluke challenge and that this
protection only appears to express itself fully when the
challenge flukes are placed in the body cavity. According
to Hughes, Harness and Doy (1977a; b) the resistance starts
2 weeks after sensitization, is affected by the duration of
the sensitizing infection but is independent of the number of
flukes present in the bile ducts. They reported loss of
the ability to kill intraperitoneally implanted adult
F. hepatica or F. gigantica in rats sensitised orally by
hepatica 12 months previously, in spite of the fact that
these rats still harboured living adult flukes from the
sensitising infection. However, Hughes, Harness and Doy
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(1977a) found that when rats with long standing primary
infections were orally reinfected they regained their ability
to resist a subsequent intraperitoneal implantation of adult
flukes within 3 weeks, irrespective of whether or not the
long-standing primary infection had been eliminated by an
anthelmintic. The young flukes of the second infection
were found to be alive and migrating in the liver parenchyma,
whereas the implanted adult flukes were killed in the body
cavity. Hence, they attributed the ability of rats to kill
*
intraperitoneally implanted adult flukes to a recent
migration by immature flukes through the liver parenchyma and
maintained that rats in which flukes have reached the bile
ducts progressively lose their ability to kill challenge flukes.
In spite of the considerable resistance stimulated against
challenge by primary infections in rats, Hayes et al. (1972;
1973) and Goose and Macgregor (1973a) agree that primary
infections are not affected by challenge infections . Also,
Goose and Macgregor's (1973a; b) finding that anthelmintic
treatment does not interfere with the ability of rats to
resist reinfection was confirmed by Armour and Dargie (1974).
The latter authors infected rats with 20 metacercariae each of
F. hepatica. treated them with diamphenthide after 8 weeks and
then challenged them with 20 metacercariae per rat 2 weeks
after treatment. At necropsy, 10 weeks after challenge, a
highly significant difference was found between the number of
flukes recovered from the previously infected rats (2.6 - 0.2)
and the controls (5.5 - 0.4), indicating a high level of
resistance to challenge due to previous infection.
Rats which can relatively quickly eliminate their fluke
burdens retain their ability to resist, re-infection (Hughes,
Harness and Doy, 1976 ), These workers found that when
rats of the Piebald Virol Glaxo (PVG) strain, which had lost
their natural burden, 7 to 8 months after infection were
challenged with 20 cysts of F. hepatica. killed and examined
4 months after challenge, they were found to have been markedly
resistant to challenge as compared with controls.
The work of Rajasekariah and Howell (1978) further
supports the conclusion that in rats primary infection
initiates a high degree of resistance to re-infection. They
reported that a primary infection with 5 metacercariae con¬
ferred a significant degree of resistance to challenge with
30 metacercariae per os. However, previously infected rats,
still succumbed to intraperitoneal challenge with metacercariae
of F. hepatica and there was no significant difference in the
mean recovery from rats previously infected with 5 metacercariae
and intraperitoneally challenged with 30 metacercariae as
compared with controls.
2.2.1.2. Rabbits
Kealy (1955) investigated the effect of repeated infections
on the resistance of rabbits to F, hepatica. He found no
difference in worm recoveries from previously infected rabbits
and controls 60 days after challenge, although there was a
reduction in the size of the flukes recovered 35 days after
challenge frcsa the hepatic parenchyma of previously infected
rabbits. The secondary infection had no effect on the
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primary one. In contrast, Ruther (1963) found that only 7%
of the metacercariae of a challenge infection developed in
rabbits with 2 cr more previous infections whereas 46%
developed in controls. He also noted a reduction in size of
more than 63% in flukes recovered from previously infected
rabbits as compared with flukes recovered from a single
infection. When Ross (1966a) challenged 4 rabbits with 50
metacercariae each, 24 weeks after a primary infection with
75 metacercariae, he also found a reduction in the number and
size of flukes recovered from the second infection. He
reported much individual variation, to which he attributed the
widely differing results reported in attempts to vaccinate
rabbits against fascioliases.
The effect of an existing infection on a subsequent one
in rabbits was also investigated by Kendall, Hebert, Parfitt
and Peirce (1967) and Kendall (1967). These authors showed
that fewer flukes were recovered from a challenge infection in
previously infected hosts than from those which had received
a single infection. They were not convinced, however, that
this reduction was due to destruction of flukes from the second
infection. Rather, they thought it more likely to be due to
a reduction in their growth rate, resulting from competitive
inhibition, that makes them difficult to find in the hepatic
parenchyma.
Kendall and Sinclair (1971) confirmed that no resistance
developed in rabbits which had experienced a primary infection
when judged by the number of flukes recovered from the
secondary infection. However removal of the primary
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infection with hexachlorophane 2 days before the second
infection, resulted in a significant reduction in the number
of flukes recovered.
Conversely Bolbol (1975) found no reduction in the number
of flukes recovered from rabbits challenged with lOO cysts 4
weeks after the removal of a single primary infection of either
lOO or 500 cysts. However, a statistically significant
reduction was obtained in the number of flukes recovered from
rabbits which had received two similar previous infections and
treatments before challenge.
Fortmeyer (1973) found that oral superinfection of rabbits
previously infected by the same route may result in a significant
reduction in both the number and size of flukes recovered from
the challenge infection. However, when rabbits were super-
infected intraperitoneally, the flukes were reduced in size
but not in number. Furthermore, Fortmeyer (1974) reported
that rabbits infected intraperitoneally with 20-30 cysts of
F. hepatica and subsequently challenged orally with 50 cysts
showed no resistance to the challenge infection when the
interval between the primary infection and challenge was 6
weeks. However, when the interval was increased to 13-16
weeks a significant resistance was encountered.
The evidence for resistance in rabbits to reinfection
with F. hepatica is therefore somewhat contradictory, but it is
quite clear that the effect of such resistance, when it can




The studies of Lang (1967) have shown in mice that
previous infection with F. hepatica stimulates resistance to
subsequent infection. A single immunising infection of two
metacercariae tested after 40 or 60 days by a similar challenge
infection resulted in a significant reduction in the number of
flukes recovered from the challenge. In a further experiment,
two previous infections, each with 2 metacercariae separated
by 60 days were also found to result in a significant
reduction of the fluke burden from a challenge infection
administered 40 days after the second immunising infection.
The author also observed earlier migration of the worms of
the challenge infection from the liver parenchyma to the bile
ducts in resistant mice. Furthermore various host responses
including total body weight, total and differential leucocyte
counts, spleen weights, serological response and liver
histopathology were found to indicate a much more rapid
response in the resistant animals than in controls. The
histopathology of the liver including the timing and degree
of lymphocytic infiltration in resistant and control mice
led the author to the conclusion that delayed (cellular)
hypersensitivity was responsible for this resistance.
Lang (1968) compared the numberjof flukes recovered from
a group of mice with one or two previous infections 25 days
after challenge with those recovered from a similar group 40
days after challenge. There was no significant difference.
In contrast, a significant difference was found between the
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fluke burdens from either of these previously infected groups
as compared with previously uninfected controls. However,
no such difference was found between the burdens recovered from
the previously infected mice or the controls 20 days after
challenge. Hence, the author suggested that the factors
responsible for the stimulation of resistance are effective
between 20 and 25 days after challenge. Lang's work was,
however, criticised by Dawes and Hughes (1970) on the grounds
that he had not included results obtained from all the 56 mice
which received two immunising infections followed by challenges
and that the selection of groups of 12 mice for post-mortem
examination 20 and 40 days after challenge could have influenced
his results.
Harness, Doy and Hughes (1977a; b) reported that significantly
more flukes reach the liver 2 days after challenge in mice
sensitised with a primary infection of 2 metacercariae, which
is terminated by an anthelmintic after 10 days or in mice with
a 3-week sensitising infection of irradiated metacercariae than
in controls. However, no difference was observed in the
numbers of flukes recovered from the livers of sensitised or
control mice after 2 weeks. When the sensitising
metacercariae were allowed to develop to maturity before challenge,
no such rapid migration to the liver by the flukes from the
challenge infection was observed and at 2 weeks after challenge
significantly fewer flukes were recovered from the livers of
the sensitised mice than from the controls.
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Thus, experimental evidence appears to indicate that
previous infections generally stimulate resistance to challenge
with F. heparica in mice. However, Harness, Hughes and Doy
(1976) considered this evidence to be equivocal. They
reported that experimental infections of mice are usually
limited to 2 metacercariae because of the danger of death
from a larger infective dose. Hence, they concluded that it
is difficult to assess an immune response in mice by comparing
the number of flukes recovered from resistant and control
groups.
2.2.1.4. Sheep
Sinclair (1962) infected sheep with ISO metacercariae on
4 occasions and observed that there was little to indicate
that previous infections induced any immunity which could
prevent the successful development of subsequent infections.
However, he observed delayed onset and reduced egg production
by the adult flukes. The findings of Boray (1967a) also
suggested that in repeated heavy infections, the tissue
reaction caused by the migrating flukes may hinder the
establishment of flukes from subsequent infections. Further¬
more, sheep treated with an anthelmintic to eliminate a 5-
week or 12-week primary infection were found to succumb to
challenge with 200-4000 metacercariae, with no appreciable
difference in the fluke burden, clinical symptoms or
pathology between them and controls (Boray, 1967a; b).
Sinclair (1970) stated that, if sheep have any ability
to acquire resistance against F. hepatica, the cellular
reactions in the liver must be involved. To verify this
hypothesis, he investigated the development and pathogenicity
of challenge infections with F. hepatica in lambs in which the
inflammatory reaction to a previous infection had been
suppressed by corticosteroids. In earlier studies he had
demonstrated accelerated development and enhanced pathogenicity
of F, hepatica in lambs which received daily injections of
corticosteroids® The results of his later investigation
convinced him that sheep with a previous infection do acquire
a measure of resistance to a secondary infection® This
resistance could be expressed by a reduction in the proportion
of metacercariae from the challenge dose which reach maturity
as well as by retardation during the early development of the
flukes. Also, more rapid migration of flukes to the bile
ducts may occur in resistant lambs resulting in earlier
haematological changes. These findings are comparable to
those of Lang (1967) in mice® According to Sinclair (1970)
the cause of this rapid migration may be that the flukes enter
the bile ducts to escape from the increasing tissue reaction in
the host's liver parenchyma.
Another phenomenon observed by Sinclair (1970) was that the
flukes of the challenge infection grew to a larger size in the
corticosteroid treated lambs. He attributed this to the
suppressive effect of corticosteroids on the development of
biliary hyperplasia, which resulted in a more favourable
environment for the flukes.
The role of the migrating immature flukes per se in
stimulating resistance against a challenge infection was
investigated by Sinclair (1971a). He used emetine hydrochloride
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to eliminate a 4-week-old primary infection of 300
netacercariae in sheep. Six weeks later he challenged them
and controls with 600 metacercariae. Contrary to his
findings in 1970, he now observed delayed onset of anaemia and
a later appearance of haemorrhagic lesions in the livers of
the reinfected sheep, which led him to the conclusion that the
flukes remained longer in the parenchyma than in controls <.
No significant difference was encountered between the recoveries
from the challenged and control groups but the development of
the challenge flukes was retarded. This retardation,
occurring between the 6th and lOth weeks after challenge, was
taken to be the expression of the measure of resistance
initiated by the activity of the migrating immature flukes.
Confirmation of these results came from Sinclair's (1973)
studies in which he compared the development and pathogenicity
of F, heoatica in three groups of sheep. One group had been
treated with diamphenethide to eliminate a nine-week-old
primary infection, one had received five previous infections
each terminated after one week and one was previously uninfected.
Temporary retardation of the development of the flukes derived
from the challenge infections with delayed entry into the
bile ducts resulted in both previously infected groups. As in
the experiments in 1971a,no evidence was found of a reduced
fluke burden in the previously infected sheep. Two of the
findings led the author to suggest that an immunological
type of response occurs in sheep after reinfection with
F. hepatica. - The first of these was the retardation of the
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development of the flukes, particularly in the group of
sheep which had received 5 previous weekly infections, in
spite of the fact that the hepatic damage was not thought to
be extensive at the time of challenge. The second was that
gross examination of the livers of the challenged groups
revealed a less severe reaction than in the controls. How¬
ever, the effect of this immunological response on the flukes
from the challenge infection was slight, being mainly
expressed as a temporary retardation of development. Further¬
more, the author did not exclude the possibility of an
additional effect due to structural changes, provoked in the
liver by the previous infections, acting as a physical
barrier to the migration of the flukes derived from challenge
and in particular to their entrance into the bile ducts.
Results and conclusions consistent with those of Sinclair
(1971a; 1973) were also reported by Rushton (1977) who carried
out his experiments in three groups of sheep. One group was
superinfected with 400 metacercariae 11 weeks after a primary
infection of 400 metacercariae, another group was challenged
with 400 metacercariae one week adfter the elimination of a
10-week primary infection of 4QO metacercariae and a control
group which received only a single infection of 400
metacercariae.
Sinclair (1975) further examined the effects of previous
infections in sheep by determining the levels of circulating
eosinophils, plasma proteins, plasma giutaunatic dehydrogenase,
voluntary dry matter intake and plasma loss in the faeces in
three groups of sheep. One group was previously uninfected,
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one with 5 previous infections, each terminated after one week
and one with a primary infection terminated after 15 weeks,
He found no evidence to indicate resistance to the patho¬
physiological effects of the infection in either of the
challenged groups. He considered this to confirm his previous
conclusion of the occurrence only of an immunological type of
response which is ineffective in protecting the repeatedly
infected sheep.
Hence, as in rabbits, the ability of sheep to acquire
resistance to reinfection with F. hepatica is controversial.
2.2.1.5. Cattle
The ability of cattle to acquire resistance to reinfection
with F. hepatica has been demonstrated by many workers. Ross
(1966b, 1967b) found that in calves initially infected with
200 metacercariae and then reinfected with 300 metacercariae
3 weeks later, there was no significant reduction in the
numbers of flukes recovered. However, a significantly
reduced total fluke burden was encountered when the challenge
infection was administered 18 weeks after the primary infection.
He referred to this penomenon as an "acquired self cure".
Elimination of a primary infection with an anthelmintic
does not interfere with the ability of cattle to acquire
resistance to reinfection (Boray 1967a), This author
initially infected steers with lOCO metacercariae, treated them
with hexachlorophene between the 14th and 19th week, and re¬
infected both them and controls with 5CQO metacercariae 3 weeks
after treatment. The steers were slaughtered 22 weeks after
challenge and a reduction of about 78% in the fluke burden from
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the previously infected steers, as compared with controls was
found. Previously infected animals also showed fewer clinical
signs, lower egg output and a short patency in the challenge
infections. These findings were confirmed by Doyle (1971,
1973). In 1971, this author found that there was no
significant difference in the number of flukes recovered from
calves infected with 750 metacercariae and superinfected with
1650 metacercariae after 17 weeks, whether or not the primary
infection had been eliminated with nitroxynil one week before
challenge. All the calves were killed 13 weeks after
challenge. The treated and reinfected calves contained 88%
fewer flukes than the controls.
Doyle (1973) demonstrated a relationship between the
duration of the primary infection and resistance to challenge
with F. hepatica. Furthermore, he suggested that
resistance increases with the duration of the primary infection.
He found no significant resistance to challenge in calves after
a primary infection of 7 weeks. However, a significant
reduction (72.5%) in the number of flukes in reinfected calves
was encountered after a primary infection of 12 weeks. As
previously mentioned, Boray (1967a) and Doyle (1971) both
reported 77-88% resistance after primary infections of 14-19
weeks and 16 weeks respectively. Van Tiggele and Over (1975)
also reported that after a 12-month primary infection some
immunity developed against reinfection, whereas after a
primary infection of 6 months there was only slower development
of the flukes with no reduction in the numbers.
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As Doyle (1973) found no resistance to challenge with
F. hepatica in calves after a primary infection of 7 weeks in
spite of the evidence ox fibrosis alter this period (Dow,
Ross and Todd, 1967), he excluded the possibility of the
resistance being due to physical factors such as the degree
of fibrosis or cholangitis and suggested that the resistance
is dependant on acquired immunity in the host.
Armour, Dargie, Doyle, Murray, Robinson and Rushton
(1974) eliminated an 11-week-old primary infection of 750
metacercariae with an anthelmintic and then found that the
treated cattle were still highly resistent to challenge with
1650 metacercariae as compared to controls. Also, Kendall,
Sinclair, Everett and Parfitt (1978) terminated a 32-week
primary infection of lOOO metacercariae of F. hepatica in
two groups of calves and then challenged them with lOOO
metacercariae at 3 and 22 weeks respectively. They found
that the resistance to reinfection was independent of the
continued presence of the primary infection and thax the
degree of resistance to challenge 3 weeks after the elimination
of the primary infection was similar to that found after 22
weeks. The number of flukes recovered from both groups was
reduced by 82% as compared with single-infection controls.
There was also a reduction in the size of the flukes recovered
from both reinfected groups.
2.2.2. Stimulation of resistance to Fasciola hepatica by
infection with attenuated metacercariae.
The successful vaccination of calves with X-irradiated
larvae of Dictyocaulus viviparus against parasitic bronchitis
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(Jarrett, Jennings, Martin, Macintyre, Mulligan, Sharp and
Urquhart, 1958) initiared many attempts to find a similar way
to vaccinate against fascioliasis „ These attempts depended
on achieving attenuation of metacercariae by ionising radiation
with X- or gamma-rays so that the pathogenicity of the flukes
which emerge from them is reduced b!i"ttheir ability to
initiate protective host response, identified by histological
and serological methods, is maintained (Hughes, 1962a; b;
Movesesijan and Cuperlovic, 1970; Sokolic, 1971).
The first report on attenuation of Fascioia was given by
Jarrett, Jennings, Macintyre, Mulligan and Sharp (1959),
Working with metacercariae of Fascioia qicantica they stated
that 5 kiloroentgens (Kr) were sufficient for their inacti-
vation. Many workers afterwards attenuated F. hepatica
by X-irradiation of the metacercariae before administration
into different hosts. Wikerhauser (1961a) reported
reduced pathogenicity of F, hepatica in rabbits infected with
metacercariae X-irradiated at levels ranging from 3-20 Kr.
Also Hughes (1962b) found that X-irradiation of meta¬
cercariae of F. hepatica at levels from 4-100 Kr reduced
the pathogenicity of metacercariae to such an extent that
mice did not die 3-4 weeks after infection as they would
if they had been infected with normal metacercariae.
Hughes (1962b) found that the minimum level of X-irradiation
which attenuates the flukes so that they do not kill mice was
2 - 4 Kr, Reduced pathogenicity of young flukes following
X-irradiation of metacercariae was also reported in rats
(Thorpe and Broome, 1962), rabbits and sheep (Hughes, 1963)
and cattle (Boray, 1967a).
Sokolic (1968) suggested that a greater antigenic
stimulation might result from the administration of irradiated
rather than normal metacercariae because of the larger dose of
the former which a host can withstand. However, attempts to
vaccinate animals with such irradiated metacercariae produced
conflicting results.
2.2.2.1. Rats
Thorpe and Broome (1962) vaccinated rats with single
doses of metacercariae irradiated at levels ranging from 1-10
Kr and challenged them either 7 weeks or 11 weeks later.
Vaccination with metacercariae irradiated at 2.5 Kr initiated
a significant resistance with a mean reduction of 50% in the
fluke burdens in rats challenged 7 or 11 weeks after
vaccination. A significant resistance was also found in
rats vaccinated with metacercariae exposed to 5 Kr or 7.5 Kr
and challenged after 11 weeks. The mean fluke burden per rat
from the vaccinated and challenged groups was 7.7 and 6.6 for
animals challenged after 7 weeks and 11 weeks respectively.
According to the authors if there had been no immunity the mean
recovery per rat would have been 11.5 and 8 respectively. The
latter figures were the sum of the mean recoveries from the un¬
challenged vaccinated control group and the challenge control
group. These results, however, were criticised by Dawes and
Hughes (1964) who considered that this procedure of summating
fluke numbers from two control groups was of questionable
validity.
On the other hand, the findings of Thorpe and Broome (1962)
gained support from the work of Corba, Armour, Roberts and
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Urquhart (1971), Armour and Dargie (1974) and Armour, Dargie,
Doyle, Murray, Robinson and Rushton (1974). These authors
vaccinated rats wixh 2 or 3 doses of 20 irradiated
metacercariae (2.5 - 3.5 Kr) at weekly intervals and challenged
them with 20 normal metacercariae. A highly significant
resistance to challenge was found in vaccinated rats as
compared with non-vaccinated controls.
2.2.2.2. Rabbits
All attempts to vaccinate rabbits with irradiated
metacercariae of F. hepatica have prodiced negative results.
Thus Hughes (1962b) used metacercariae X-irxadiated with 2-4
Kr but no difference was found between the numbers of flukes
recovered from vaccinated rabbits and from controls. A
similar result was also obtained by Hughes (1963) when rabbits
were given 2 doses of 500 irradiated metacercariae (4 Kr) at
an interval of 3 weeks and challenged 4 weeks afterwards with
15 normal metacercariae.
2.2.2.3. Mice
Most attempts to immunise mice with irradiated
metacercariae of F. hepatica also failed. Hughes (1962b)
found no resistance to challenge in mice previously infected
with metacercariae irradiated at 2-4 Kr. Furthermore, no
evidence of resistance was found by Hughes (1963) in mice
infected with two doses of either 20 or 40 irradiated
metacercariae (3-4 Kr) at an interval of 3 weeks and challenged
3 weeks or 7 weeks later with 10 normal metacercariae.
34.
Dawes (1963; 1964) repeated Hughes' (1963) experiments in
mice and also found no evidence of resistance to challenge
in terms of a reduction of fluke burden or delayed maturation,
but he reported reduced growth by the flukes 3-4 weeks
after challenge. Sokolic (1967) again found no significant
resistance to challenge with normal cysts after previous in¬
fection with irradiated metacercariae in mice.
In contrast to these previous findings, Harness, Hughes
and Doy (1976) reported that a protective mechanism may
operate in mice vaccinated with irradiated metacercariae.
Vaccination comprised either one oral dose of 20 metacercariae
irradiated at 3.8 Kr or 2 suc3i doses given at an interval of
one week. Three weeks later both vaccinated mice and controls
were challenged with 100 normal metacercariae. At a.utopsy
2 days after, challenge the immature flukes xvere recovered
from the peritoneal cavities of all mice. The fluke
burdens from both vaccinated groups were significantly loiver
than those from controls. Thus Harness _et_ al. concluded
that a protective response had operated at the intestinal wall.
However the results of a similar experiment(Harness, Doy and
Hughes, 1977b) in which they killed the mice 12 or 14 days
after challenge did not lend support to this conclusion as a
similar number of flukes were recovered from both groups.
This result indicated that the immature flukes migrated more
quickly from the peritoneal cavity of mice with a previous in¬
fection with irradiated metacercariae than in controls. The authors
therefore concluded that this rapid migration in the sensitised
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mice could account for the reduced number of flukes recovered
from the peritoneal cavity of such mice 2 days after challenge,
as compared to contr-els.
2.2.2.4. Sheep
Vaccination of sheep with 2 doses of X-irradiated
metacercariae (3 Kr) at intervals of 3 weeks failed to stimulate
resistance to challenge with F. hepatica (Hughes, 1963).
Boray (1967a) also found no evidence of an immune response in
sheep previously infected with 3 doses of 1000 X-irradiated
metacercariae (20 Kr) and challenged with 4COO normal
metacercariae. However the onset of anaemia was delayed in
the vaccinated sheep.
On the other hand, Dargie, Armour, Rushton and Murray
(1974) carried out an experiment in which sheep were infected
with 6 doses of 100 irradiated metacercariae (3 Kr) of
F. hepatica before challenge with 750 metacercariae. A mean
of 36 flukes was recovered from the vaccinated group compared
to a mean of 105 flukes from non-vaccinated controls. Even
this considerable difference in the fluke burdens was not
statistically significant, but the authors considered it to
be some evidence for the ability of sheep to acquire
resistance against challenge with F. hepatica.
2.2.2.5. Cattle
Attempts to vaccinate cattle against fascioliasis with
irradiated metacercariae gave more favourable results. Boray
(1967a) infected calves with 3 doses of 30QO X-irradiated
metacercariae (20 Kr) at intervals of 6 weeks and challenged
them with 500O normal metacercariae 3 weeks later. At
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autopsy 16 weeks after challenge, there was no significant
difference between the fluke burdens in the previously infected
calves and in the controls. However the vaccinated calves
showed fewer pathological changes in the liver.
Bitakaramire (1973) infected 7 calves with 2 doses of 1000
gamma-irradiated metacercariae of F. qiqantica (3 Kr) at intervals
of 6 weeks. These calves were then challenged together with
controls 14 weeks after the second immunising dose. Twelve
weeks after challenge, 5 of the vaccinated calves were found to
be free of any Fasciola burden and did not show pathological
changes in the liver. A fluke burden of 1 - 2 % of the
challenge dose was recovered from the other two vaccinated
calves, whereas the mean recovery from the non-vaccinated control
group was 23.1% of the challenge. However, Armour and Dargie
(1973) reported that when Armour, Dargie and Doyle (unpublished
results) repeated Bitakaramire's (1973) experiment in calves
using irradiated metacercariae of F. hepatica for vaccination,
they found only 68% resistance in comparison to the 98% reported
by Bitakaramire.
Armour, Dargie, Doyle, Murray, Robinson and Rushton (1974)
vaccinated calves with 2 doses of 1000 metacercariae, irradiated
at 3.5 Kr, at an interval of one month. Four and eight weeks
after the second immunising dose two groups of calves were
challenged with 850 normal metacercariae together with controls
of the same age. A reduction of 30% in the fluke burden was
found in the group challenged 4 weeks after immunisation compared
with controls, whereas a reduction of 70% was found in the group
challenged 8 weeks after immunisation. However, the
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pathological changes were similar in the livers of both
vaccinated and control calves.
Nansen (1975) reported that vaccination of calves with
metacercariae of F. hepatica irradiated at 3 Kr may result in
a significant resistance to natural infection. He vaccinated
groups of calves with 3 doses of 1500 attenuated metacercariae
at intervals of 4 weeks before they were turned out onto a fluke
infected pasture for a grazing season of 24 weeks. Twelve
weeks after the end of the grazing season, 71% fewer flukes
were recovered from the vaccinated calves as compared with
controls. Further evidence of resistance was also shown by
the stable serum Y - glutamyltranspeptidase levels in the
vaccinated calves in comparison with the elevated levels in non
vaccinated controls, the enzyme being used as a measure of
hepato-biliary damage caused by the flukes. From these results
the author suggested that vaccination of calves with gamma-
irradiated raetacercariae could be an acceptable method of
vaccination, since the hepatic pathological changes due to the
vaccine do not greatly disturb liver function. However,
he also pointed out an important deficiency in the vaccine,
namely, the development of some vaccine-derived parasites to
maturity. Nansen therefore called for further investigations
to determine the appropriate dose of irradiation which prevents
the maturation of flukes and to elucidate whether resistance
can be stimulated without mature flukes in the liver, as well
as to define the appropriate vaccination dose and the interval
between vaccination and challenge.
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2.2,3. Stimulation of resistance to Fasciola hepatica
with homologous somatic extracts.
The use of antigen preparations from whole flukes or
fractions of crude fluke material for vaccination against
fascioliasis have produced conflicting results in different
hosts. Eriksen and Flagstad (1974a) and Lang (1976) reported
that parenteral injection of whole fluke antigen did not
produce resistance against fascioliasis in rats and mice
respectively. However, Lang and Hall (1977) stimulated
resistance in mice by vaccination with antigens prepared by
sonic disruption of immature F. hepatica. Pooled homcgenate
of 16-day-old flukes was sonicated until all the cells were
disrupted. It was then centrifuged and the supernatant
used as antigen. This contained about 500 pg of protein/ml.
Vaccination with one injection of the sonicated antigen
stimulated resistance which resulted in an 86% reduction in
worm burden. Two injections resulted in an 82% reduction but
the pathological changes in the liver were severe. The authors
therefore considered that two injections with the sonicated
antigen may have produced hypersensitivity in the test animals.
Most attempts at vaccination were however, carried out in
rabbits. Kerr and Petkovich (1935) gave nine 1 ml intra¬
peritoneal injections of a 1% suspension of dried flukes to
each of seven rabbits at intervals of one or two days. Five
weeks later, each rabbit was challenged with 13 metacercariae,
together with 3 controls. At autopsy 13 - 17 weeks after
infection, the mean number of flukes recovered from vaccinated
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rabbits was 2.1 and that from controls was 8.3. It was
also observed that the flukes were calcified in two of the
vaccinated rabbits and that eggs did not appear in their
faeces. According to these authors, this result indicated
that it is possible to stimulate immunity by injections of
dried fluke material. However, Urquhart, Mulligan and
Jennings (1954) questioned the significance of these findings
in view of the small number of control rabbits. They
suggested that the reduction could be due to the normal
variation in 'take*. Urquhart et al. (1954) also vaccinated
two groups of 7 rabbits with an alum precipitated protein
antigen (10 mg proxein N/ml) prepared from crude adult fluke
homogenate. This antigen was given intramuscularly at
intervals of 8 - 10 days. One group received 3 injections
and the other received 6. Both vaccinated groups and 11
control rabbits were challenged with 50 metacercariae of
F. hepatica each. It was found that although high titres of
precipitins were produced, vaccination with these fluke proteins
had no influence on the number of F. hepatica which developed.
However, determination of their total nitrogen content showed
that there was retardation of development of the flukes recovered
from the vaccinated rabbits. These authors therefore con¬
cluded that if the reduction previously reported by Kerr and
Petkovich (1935) was real it might have been due to the influence
of antigens other than the proteins.
The histopathological changes in the livers of rabbits
vaccinated with fluke antigens were found to be less severe than
in the livers of unvaccinated controls by Shibanai, Tozawa,
Takahashi and Isoda (1956). They vaccinated separate
groups of rabbits intradermally. subcutaneously, intraoerit-
oneally and orally and challenged them after 10 weeks together
with controls. At post-mortem examination 8 weeks later, the
livers of the rabbits which had received intraperitoneal or
oral vaccinations showed lesions of medium severity. The
lesions in the livers of rabbits vaccinated intradermally or
subcutaneously were least severe whereas the un-vaccinated
controls had the most severe lesions. However these authors
were unsure whether the reduced severity of lesions in the livers
of vaccinated rabbits was due to the vaccine.
Complete resistance to challenge was reported by
Babadzhanov and Tukhmanynts (1958) in rabbits vaccinated 'with
a whole F. hepatica extract which contained a considerable amount
of polysaccharide but no proteins or lipids. These rabbits
were vaccinated with 6 intravenous injections and challenged
2 weeks later with 10 metacercariae. However many other
workers have found no evidence cf immunity in rabbits
vaccinated with whole fluke extracts. Healy (1955)
vaccinated rabbits with such extracts and reported no evidence
of resistance in animals autopsied 60 days after challenge,
although retarded development of the flukes 'was found when the
vaccinated rabbits were killed 35 days after challenge. Geyer
(1967) made reference to his unpublished results which ha.d
indicated no evidence of immunity in rabbits vaccinated with
5 injections of materials from homogenized and lyophilized flukes
containing proteins, carbohydrates and lipids. Antigens
prepared from lyophilized adult flukes were also used by Hughes
(1963) in attempts to vaccinate rabbits against fascioliasis.
In an experiment similar tc that of Kerr and Pitkovich (1935)
Hughes vaccinated rabbits with 9 intraperitoneal injections
of the antigen before challenging them with 13 metacercariae
each. At post-mortem examination 14 weeks later a mean of
1.7 flukes was recovered from vaccinated rabbits whereas a
mean of 5.6 flukes was recovered from unvaccinated controls.
Howeverj no evidence of resistance was found when the experiment
was again repeated. Ross (1967c) also found no evidence of
resistance in rabbits vaccinated with 5 subcutaneous injections
of 1 ml of whole fluke homogenate. However, 2 subcutaneous
injections of 1 ml of homogenate containing 0.66g% protein
prepared from immature (6-week-old) flukes at a 2-week interval
resulted in retarded growth of flukes from a challenge in¬
fection between the 6th and 7th weeks after infection.
Attempts to vaccinate sheep with fluke antigen were also
discouraging. Ershov (1959) used as a fluke antigen a complex
containing about 60% polysaccharide and 30 to 40% albumen com¬
ponent. In a total of 97 vaccinated sheep, 10-25% were found
to be solidly resistant to challenge, while the rest showed
reduced susceptibility. However, vaccination resulted only in
a short term immunity as no resistance was found in sheep in¬
fected 45 days after vaccination. The absence of any
resistance to challenge was also reported by Hughes (1963) in
sheep vaccinated with 9 intraperitoneal injections of adult
fluke antigen over a period of 3 weeks. Similar results were
also reported by Ross (1967c)in a lamb and a calf vaccinated
with 5 subcutaneous injections^of 1 ml of whole fluke homo-
genate.
2.2.4. Stimulation of resistance to Fasciola hepatica by
homologous metabolic products
The metabolic products of helminths have been used in
attempts to stimulate immunity against many of these parasites
(Soulsby, 1957a; Urquhart, Jarrett-and Mulligan, 1962; Lehner,
1977). In fascioliasis, Healy (1955) attempted to vaccinate
rabbits with pooled regurgitated caecal contents of adult
flukes. No evidence of resistance to challenge was found
when the vaccinated rabbits were killed after 60 days. However,
retarded development of the flukes was found when the rabbits
were killed after 35 days, while the flukes were still in the
liver parenchyma. Purified caecal contents from adult
F. hepatica were used by Lalic, Cuperlovic and Movsesijan (1976)
to vaccinate rabbits against F. heoa tica. Three injections of
the vaccine (a total of 6y.g of protein) were given to each
rabbit at 2-week intervals before challenge with 25 metacercariae.
The antigen provoked an immune response and specific antibodies
were found by precipitation, complement fixation and fluorescent
antibody tests. At autopsy it was found that a mean of 16.8%
of the infective dose developed in vaccinated rabbits whereas
4.8% developed in the non-vaccinated controls. Greater
pathological changes were also found in the livers of vaccinated
rabbits. The authors suggested that the immune mechanism
provoked by the antigen may have influenced the susceptibility
of the host.
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Lang (1976) used metabolic products of 16-day-oid
• hepatica maintained in Medium 199 for various periods of
time as a vaccine against F, hepatica in mice. A single
injection of medium in which the flukes had been incubated for
4 hours (4-hour incubate antigen) or 24-hours (24-hour in¬
cubate antigen) and which contained 160 ug or 480 - 500 ^g
protein respectively, failed to stimulate resistance against
challenge, although host mortality was significantly lowered.
On the other hand, four sequential vaccinations with 24-hour
incubate antigen (520 - 560 ug protein) reduced the fluke
burden by a mean of 83.3%.
Lang and Hall (1977) attempted to determine the time at
which these protective antigens are produced by 16-day-old
F. hepatica in vitro. They vaccinated groups of mice with
incubate antigens produced over various periods of time. The
highest resistance (86%) was shown by the group vaccinated
with 12 or 24 hours incubate antigens. The authors therefore
suggested that qualitatively different protective antigens are
produced between 12 and 24 hours . Contrary to the previous
report of Lang (1976) this later work suggested that sequential
injections were not necessary for successful vaccination.
Lang's (1976) findings that resistance to F. hepatica can
be stimulated in mice by sequential vaccination with 24-hours
incubate antigens were not supported by Lehner (1977). The
latter author carried out a similar experiment and obtained
results in marked contrast to those reported by Lang. Lehner
found no difference between vaccinated mice and controls in
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infactivity rate, mortality rate or fluke burden. He also
vaccinated rabbits and rats with metabolic antigens from
adult and immature F. hepatica. Metabolic antigen for
vaccination of rabbits was prepared by maintaining flukes re¬
covered from rabbits in a continuous flow recirculating system
containing Medium 199 for 7 days. The antigen used contained
2 ug/ml protein. Rabbits were vaccinated 3 times at
intervals of 4 weeks and challenged with 100 metacercariae each,
as were unvaccinated controls. Antibodies similar in some
features to those in the serum of rabbits with a patent fluke
infection were detected in the serum of vaccinated rabbits.
However, at post-mortem examination, 8 weeks after challenge, no
significant difference was found in the fluke burdens recovered
from vaccinated or unvaccinated rabbits. Nonetheless, the flukes
recovered from the vaccinated rabbits were significantly smaller
than those recovered from the controls.
Similar experiments were also carried out by Lehner (1977)
in rats using antigens from adult and immature flukes. Although
the vaccinated rats also produced antibodies with some features
in common with those in the serum of animals with patent infections,
clear differences were also evident, as it was found that the
vaccinated rats did not respond well to the non-protein com¬
ponent of the metabolic antigen, whereas infected animals showed
a strong reaction with this component. In no case was any
evidence of resistance to challenge found in vaccinated rats.
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2.2.5. Stimulation of resistance to Fasciola hepatica
by implantation of living flukes.
As protective immunity has generally been found to be
best stimulated by living parasites, it was thought that the
antigens responsible for this immunity may be released by
the parasites during their development in the host (Rickard
and Bell, 1971 a; b; c). Many authors have tried to
stimulate immunity to infection with various helminths by
implanting the particular parasite in a site different from
its normal location in the host, so that it can release
antigenic metabolic products '.without causing significant
pathological changes. Rickard and Bell (1971b; c) ex¬
cluded any possible effect from direct contact between the im¬
planted parasite and the host by enclosing the implanted
parasites in membrane diffusion chambers. They reported that
activated embryos of Taenia taeniaformis and Taenia ovis con¬
tained in such chambers and implanted intraperitoneallv into
rats and lambs respectively produced diffusible 'functional'
antigens that stimulated a high degree of resistance to sub¬
sequent challenge. This technique has not previously been used
in fascioliasis, but direct implantation of flukes has proved to
be a useful technique for immunological studies in this disease.
Ross (1967c) implanted 6-week-old flukes into the
gluteal muscles of 6 rabbits, a lamb and a calf which had
been given 5 subcutaneous injections of whole fluke homogenate
over 4 weeks. Two weeks later they were challenged,
together with a group of animals which had also received the
whole fluke homogenate but not the implant and a control
group which had received neither homogenate nor the implant.
At post-mortem examination after 8 weeks both vaccinated groups
contained smaller numbers of flukes than the controls, but
the difference was not conventionally significant. P.oss
also implanted a group of sheep in the intercostal muscles
with 6-week-old flukes and similarly implanted another group
twice at an interval of 3 weeks. Both groups were challenged
with 10O metacercariae of F. hepatica together with controls.
At post-mortem examination 10 weeks after challenge there was
no significant difference in the lengths of flukes recovered
from implanted and control groups. Once again both implanted
groups contained fewer flukes than the control group, but this
difference was also not conventionally significant. However,
the author considered that the retardation of fluke development
following injections of flukes extracts and the reduction in
the numbers of flukes recovered from vaccinated groups, though
conventionally not significant, probably indicated the
involvement of acquired immunity.
Hughes and Harness (1972) transferred adult flukes from
the bile ducts of rats, rabbits and goats into the peritoneal
cavities of rats and rabbits to determine the survival time
in the host, to assess the adaptation of the parasite to
the host and to see the effect of maintaining flxikes in vitro
on their development after transfer into a new host. Adult
flukes implanted in the peritoneal cavities of rats showed
no predilection for the liver but were found encapsulated in
fibrous vascular cysts. As these cysts did not form around
dead flukes, the authors suggested that they may be a host
response to the presence of living flukes serving to prevent
more widespread trauma. Flukes survived within these cysts
for at least 6-7 weeks. They appeared to thrive well and
laid eggs normally. However, those implanted into the
intraperitoneal cavities of rabbits did not thrive, were
reduced in size and either had no eggs or abnormal eggs in
their uteri. The authors suggested that this could be
attributed to the inadequate nature of the nutrition available
in the body cavity of the rabbits and to the inability of the
fluke to adapt to this host. This work was taken as a baseline
for a subsequent experiment by Hughes and Harness (1973a)
designed to study whether there are shared antigens between
F. hepatica and its hosts and, if so, the significance of this
for the adaptation of the fluke to the host. Such a 'host-
antigen' effect had been reported by Smithers, Terry and Hockley
(1969) with another trematode, Schistosoma mansoni. These
workers showed that schistosomes taken from mice and
implanted into monkeys, which had been sensitised against mouse
tissue, were soon killed and that the response in the "anti-
mouse" monkeys was highly specific for schistosomes derived
from mice. Hughes and Harness (1973a) used either
erythrocytes or liver and spleen tissues mixed with Freund's
complete adjuvant to immunise rats and rabbits against goats
and against each other. However, they could not detect any
harmful effects on adult flukes implanted into a recipient
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host which had been immunised against the donor's tissue.
Hence, under the conditions of this experiment, they found no
evidence of any 'host-antigen' associated with F. hepatica.
However, in a later paper (1973b) these authors stated that
this failure to demonstrate any harmful 'host-antigen' effect
might be due to the large size of the adult flukes as '.veil as
to their unusual site away from the liver, as this might make
them less accessible to immunological attack. To exclude such
factors they transferred young flukes into the intraperitoneal
cavities of rats immunised against the donor host's tissues.
These transferred immature flukes showed a predilection for
the liver and became sexually mature in the bile ducts, but
they were not affected by any harmful 'host-antigen' effect.
Furthermore, the results of a mixed agglutination test did not
demonstrate any shared antigens. However, these findings,
were not considered by the authors as conclusive proof of the
absence of shared antigens between F. hepatica and its hosts,
but rather as indicating that if such antigens occur they are
either not accessible surface or tegument antigens or are not
similar to erythrocyte antigens.
Lang (1974a) observed that F. hepatica incubated in
immune homologous serum for 4 hours and then transferred into
the peritoneal cavity of mice, migrated into the bile ducts at
an earlier time than flukes incubated in normal serum. He
suggested that the development of the host immune response
during the parenchymal migration phase initiates rapid movement
of the flukes into the bile ducts, where they are protected from
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most of the host's immune responses. According to this
author, such a response may explain why the 'host-antigen'
effect could not be demonstrated \vith F. hepatica by Hughes
and Harness (1973a; b).
Hughes, Treacher and Harness (1973) reported a new
technique whereby either adult or immature flukes can be
transferred into the gall-bladder of a recepient host. The
adult flukes were found to remain and produce eggs in the gall¬
bladder while the immature flukes migrated into the bile ducts,
produced hyperplasia and became sexually mature. Hughes and
Harness (1974 ) used this technique to stimulate immunity to
F. hepatica in cattle. Their preliminary results showed that
immature flukes from mice implanted into calves reached sexual
maturity and produced calcification of the bile ducts. The
calves were then challenged orally with F. hepatica metacercariae
but the final results were not reported in this paper as the
experiment was still in progress.
Elagstad and Eriksen (1974) examined the survival and
activity of adult flukes from cattle, sheep and goats in the
subcutis of albino rats. They found that the flukes became
encysted one or two days after transfer and that 2% of the flukes
were still alive after 15 weeks. Eriksen and Flagstad (1974b)
stimulated immunity in rats using this technique. They im¬
planted rats subcutaneously with adult flukes from sheep and
goats and challenged them orally after 3 weeks together with
controls. At post-mortem examination, 3 months after im¬
plantation, 6% of the transferred flukes were found alive within
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cysts. Subcutaneously implanted rats showed 50% resistance
against oral challenge with metacercariae as compared to
normal rats. The authors considered that the involvement of
an immunological mechanism against the challenge infection was
supported by the lack of fibrosis in the livers of implanted
rats. Furthermore, they suggested that the antigens
associated with this immunity might be in the form of a meta¬
bolic product from the implanted flukes. The possibility of
a role for the eggs produced by the implanted flukes in this
immunity was however not excluded.
Anderson, Hughes and Harness (1975) also transferred
adult flukes into the subcutaneous tissues of rats to study
the possibility of stimulating immunity against challenge when
the hepatic migration stage is by-passed. Rats were implanted
subcutaneously. with one adult fluke and challenged orally with
20 metacercariae 12 days later. The implanted flukes became
surrounded with a fibrous cyst. Flukes were found alive within
these cysts 34 days after transfer, though their testicular
activity had decreased by that time. Histological changes
characteristic of cell mediated immunity and of antibody
production were found in the lymph node draining the site of
implantation whereas the contralateral lymph node remained
non-reactive. An average 8-fold difference in weight was
found between the draining and contralateral lymph nodes.
Injection with adult fluke antigen produced evidence of intra¬
dermal hypersensitivity and circulating precipitating antibodies
were present in the implanted rats, thus supporting the
histological evidence for antibody production. According to
these authors, this finding demonstrated a state of hyper¬
sensitivity concomitant with antibody production induced by
F. hepatica in the rat. The protective value of this
hypersensitivity and antibody production was proved by a
significant reduction in the fluke burden (34%) recovered from
the implanted rats as compared with controls.
Hughes, Anderson and Harness (1976) reported that
sensitisation of different hosts by subcutaneous implantation
of adult flukes involves antigens in the metabolic products
as well as the eggs of the adult flukes, whereas sensitisation
by an oral infection involves antigens from all stages of the
parasite. These authors compared the two routes of sensitisation
in rats and reported that, when they were sensitised by sub¬
cutaneous implantation of adult flukes and subsequently
challenged by implanting adult flukes in the peritoneal cavity,
23% of the challenge flukes were killed. On the other hand,
71% of adult flukes intraperitoneally implanted as a challenge
infection were killed in rats sensitised by an oral infection.
However, sensitisation by neither of the two routes proved
effective against subcutaneously implanted adult flukes. Histo¬
logical studies showed that about half the dead flukes had been
rapidly killed after transfer and were surrounded by mono¬
nuclear cells. The authors considered that the rapidity with
which these flukes were killed indicated the involvement of
antibodies. However, the rest of the dead flukes were
surrounded by neutrophils and it was suggested that although the
death of these flukes was probably also mediated by antibody,
the rate of the response was sufficiently slow to allow the
formation of sufficient antibody-antigen complex to give rise
to the chemotactic response that attracted the neutrophils
which could digest the dead flukes.
The role of different developmental stages of the fluke
in stimulating resistance to F. herntica was investigated by
Rajasekariah and Howell (1978). They sensitised groups of
rats by subcutaneous implantation of either cetacercariae of
F. hepatica, 4-week-old immature flukes, adult flukes or fluke
eggs and challenged each group after 2 weeks. The resulting
fluke burdens indicated that implantation of all the stages,
except the adult worms, stimulated a significant degree of
resistance against oral challenge. Implanted adult flukes
were incapable of stimulating such resistance even though the
period of sensitisation before challenge was extended and
flukes from different donors (cattle and sheep as well as rats)
were used. It was found that implanted metacercariae were able
to excyst and migrate from the implantation site, to reach the
liver and cause hepatic damage. On the other hand, although 4-
week-old worms and eggs stimulated immunity they were not found
to cause any liver damage. On the basis of these results, the
authors suggested that the role of liver damage in the stimu¬
lation of resistance is not of major importance, at least in ra
The finding that implanted adult flukes are incapable of stimu¬
lating resistance to challenge in recepients is contrary to the
previous results reported by Eriksen and Flagstad (1974b) and
Anderson et al. (1975). Rajasekariah and Howell suggested
that this discrepancy might be because they used a different
strain of rats in their experiment . They also- suggested
that the stimulation of resistance by implanted eggs but
not by eggs laid by implanted adult flukes could be explained
by the fact that the former are more widely dessiminated, as
the latter become encapsulated and confined within a cyst.
Several authors have studied the results of implanting
F. heoatica in mice. Thus Gold and Lengy (1972) investigated
the migratory behaviour, survival time and the immunising
effect of implanted adult F. hepatica in this host. The
flukes were obtained from rabbits and guinea pigs and im¬
planted into the intraperitoneal cavities of 20 mice. These
mice were orally challenged after 10 days with metacercariae,
as were 15 controls. Eleven mice died before challenge but
6 survived for at least 30 days after challenge. The per¬
centage of fluke recovery from implanted mice and controls was
11.1% and 12.7% respectively thus indicating that the implanted
adult flukes had failed to stimulate resistance to challenge.
Most mice implanted with 1 or 2 flukes survived for at least
lO days, those implanted with 3 or 4 adult flukes died on the
following day. Implanted adult flukes were generally found
to be capable of extensive migration and some even reached
the liver, although they were not able to 'relocate' within
the bile ducts. Two implanted flukes survived for 25 and
40 days respectively in mice without apparent harm.
An attempt to determine the age of F. hepatica responsible
for inducing acquired immunity in the mouse was made by Lang and
Dronen (1972). They inserted 8 - and 16 - day-old flukes into
the intraperitoneal cavities of mice. Both groups of flukes
reached the liver after 3 days and the bile ducts when they
were 32 days old. When the transferred flukes reached the age
of 4Q days, the implanted mice were orally challenged with 2
metacercariae per mouse and post-mortem examination was carried
out 25 days later. Significantly fewer flukes were recovered
from groups of mice immunised with 8 - or 16-day-old flukes
than from unimplanted controls.
Although the 8-day-old flukes were present in the hepatic
parenchyma for 21 days, while the 16-day-old flukes were only
there for 13 days, the pathological changes caused in the liver
by the latter were greater. The authors attributed these
changes to substances produced by immature flukes which are
antigenic and toxic to the hepatic tissue and suggested that the
16-day-old flukes produced more of these toxic products than the
eight-day-old flukes, resulting in both the increased liver
damage and the enhanced stimulation of the protective immune
response.
Lang (1974b) transferred 12, 14, 18, 20 and 24-day-old
flukes into mice and reported that they all reached the bile
ducts when they were 30 to 32 days old. When the transferred
flukes reached an age of 40 days he challenged each of the im¬
planted mice orally with 2 metacercariae. At necropsy 25 days
after challenge mice implanted with 12-, 14-, 16- cr 18-day-
old flukes showed a significant resistance to challenge, where¬
as mice implanted with 20- or 24-day-old flukes did not. On
the basis of these results the author suggested that the
critical factor in the stimulation of immunity is the duration
of parenchymal migration by young flukes and not their age.
As no resistance was stimulated when hepatic migration of
transferred flukes was shorter than 8 days, while a significant
resistance was stimulated by 18-day-old flukes which migrated
in the liver for iO to 11 days, Lang suggested that a
parenchymal migration of at least 10 days is a prerequisite
for the stimulation of acquired immunity in mice.
Lang (1974a) later carried out further studies to in¬
vestigate the importance of the age of the transferred flukes
in the stimulation of resistance in mice. He incubated 12, 16,
18, 20 and 24 day-old flukes at 37.5°C for 4 hours in immune
serum from mice and transferred them into the peritoneal
cavity of recepient mice. The latter were necropsied when the
transferred flukes reached an age of 34 days. A significant
reduction in the number of flukes recovered from these mice
was found when compared to those from mice implanted with flukes
incubated in heat-inactivated immune serum, normal serum,
Medium 199 or buffered saline. No significant differences
were observed in the number of flukes recovered from any of the
former control groups. Since 12-24-day-old flukes were de¬
bilitated by immune serum and it had been previously shown that
12-18-day-old flukes were capable of stimulating resistance
(Lang and Dronen, 1972; Lang, 1974b) it was concluded that
the duration of parenchymal migration is of greater importance
J
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in the stimulation of resistance than the fluke's age.
2.2.6. Passive Transfer of immunity to Fasciola hepatica
by serum.
The efforts to elucidate the significance and mechanism
of resistance to fascioliasis have included attempts at passive
transfer of immunity by immune serum.
2.2.6.1. Rats
Armour, Corba, Dargie and Urquhart (1971) found that
serum from rats with an immature infection failed to protect
recepient rats from challenge with metacercariae of F. hepatica.
Also the intraperitoneal transfer of immune serum from donor
rats with a 10-week-old mature infection failed to confer
resistance in recepient rats weighing 12O-180 g, when each
received about 4 ml of immune serum. Later however,
Dargie (1973) and Armour and Dargie (1973; 1974) showed that
rats can be immunised with homologous or heterologous immune
sera. They injected 91 rats intraperitoneally, with 10 ml
each of immune serum from donor rats, cattle or sheep infected
with F. hepatica, both at the time of challenge with 20
metacercariae and again 2 days later. An overall reduction of
67% (mean 1.7 flukes) was found in the number of parasites
recovered from these rats as compared with rats which received
no serum or which received serum from un-infected donors (mean
5.1 flukes). A direct relationship was observed between
the volume of immune serum transferred and the degree of
protection obtained. Thus the mean number of flukes recovered
from rats given 0, 5, 10 or 20 ml was 3.6, 2.0, 1.4 and 0.6
respectively. As immune serum transfer was found to be
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protective if given within the first two days of challenge,
but not if given 2 weeks before or 2 weeks after challenge,
the authors concluded that immune serum is only protective
against young flukes before their entry into the liver.
Antibodies of various immunoglobulin classes and sub¬
classes differ in their biological activities and under
certain circumstances an immune response can be restricted
to one or another subclass (Spiegelberg, 1974), Armour and
Dargie (1973) in a preliminary attempt to determine the
immunoglobulin class involved in the transfer of passive
immunity in rats at the time of challenge, transferred only
the fraction IgG. A significant protection of 55% was
found in the immunised rats as compared with controls. Such
a protection was not found with IgM. Further work using a
fraction of immune serum from rats and cattle which conferred
68 - 73% resistance to rats also indicated that IgG was a
prerequisite for successful protection (Dargie, Armour and
Urquhart, 1973).
Hayes, Bailer and Mitrovic (1974b) found similar results
when they investigated the immunising effect of transferring
homologous immune serum into rats at O and 14 days after
challenge. Immune serum was obtained from rats infected
with F. hepatica 7-8 weeks previously. Recepient rats
had a mean weight of 64 g and were given intraperitoneal
injection of 5 ml of serum and challenged with 10 meta-
cercariae. At post-mortem examination 4 weeks later 66%
fewer flukes were recovered from rats injected with normal
serum at day 0, and 73% fewer flukes than from rats which
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received no serum. These differences were highly
significant while the difference between the two control groups
was net significant. Furthermore, no significant difference
was found between the number of flukes recovered from rats
injected with immune serum 14 days after challenge ana controls
injected at a similar time with normal serum or controls which
received no serum. However, a significant difference in
fluke burden was found between the group of rats injected with
immune serum at day O and that injected on day 14. Hence,
the authors concluded that resistance due to immune serum is
expressed against flukes younger than 14 days and that humoral
antibodies are at least partially responsible for this resistance.
Hayes, Bailer and Mitrovic (1974c) confirmed their earlier
(1974b) results and reported evidence of resistance to F. hepatica
due to immune .serum transfer in two strains of rats, Fisher
344 and Sprague Dawley, thus indicating that this resistance
was not limited to one strain. They found that volumes of
5, 2.5 or 1 ml of immune serum all gave a similar protective
effect which was higher than that conferred by a volume of 0.2
ml. However even the rats which received only 0.2 ml of serum
had significantly fewer flukes than controls which received no
serum. The best results were obtained when serum was
administered at the time of infection. Serum given 2, 4, 6
or 8 days after infection did not result in significant
resistance, although there appeared to be a slight protective
effect following transfer 2 or 4 days after infection. Immune
serum from rats with a more chronic infection of 25 weeks was
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found to have no protective effect. The protective effect
could be eliminated by heating the serum for 30 minutes at
56°C and was also absorbed by live or dead F. herat lea. A.s
most of the flukes recovered from immunised rats were the same
size or were slightly larger than those from the controls,
the authors suggested that immune serum has an 'all-or-
nothing effect' against individual young F. hepatica.
Howell, Sandeman and Rajasekariah (1977) carried out in
vivo and in vitro studies of the effects of immune rat serum
on F. hepatica. Their results confirmed the previous findings
that immune serum confers resistance in recepient rats. They
used three batches of immune serum from two strains of rats.
The first batch was collected from inbred DA rats which had
been given a primary infection of 5 metacercariae at 5 weeks of
age, a second infection with 30 metacercariae after 7 weeks
and exanguinated 8 weeks later. The second batch was collected
from Wistar rats in the same way except that they were
exanguinated 1 week after the second infection. The third
batch was similarly collected from Wistar rats but the levels
of primary and secondary infections were 10 and 20
metacercariae respectively. The recapient rats were injected
intraperitoneally with immune serum varying from 10 ml
immediately before and after infection to 5 ml immediately
after infection. In all cases a significant degree of
protection was achieved. As no significant difference was
found between the number of flukes recovered after injection
with normal serum from 13-20 week old rats, and that from
rats which received no serum, the authors concluded that the
factors involved in age resistance are not transmitted in
serum.
The results of the in vitro studies of Howell _et al.
(1977) on the effects of immune serum on newly excysted flukes
were similar to those of Wikerhauser (1961b). In both
cases a precipitate was formed around newly excysted flukes
in the presence of immune serum. This precipitate was con¬
sidered to be made of one or more rat antibody-fluke antigen
complexes. Howell jat auL. (1977) also found that although
immune serum did not have a pronounced effect on the
mortality of metacercariae _in vitro, such metacercariae did
not develop in vivo.
2.2.6.2. Rabbits and Guinea pigs
The phenomenon of precipitation which occurs around live
larval stages of many nematodes and trematodes when they are
incubated in immune serum has been used for the microscopic
diagnosis of many of these infections e.g. trichinosis (Roth,
1941), ascariasis (Soresco and Panaitesco, 1958), meta-
strongylosis (Becht, 1960) and schistosomiasis (Papirmeister
and Bang, 1948), However, the role of such precipitation in
immunity has been controversial. Some workers have reported
that it has an inhibitory effect on the young stages of
parasites. Thus Sarles (1938) observed this effect on the
larvae of Nippostronqylus muris, Otto (1940) on those of
Ancylostoma caninum, Gonzales (1940) on those of Trichinella
spiralis and P'apirmeister and Bang (1948) and Standen (1952)
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on the cercariae of Schistosoma mansoni. On the other hand,
Roth (1941) found no such an effect on the larval of
T. spiralis. Precipitation was reported by wikerhauser
(1961b) around excysted metacercariae of F. hepatica when
these were incubated in immune rabbit or bovine sera.
According to this author, this precipitation was a sensitive
and specific test for the immunological diagnosis of
fascioliasis in these animals. Sewell (1968) also found
such precipitation when newly excysted flukes were incubated
in immune rabbit, ovine or bovine serum. He reported that
the antibodies involved in this precipitation were absorbed
by none of the serologically active components in the
metabolic products of F. hepatica.
To test the inhibitory effect of precipitating serum on
F. hepatica in vivo, Wikerhauser (1961b) carried out the
following experiments. Two groups, each of 3 guinea pigs
(500 - 950 g body weight) were infected intraperitoneally
with 5 excysted metacercariae that had been incubated in
either immune or normal bovine serum at 37°C for 18 hours.
The guinea pigs also received 1 ml of the corresponding serum
intraperitoneally at the same time. 'A lighter' infection was
found in the animals which had received metacercariae in¬
cubated in immune compared to those given metacercariae in¬
cubated in normal serum. The former guinea pigs also
survived longer and had less severe changes in the liver and
peritoneum. Similar results were obtained in another
experiment in which each animal was simultaneously injected
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intraperitoneally with 10 freshly excystea raetacercariae
and 2 ml of immune or normal bovine serum per kg body weight,
in a further experiment in which guinea pigs were infected
orally with 10 or 20 metacercariae and given 2 ml immune
bovine serum subcutaneously or intraperitoneally per Kg body
weight 4-3 hours later, the immune serum had no effect.
However the author pointed out that these results are only of
relative significance because of the small number of animals
in each group (3).
Baalway (1975) transferred either homologous immune
serum from rabbits infected with F. qiqantica or heterologous
immune serum from infected goats into groups of 3 rabbits both
at the same time and 2 days after challenge with metacercariae
of F. giqantica. He found that resistance ranged from 25 to
40% after intraperitoneal transfer of 1 to 10 ml of concentrated
homologous immune serum. The highest protection was found
in rabbits which received 10 ml. The same dose of concentrated
immune serum from infected goats also conferred the highest
resistance (78%). The author concluded that for immune
serum to be effective it must be in high concentration, in a
sufficiently high dose and must be collected while the young
flukes are still migrating in the peritoneum of the donor.
2.2.6.3. Mice
Hughes (1963) found that when mice which had received
serum intraperitoneally from infected rabbits or from rabbits
in which vaccination had been attempted were infected with 5
metacercariae together with controls, no difference was to be
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found in the degree of infection or in the survival time
between the two groups. These results support those of
Wikerhauser (1961b) in guinea pigs. However, Ruther (1963)
infected each of 10 mice with 5 metacercariae which had been
incubated in immune rabbit serum at 37°C for 24 hours. Three
weeks after infection the mean fluke recovery from these mice
was 0.3 while that from controls infected with cysts incubated
in normal rabbit serum was 3.0. A significant reduction in
size was also observed. Further, as already mentioned,
Lang (1974a) found that when 12-24-day-old flukes were in¬
cubated in homologous immune serum and transferred into
recepient mice, the number of flukes recovered was reduced
compared with that from mice implanted with flukes incubated
in heat-inactivated immune serum, normal serum, Medium 199 or
buffered saline. From this result and in particular since
the effect of immune serum was significantly decreased by heat
o
mactivation at 56 C for 30 minutes, the author suggested that
complement was necessary for the antigen-antibody reaction
involved in this type of resistance. However there was a
significant reduction in the lengths of the flukes recovered from
mice implanted with flukes incubated in inactivated immune serum
as compared to those from mice implanted with flukes incubated
in normal serum. This led the authors to suggest that this
effect is not only due to IgG, as suggested by Dargie et al.
(1973) but also to IgM. According to Lang, the IgM may combine
with a cell membrane antigen to form a complex which can
activate complement to produce immune lysis of the cells and
death of the flukes.
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Lang (1976) incubated F. hepatica in immune serum from
mice which had been injected with fluke incubate antigen
from 16-day-old flukes or in immune serum from mice with
25-day-infections. Such flukes were then transferred into
recepient mice. At post-mortem examination it was found that
in both cases the immune serum had had a debilitating effect,
shewn by a significant decrease in fluke recovery and host
mortality. Serum from mice which had been injected with
somatic antigen or from those with lOO-day infection had no
such debilitating effects. Hence, the author suggested that
the antigens in the incubation medium which stimulate the
production of antibodies harmful to the flukes are produced
only by immature flukes. However, incubation of young flukes
in antiserum from mice with mature infections was found to
result in earlier migration after transfer. Therefore it
was suggested that the mature flukes also produce the antigens
but that their location in the bile ducts does not allow these
antigens to have sufficient contact with the host to maintain
immunogenic levels.
2.2.6.4. Sheep
Soulsby (1957b) described a thermostable component of
normal sheep serum which has a lethal effect on the miracidia
of F. hepatica in the presence of fresh guinea pig complement.
Such activity was also found in sera of sheep infected with
F. hepatica and was considered to be a natural property of the
serum. The author concluded that this component is similar
to others which have an antagonistic effect on a wide
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range of helminths and which are present in normal sera from
various animals. He suggested that such components should
be determined so that their effects could be differentiated
from manifestations of resistance.
Armour and Dargie (1973) reported that sheep could be
protected against F. hepatica if large amounts of immune
serum are used. It was found that 400 nil of immune serum
injected intraperitoneally resulted in 30% protection against
a challenge dose of 750 metacercariae.
2.2.6.5. Cattle
Armour, Corba, Dargie and Urquhart (1971) found that
immune serum from a calf with an immature infection with¬
in., hepatica failed to protect a recepient calf from challenge.
A similar result was obtained by Corba, Armour, Roberts and
Urquhart (1971) who transferred 240O ml of immune serum from
a donor calf with a mature F. hepatica infection into the
peritoneal cavity of recepient simultaneously challenged with
lOOO metacercariae. The comparison was made with a calf
which received no serum. However, Armour and Dargie (1973)
reported that cattle shouid be immunised if even larger
volumes of immune serum were used. Administration of
3.6 litres into a 250 Kg bovine recepient resulted in 99%
protection against challenge with lOOO metacercariae of
£• bepatica compared to a control which did not receive serum.
2.2.7. Transfer of immunity to Fasciola hepatica by
lymphoid cells.
2.2 .7 .1. Rats
Corba, Armour, Roberts and Urquhart (1971) investigated
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the immunising effect of lymphocytes transferred into rats
from infected donors. Suspensions of lymphoid cells ivere
prepared from the spleens and lymph nodes of rats with an
immature F. hepatica infection (4 weeks), mature infections
(8 and 10 weeks) or vaccinated with 3 weekly doses of
irradiated metacercariae. Lymphoid cells from the last two
donors transferred intraperitoneally into syngeneic recepients
conferred a significant resistance of 66.7% - 73.7% and 100%
respectively. However, lymphoid cells from donor rats with
immature infections failed to confer protection.
Although the successful transfer of immunity required
lymphoid cells from donors with a minimum infection of 8
weeks the authors excluded the possibility that the parasite
should be mature for the successful transfer of resistance.
This is because the best protection was obtained by lymphoid
cells from donors infected with irradiated metacercariae whose
survival time does not exceed 3 or 4 weeks. As immune serum
from these donors conferred no protection on recepients, the
authors suggested that the immune reaction to F. hepatica
could be cell-mediated, at least in the rat. These results
were confirmed by Armour and Dargie (1974) who transferred
viable lymphoid cells from donor rats with 10-week infections
to syngeneic rats which were challenged at the time of transfer.
A significant reduction in fluke burden was obtained in the
immunised rats compared to controls which received either no
cells or non-viable cells. This reduction was found to be
related to the quantity and persistence of the antigenic
stimulus in the donor. Thus the transfer of lymphoid cells
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from donor rats with a mean burden of 7, 6 or 3 flukes resulted
in reductions of 81%, 68% and of 30% respectively, the latter
result not being significantly different from the controls.
2.2.7.2. Mice
Lang, Larsh, Weatherley and Goulson (1967) investigated the
role of delayed (cellular) hypersensitivity in immunity to
F. hepatica. They obtained peritoneal exudate cells from
donor mice with 35-week infections and injected them intra-
peritoneally into recepient mice which were each challenged
with 2 metacercariae 3 weeks later. At necropsy 40 days after
challenge, there was a highly significant reduction in the number
of flukes recovered from the immunised mice as compared with
the untreated mice. More rapid responses were also observed
in the vaccinated mice. These were manifested by an earlier
loss of weight and earlier changes in the differential
leucocyte counts compared to the controls. According to the
authors these results together with previous histopathological
findings in the liver (Lang, 1967) indicate that a specific
delayed sensitivity reaction takes place auid causes local tissue
damage. This damage results in nonspecific allergic in¬
flammation and biochemical changes which lead to the rapid
migration of flukes to the bile ducts and may cause the death
of some of the young flukes.
2.2.7.3. Sheep
Sinclair (1971b) investigated the role of lymphoid cells in
resistance to F. hepatica in inbred sheep. He prepared homo-
genates of lymph nodes and spleen from donor sheep infected
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with F. hepatica 8 weeks previously, as well as from un¬
infected control sheep. These homogenates were administered
intravenously or intraperitoneallv immediately before challenge.
The number and size of flukes recovered as well as the live-
weight, packed cell volume, eosinophil counts and faecal loss
of Cr"5"*" labelled plasma showed no evidence of resistance in
the vaccinated group. In contrast, Dargie (1973) reported
briefly that lymphoid cells from infected sheep can confer
immunity on highly inbred recepients.
2.2.7.4. Cattle
Corba, Armour, Roberts and Urquhart (1971) transferred
lymphoid cells from the hepatic lymph nodes of a calf which had
received 2 injections 15 weeks apart of 1000 metacercariae into
the peritoneal cavity of a monozygous twin calf. At post¬
mortem examination a significant reduction of 79.7% was
found in the number of flukes recovered from the immunised
calf as compared with the monozygous control. These results
were confirmed by Dargie (1973).
2.2.8. The stimulation of resistance to Fasciola hepatica
in sheep by infection with the metacestodes of
Taenia hydatiqena
This procedure was suggested as to be "new initiative1
in the attempt to stimulate immunity to fascioliasis in the
natural host (Campbell,,Kelly, Townsend and Dineen, 1977).
The proposal was based on the work of Dineen, Gregg, Windon,
Donald and Kelly (1977) who found that vaccination of sheep
with irradiated Trichostronqylus colubriformis larvae resulted
69.
in a protection of 98-100% against the simultaneous challenge
with infective larvae of the same species, or of a closely
related species (T. vitrinus) and also of a genetically un¬
related nematode (Nematodirus spathiqer) , From these results,
they concluded that 'vigorous immunological reaction to a
helminth parasite can cause the simultaneous expulsion of
other generically related and unrelated species 'and that it
may not be essential for the target parasite to be anti-
genically related to the species used to promote the response'«
Campbell et al. (1977) therefore tried to stimulate resistance
to F, hepatica by previous infection with Taenia hydatigena
(Cysticercus tenuicollis). The latter was chosen because of
three characteristics. Firstly, it has a migratory pattern
similar to that of F. hepatica in sheep; secondly, it is
possible to stimulate a high level of resistance to homologous
challenge and thirdly, it is of low pathogenicity in sheep.
All the sheep used in the experiment were first treated
with levamisole to eliminate nematode infections before they
were allocated to 5 groups of 8 animals. Each animal in 4
of the groups was orally infected with 1O0O Taenia nydatiqena
eggs. Two of these groups were treated with mebendazole to
eliminate the metacestodes either 3 or 12 weeks after infection,
before intra-ruminal challenge with 400 metacercariae of
F. hepatica. The other two groups were superinfected with a
similar dose of F. hepatica either 3 or 12 weeks after infection
with the cestode. The fifth group was a control for the
challenge with F. hepatica. Fifteen weeks after challenge
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high levels of resistance, namely 96% and 98% were found in
the group infected with cysticerci for 12 weeks and in the
group whose infection with cysticerci was removed after 12
weeks respectively. These two resistant groups also showed
less hepatic fibrosis and their packed cell volumes were
not reduced, as compared to the controls. On the other
hand, there was no evidence of resistance in the two groups
infected with the cestode for only 3 weeks. Half the number
of sheep in each of the 5 groups was left alive for a
further experiment described by Dineen, Kelly and Campbell
(1978). These authors found that the group of sheep
which resisted challenge with F, hepatica after a previous
infection with T. hydatigena for 12 weeks maintained this
resistance against another challenge 9 months later. How¬
ever, the group of sheep in which the cestodes infection had
been eliminated after 12 weeks were fully susceptible to the
second challenge with F. hepatica after 9 months, even though
they were resistant after 12 weeks. The two groups which
were susceptible to challenge with F. hepatica after a 3-
week infection with T. hydatiqena, were also susceptible to
the second challenge with F. hepatica after 9 months. The
observations that the maintenance of resistance against
F. hepatica was dependent on the persistence of infections
with the metacestodes and that this resistance was maintained
by the cysticerci in a site remote from the reactive tissue,
led the authors to suggest that infection with T. hydatigena
stimulates an immunological mechanism rather than a physical
barrier against F. hepatica. Furthermore, the observation
that the sheep which had been susceptible to challenge with
F, hepatica after a 3-week infection with the cysticerci were
also susceptible to the second challenge 9 months later, led
them to suggest that the first challenge with F. hepatica
prevented the development of cross-protection because it
destroyed the cysticerci before they were able to initiate
resistance against Fasciola. Alternatively, fascioliasis
could be immunosuppressive. According to the authors the
latter suggestion may explain why the group of sheep which
acted as a control for challenge with F. hepatica succumbed
to rechallenge after 9 months.
CHAPTER 3
MATERIALS AND METHODS
3.1. Production of infective material
The need for a constant supply of metacercariae of
F. hepatica as infective material throughout the course of the
work necessitated the maintenance of the intermediate host,
Lymnaea truncatula (Muller) in the laboratory. Snails were
obtained from the stock colony at the Department of Tropical
Animal Health; culture techniques adopted were essentially
those described by Sewell (1961) and Pullan (1968).
The snails were fed on green algae, mainly Oscillatoria
spp., growing on the surface of a layer of mud in plastic
boxes (Pullan, 1968). Mixing the local soil in a specially
formulated mineral solution instead of tap water (Lehner,
1977) and incubating the algal cultures at 23°C under two
30 watt fluorescent strip lights ensured good algal growth.
A small amount of algae from an old green culture
transferred to the middle of fresh mud layer covered the
surface of the mud after 3-4 days. If not required immediately,
the boxes containing the algal cultures were stored in the cold
room at 10°C. When so stored, algal cultures became dark
green-brown in colour and before use they were rewetted with
mineral fluid and placed under strip lights at 23°C overnight
to restore their original state.
Some boxes containing adult snails were kept in the cold
room for periods of aestivation not exceeding three months.
When needed, these were taken out and placed on algal cultures
at 23°C.
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Egg masses from these snails hatched after about lO days
o
at 23 C. Strips of algae were put into the boxes of newly
hatched snails for the first 2-3 days. The young snails were
then carefully transferred by forceps into fresh algal cultures.
When they reached a length of 2-5mm the snails were infected
with miracidia of F. heoatica.
Eggs of F. hepatica were obtained from the gall bladders
of infected sheep from the local abbatoir. They were washed and
kept in distilled water in a petri dish at 23°C. The water was
changed daily during the first week. Thereafter they were
kept in the dark, in an amber bottle covered with aluminium foil
at 23°C. On exposure to daylight 2 weeks or more after setting
up the culture the miracidia soon hatched and were used as soon
as possible to infect the snails.
Each snail was placed individually in a well of a perspex
haemagglutination plate containing 5-10 miracidia in a little
distilled water. The plates were then covered and left over¬
night at room temperature. Infected snails were maintained on
algal cultures at 23°C and cercariae were shed about 5 weeks
after infection.
To induce shedding, the infected snails were put into a
small polythene bag (12x7.5cm) half-filled with distilled water
at 10°C and left in the light at room temperature. The
cercariae were shed as the water warmed up to room temperature.
After about 6 hours the snails were removed onto fresh algal
cultures at 23°C. Snail debris in the polythene bag containing
the metacercariae was gently washed off. The polythene bag was
then half filled with distilled water and left at room temperature
for a week before transfer to the cold room at 10°C for storage,
3 .2. Experimental animals
The rats used in all experiments were Porton Wistar
males, 6-7 xveeks old at the start of experiments (300-350 g) „
The rabbits were New Zealand White males about 3 months old
(2.5 - 3 Kg). Rats and rabbits were all purchased from the
Centre for Laboratory Animals, Bush Estate, Roslin, Midlothian.
Sheep and calves were all males, about 4 months old,
Cheviots and Ayrshires respectively. They were obtained
from Easter Bush Farm, Roslin, Midlothian.
3.3. Infection of animals
A small piece of polythene bag containing metacercariae
was cut off and the metacercariae were examined for viability.
Viable metacercariae showed a characteristic granular appear¬
ance under the microscope. The required number of viable
metacercariae was then scraped off into a watch glass pre-
treated with silicone "Replecote" (Hopkin and Williams Ltd.,
Chadwell Heath, Essex).
For the infection of rats, the metacercariae were sus¬
pended in 1% gum tragacanth. A pasteur pipette fitted with
about 5 cm of 1 mm i„d, plastic tubing and treated with
silicone was used to administer metacercariae into the pharynx
of a rat which was lightly anaesthetised with ether.
For the infection of rabbits, sheep and calves the re¬
quired number of viable metacercariae was scraped off the
polythene bag and mixed with a small quantity of cellulose
powder ('Whatman CF1', Whatman Biochemicals Ltd., Maidstone,
Kent) in a watch glass containing few drops of distilled
water. The cellulose powder absorbed the water and the re¬
sulting doughy mixture was transferred to a gelatine capsule
(Parke Davies and Co., Hounsiow, London).
Such a capsule was administered to a rabbit using long
forceps to place it at the base of the tongue, while a balling
gun was used to infect sheep and calves.
3.4. Faecal examination
Faeceal samples from sheep and calves were examined for
£• hepatica eggs to establish maturity of flukes. The Sello-
tape (Sellotape Products Ltd., Borehamwood, Herts) modification
of the zinc sulphate flotation method (Sewell and Hammond, 1972)
was used. A suspension of 1 g of faeces in water was
centrifuged and the sediment was resuspended in saturated salt
solution and again centrifuged. The sediment was then re-
suspended in zinc sulphate solution of specific gravity 1.3,
so that the convex meniscus was slightly above the top of a
lipped plastic centrifuge tube. A short length of sellotape
was then placed flat over the top of the tube and pressed on¬
to the rim. After centrifugation at 1500 c[ for 3 minutes the
sellotape was examined under the microscope.
In this technique the concentration of the eggs on the
sellotape allows the detection of eggs at very low concentrations.
3.5. Collection of blood and serum
3.5.1. Rats
Rats were bled .from the tail using the following method:
A rubber bung was fixed around the neck of a plastic filter
funnel and silicone rubber tubing was used to attach a blood
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collecting vial to the neck of the filter funnel. The
funnel was then inserted into a conical flask with the vial
hanging inside the flask. The funnel was supported tightly
to the flask by means of the rubber bung (Plate 3.1.).
After light ether anaesthesia, the tail was swabbed with
xylol to engorge the blood vessels and then covered with a
thin layer of petroleum jelly to facilitate the flow of blood.
A small incision was made towards the tip of the tail leaving
sufficient space for succeeding bleedings. The rat was then
placed in the filter funnel with the tail extending down the
neck of the funnel. About 1 ml of blood was collected into
a 2.5 ml plastic vial containing disodium ethylenediamine
tetra-acetic acid (EDTA) (Becton, Dickinson, U.K. Ltd.,
Wembley, Middlesex) as anticoagulant.
For the preparation of serum, blood was collected in vials
without an anticoagulant, left overnight at 4°C and centrifuged
at 250O g for 20 minutes. Serum was then collected and kept
in plastic vials (Luckham Ltd., Labro Works, Burgess Hill,
Sussex) stored at -20°C.
3.5.2. Rabbits
A suitable site was shaved at the margin of the ear and
the ear veins were dilated by applying a little xylol. A 20 g
needle (Becton, Dickinson, U.K. Ltd., Wembley, Middlesex) was
inserted into one of the engorged peripheral veins and about
.1 ml of blood was collected into a 2.5 ml plastic vial con¬
taining EDTA.
For serum preparation blood was collected in a universal
bottle, allowed to clot and kept at 4°C overnight. It was then
centrifuged at 2500 g for 20 minutes and the serum was collected
Plate 3.1. Bleeding of a rat.
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and kept at -20°C.
3.5.3. Sheep and Calves
Blood was collected into a wide necked plastic jar from
the jugular veins of sheep and calves using 18 g disposable
hypodermic needles (Sherwood Medical Industries Ltd., Crawley,
Sussex) attached to silicone rubber tubing. The blood was
left for about an hour at 37°C to clot. To allow better re¬
traction, the clot was then cut into small pieces using a
sharp knife and kept at 4°C overnight. The exudate was then
centrifuged at 2SOO g for 20 minutes and the serum was collected
and kept at -20°C.
3.6. Fasciolicidal drugs
Deacetylated diamphenethide (7-bis-2-p-aminop'nenoxy-ethyl
ether) (Wellcome Research Laboratories, Berkhamsted, Herts.)
was used at 150 mg/kg body weight to eliminate young and adult
F. hepatica in rats. The drug was suspended in a small amount
of water and administered, by means of a pasteur pipette with
a piece of plastic tubing attached to the end, into the
oesophagus of a rat which had been lightly anaesthetised with
ether. A pilot experiment (4.1.) proved the efficiency of
deacetylated diamphenethide against immature and mature flukes
in rats.
Rabbits were treated with rafoxanide "Flukanide" (Merck,
Sharp and Dohme Ltd., Hoddesdon, Hertfordshire) at the rate of
26 mg/kg body weight. The dose was administered by stomach
tube. Bolbol (1975) had shown rafoxanide to be an effective
anthelmintic against the immature stages of F, hepatica
in rabbits.
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3.7. Post-mortem procedure and recovery of flukes from
rats and rabbits
Rats were lei lied with--ether and rabbits were lei lied by
an intravenous injection of Euthatal (Abbot Laboratories,
Queenborough, Kent).
The abdominal cavity of each animal was opened, the
liver carefully removed and the gross pathological changes
recorded.
Adult flukes were recovered by incising the main bile
ducts and, in rabbits, the gall bladders. Each liver was
sliced into small pieces about 1 cm square, which was kept in
saline at 37°C for about 3 hours. Flukes which emerged were
removed and the pieces of liver were then gently squeezed to
remove any remaining flukes. The total number of flukes re¬
covered from each liver was then recorded.
3.8. Implantation procedures
3.8.1, Source and maintenance of F. hepatica
Adult flukes used for implanting into rats were obtained
from experimentally infected rats killed with ether 8 weeks
after infection. Using sterile instruments, the abdominal
cavity of a donor rat was opened in a laminar air-flow
cabinet (Microflow Ltd., Fleet, Hants). The liver was re¬
moved, the bile duct opened and the flukes transferred into the
maintenance medium.
Adult flukes for implanting into rabbits were similarly
obtained from experimentally infected rabbits killed by an
intravenous injection of pentobarbitone sodium solvition
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("Euthatal" Abbot Laboratories, Queenborough, Kent) 8 weeks
after infection.
Flukes were maintained in sterile 199 tissue culture
medium at 37°C until transfer to recepient rats or rabbits.
3.8.2. Implantation of flukes
Pentobarbitone sodium at a rate of 25 mg per kg body
weight was used as an anaesthetic. It was given intra-
peritoneally in rats and intravenously in rabbits.
The right flank of each animal was shaved and cleaned
with chlorhexidine (Hibiscrub, Imperial Chemical Industries,
Macclesfield, Cheshire) followed by 70% ethyl alchol.
For subcutaneous implantation in rats and rabbits, an
incision about lOmm long was made in the skin and the sub¬
cutaneous tissue was separated with blunt-ended forceps.
The flukes were then carefully inserted into the site and the
skin clipped together with 2 or 3 Michel Suture Clips (12 x
2.5 mm) (Thackray Ltd., Leeds, London and Glasgow). The
wound was then dressed with sulphanilamide powder (Bayer,
U.K. Ltd., Bury St. Edmunds, Suffolk).
Intraperitoneal implantation of flukes was similarly con¬
ducted, except that the incised muscle layer was sutured with
silk ('Mersilk', Ethicon, Edinburgh) before clipping the skin,
3.8.3. Preparation and implantation of diffusion
chambers
Diffusion chambers were constructed under a laminar air¬
flow cabinet. Two membrane filters ('MF Filter', Miliipore,
U.K. Ltd., London) of pore size 0.45 um were moistened with
distilled water and blotted with absorbent paper to remove
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excess water. This made the filters swell slightly and
allowed them to form a taut cover when dry.
The filters were then glued with 'MF cement' (Millipcre,
U.K. Ltd., London) to each side of a sterile Plexiglass ring
O.14 mm internal diameter and 2 mm thickness (Millipore, U.K.
Ltd,, London).
For preparing chambers containing flukes, a moistened
filter membrane was glued to one side of the ring. A small
quantity of 199 tissue culture medium was then placed in the
chamber together with an adult fluke. The second filter mem¬
brane was then glued on the top of the ring.
The procedure of subcutaneous or intraperitoneal implantation
of diffusion chambers into rats or rabbits was similar to that
described for implantation of flukes.
3.8.4. . Killing of flukes
Mature flukes were killed before implantation by keeping
them at -20°C for 10 minutes.
3.9. Haematoloqical techniques
Blood samples in vials containing EDTA were well mixed in a
Matburn Cell Suspension Mixer (Matburn Ltd., London).
For total leucocyte counts an electronic cell counter
(Model FN, Coulter Electronics, South Dunstable, Bedfordshire)
was used according to the manufacturer's instructions.
Differential leucocyte counts were made using the Undritz
modification of the peroxidase staining method (Archer, 1965),
This method facilitates the differentiation of the heterophils
from the eosinophils, which are difficult to differentiate in
rabbits, using the usual Romanowsky stains (Purvis and
Sewell, 1973).
Absolute eosinophil counts were then calculated from the
percentage of eosinophils and total leucocyte counts.
3.10. Glutamic dehydrogenase assay (B.C. No, 1,4.1.3)
This was used as an indicator of liver damage (Sewell,
1967a)and carried out by Ford and Boyd's (1962) method. A "SP
1800" spectrophotometer (Pye Unicam, Cambridge) was used to
measure the oxidation of diphosphopyridine nucleotide (CPNH)
(Sigma Chemical Company Ltd., London) at a wavelength of 340 nm.
The reduction in optical density was recorded graphically on an
"AR2" Linear Recorder (Pye Unicam, Cambridge). A reduction
of optical density of O.OOl is equivalent to the oxidation of
-4
4.83 x lO moles of DPNH and the serum enzyme activity can
thus be expressed in micro-moles of product per litre of serum
per minute (i.u.s.).
3.11. Buffers
Unless otherwise stated, all buffers were prepared as
described by Dawson, Elliott, Elliott and Jones (1969).
3.12. Sterilization Procedures
Surgical instruments were sterilized in a hot air oven at
160°C for 2 hours. Glassxvare, plexiglass rings used for con¬
struction of diffusion chambers and the apparatus used for the
continuous-flow culture system were sterilized by autoclaving
at 15 lbs. pressure for 20 minutes.
Sodium hydrogen carbonate solution was sterilized by
filtration through a 25 mm diam., 0.22 um membrane filter
(Millipore U.K. Ltd., London) in a Swinnex filter holder
S3.
(Millipore U.K. Ltd., London). Before use the holder and
filters were assembled, wrapped in aluminium foil and auto-
claved at 15 lbs. pressure for 20 minutes.
3.13. Production of Somatic fluke antigen
Adult flukes collected from the bile ducts of rats or
rabbits were washed with physiological saline, chopped into
small pieces and homogenised, in about 5 volumes of sodium
carbonate buffer (0.1M, pH 9.6), with 0.02% Na N^, in a
universal bottle with a laboratory homogeniser (Silverson
Machines Ltd., Waterside, Chesham, Bucks.). The suspension .
was incubated at 4°C overnight and then centrifuged at 25CO g
for 20 minutes. The supernatant was then separated off ,
o
its protein content determined and stored at -20 C.
3.14. Production of metabolic antigen
A simplified version of the continuous-flow culture
system described by Lehner (1977) was used to produce metabolic
antigen from adult F. hepatica.
The culture medium comprised 1 volume of lOx concentrated
199 tissue culture medium (Gibco Bio-Cult, Paisley, Scotland)
in 9 volumes of sterile NaHCO^ solution. The NaHCO^
solution was prepared by dissolving 2.2 g of NaHCQ^ in a
litre of distilled water. Antibiotics added to the culture
medium comprised ICO i.u. benzyl penicillin per ml ("Crystapen",
Glaxo Laboratories Ltd., Greenford, England), 100 mg per ml
streptomycin/dihydrostreptomycin ("Dimycin", Glaxo Laboratories
Ltd., Greenford, England) and 2mg per ml amphotericin B
("Fungizone", E.R, Squibb and Sons, Incorporation, New York).
84.
The culture medium was kept in a 2 litre "Pyrex"
aspirator (Jobling Laboratory Division, Stone, Staffordshire),
which was closed by a silicone rubber bung. The aspirator
had a side-outlet at the bottom into which a silicone rubber
bung was inserted.
A peristaltic pump (Desaga PLG-multipurpose peristaltic
pump 13 2100, Camlab, Cambridge) was used to pump the culture
medium from the aspirator through fine bore silicone rubber
tubing into a 30cm length of 8mm flat-width nylon sleeving
(Portex Ltd., Hythe, Kent), in which the flukes were kept.
Each end of the nylon sleeving containing the flukes was
tightly fixed to stainless steel tubing by cuffs of silicone
rubber tubing, and the steel tubes were supported by clips on
a wooden frame.
The used medium containing the metabolic products was
then passed through fine bore tubing into a 250 ml conical
flask.
All joints in the system were sealed with silicone sealing
compound {"Aquaseal", Dow Corning, Windsor) thus preventing
leakages.
Two sets of the continuous-flew culture system were
assembled ana sterilized and 2 litres of culture medium at 37°C
were added to each aspirator in a laminar air-flow cabinet
(Microflow Ltd., Fleet, Hants). Thirteen adult flukes were
placed in the nylon sleeving of one set and 23 adult flukes
were placed in the other set.
The two systems were then transferred to the warm room at
37 C and the pump started with two channels, each supplying 16ml/
hour. When it was stopped after 6 days all the flukes were
still alive. The medium containing the metabolic products
from the two sets was pooled and concentrated using 50% poly-
ethelene glycol 6000 (BDH Chemicals Ltd., Poole, England). It
was then dialysed against several changes of phosphate
buffered saline (PBS) (pH 7.3) (Oxoid Ltd., London). The
protein content of the final product was 4.5 mg/ml.
3.15. Protein Estimation
The technique of Warburg and Christian (1941) was used
for the estimation of the protein content in the antigen and
gamma-globulin solutions. The extinction of an appropriately
diluted protein solution was measured at both 260 nm and 280 nm
on "SP 1800" spectrophotometer (Pye Unicam, Cambridge), and
the ratio E280/E260 was calculated. Using this ratio, a
factor (F) for the calculation of the protein concentration can
be read from a standard table (Warburg and Christian, 1941).
The protein concentration was calculated by the formula:-
Protein concentration (mg/ml) = Extinction at 280 nm x Fx
d
where d = length of light path in cm.
3.16. Serum gamma-globulin precipitation by sodium sulphate
The technique of Stelos (1967) was used to precipitate
serum gamma-globulin.
Eighteen grams of sodium sulphate were added per 100 ml of
serum at about 25°C. The precipitate was washed twice with lOO
ml of 18% sodium sulphate by centrifuging and discarding the
supernatant each time. The sediment was dissolved in 40 ml of
pH8 borate-buffered saline and the globulin solution again
precipitated by adding sodium sulphate to a concentration of
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12 g per lOO ml. The precipitate was then washed twice
more with lOO ml of 12% sodium sulphate.
The precipitate was then dissolved in 20 ml of pHS borate
buffered saline and the globulin reprecipitated by adding
sodium sulphate to a concentration of 12g per lOOml. The pre¬
cipitated globulins were finally dissolved in about 10 ml of
phosphate buffered saline (PBS) pH 7.3 (Qxoid Ltd., London)
solution and dialysed against the latter solution to remove
the sodium sulphate. The protein content of the sample was
then determined ana stored at -20°C.
Although a high yield (93%) of gamma-globulin can be
obtained by this method (Stelos, 1967), it was found to be in¬
convenient as the solubility is markedly temperature dependent.
Thus precipitation of gamma-globulin with ammonium sulphate
was preferred.
3.17. Serum fractionation with ammonium sulphate
Gamma-globulins were precipitated by adding saturated
ammonium sulphate to the serum to give a final concentration of
one third saturation, as described by Campbell, Garvey, Cremer
and Sussdorf (1970).
Saturated ammonium sulphate was prepared by stirring lOOO g
ammonium sulphate in a litre of distilled water at 50°C until
most of the salt was dissolved. It was then allowed to stand
overnight at room temperature. Just prior to use the pH was
adjusted to 7.8 using 2N NaOH or sulphuric acid, thus avoiding
foreign ions. Saturated ammonium sulphate solution was added
dropwise with continual stirring to two volumes of serum, to a
final concentration of one-third saturation. The suspension
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was stirred by a magnetic stirrer (Gallenkamp and Company
Ltd., London) for about 2 hours to avoid mechanical trapping
of serum components other than gamma-globulin in the
precipitate. Proteins were recovered by centrifugation at
2500 g for 30 minutes. The precipitate was then dissolved
in physiological saline to restore the original volume of
serum. The gamma-globulin fraction was further purified
by a second and third precipitation, after which the
precipitate was dissolved in O.OIM phosphate buffer (pH 6.8)
to a final volume half that of the original serum sample.
The ammonium sulphate was removed by dialysis against re¬
peated changes of O.OIM phosphate buffer (pH 6.8) for several
days at 4°C. The dialysate was checked for the presence of
sulphate ions by adding a few drops of 10% barium chloride.
If sulphate ions were present a white turbidity or precipitate
of barium sulphate formed in which case dialysis was continued.
The sulphate-free solution was centrifuged at 4°C for 3C
minutes at 1400 g to remove any insoluble material and the
protein content of the sample was then determined.
3.18. Immuno-precipitation
This was carried out using the LKB immunodiffusion
apparatus (LKB Instruments Ltd., South Croydon, Surrey) according
to the method described by Sewell (1966b).
One percent agar in barbiturate buffer was used. To
prepare this, 5.75 g diethyl barbituric acid and 3.75 g sodium
barbitone were dissolved in about 500 ml hot distilled water
and the solution was then made up to 2 litres. Five grams of
agar (Oxoid Ltd., London), 0.5 g sodium azide and 50 g sodium
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chloride were then dissolved in 500 ml of a solution made of
lOO ml buffer and 400 ml distilled water. The mixture was
boiled to dissolve the agar and the molten agar dispensed into
universal bottles and stored at 4°C to axvait use.
A semi-quantitative immuno-diffusion technique of
(Sewell, 1967b) was used to determine the concentration of
metabolic antigen which reacted completely with an equal
volume of antibody in the gamma-globulin solution.
Equal volume of several dilutions of gamma-globulin
solution and metabolic antigen solution were mixed in the
wells of a plastic haemagglutination tray. These mixtures
were then dispensed into a row of wells cut in the agar
using a modification of the LKB apparatus described by Sewell
(1966b). A parallel,but off-set row of wells contained an
indicator sys.tem, consisting of undiluted gamma-globulin
solution and metabolic antigen dispensed into alternate wells.
Any excess antibody or antigen was detected by the
deflection of the precipitation line between the upper and lower
rows of wells. The equivalence end-point was indicated by
an undeflected precipitin line.
3.19. Enzyme-linked immunosorbent assay (ELISA)
The microplate system described for ELISA by Ruitenberg,
Steerenberg and Brosi (1975) was used with some modifications.
A pilot experiment showed that the use of O-phenylenediamine
(O-diaminobenzene) dihydrochloride (OPD) (Sigma Chemical
Company Ltd. , London) in the substrate instead of 5 amino¬
salicylic acid (5AS) (Cambrian Chemicals Ltd., Croydon) made
the ELISA assays of serum samples from rats less expensive.
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The use of 5AS and Ho0^ as substrate required an enzyme con¬
jugate at a dilution of 1/50 whereas the enzyme conjugate
dilution needed for an assay using OPD and HO was only
1/400 (Appendix Tables 2.1, 2.2.); therefore OPD and H^O^
were used as the substrate for the assay of all serum samples
from rats and rabbits.
With the change of substrate it was found preferable to
double the periods of incubation in antiserum and enzyme con¬
jugate to 60 minutes. The period of incubation in the sub¬
strate however, was halved to 30 minutes because of the more
rapid development of the colour.
The assay procedure was as follows:
The wells of Titertek/Linbro polystyrene, flat-bottomed,
microtirre trays (Flow Laboratories Ltd., Irvine, Ayrshire)
were coated with 0.3 ml somatic antigen solution containing
4.5 ug/ml protein in O.IM sodium carbonate buffer (pH 9.6)
with 0.02% NaN^ (Appendix Tables 2.3, 2.4.). The trays were
then incubated for 3 hours at 37°C and stored at 4°C until
use. Before assay, the trays were washed 3 times, for 5 minutes
each time, with O.9% NaCl containing 0.05 % Tween 20
(Polyoxyethylene sorbitan monolaurate, Sigma Chemical Company
Ltd., London).
The optimum serum dilution for the assay of serum samples
from rats was 1/25 and that for samples from rabbits was 1/50
(Appendix Tables 2.5, 2.6.). Serum samples were diluted with
PBS containing 0.05% Tween 20 and O.Q2% NaN^ and 0.3 ml of
the diluted serum was added to each well. After incubation
for 60 minutes at 37°C, the trays were again washed 3 times,
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for 5 minutes each time, with 0.9% NaCl containing 0.05%
Tween 20.
The indicator enzyme was LC 1.11.1.7 horseradish
peroxidase (HRPO). When testing rat serum, horseradish
peroxidase - conjugated rabbit anti-rat IgG (Nordic Immuno¬
logical Laboratories, Maidenhead, Berks.) was used at a dil¬
ution of 1/50 or 1/400 depending on whether the substrate
used in the assay contained 5 AS or OPD. In the assay of
rabbit serum, horseradish peroxidase - conjugated goat anti-
rabbit IgG (Nordic Laboratories, Maidenhead, Berks.) was used
at a dilution of 1/sOO.
After incubation in the enzyme - conjugated anti-immuno-
globulin for 60 minutes at 37°C, trays were again washed 3
times for 5 minutes each time with 0.9% NaCl containing 0.05%
Tween 20. Then 0.3 ml of substrate was added to each well.
The substrates for horseradish peroxidase - conjugated
anti-immunoglobulin were either 5AS and H^O^ (Kuitenberg
et al. , 1975) or CPD and H O (Wolters, Kuijpers, Kacaki and
Schuurs, 1976). The former substrate was prepared by
dissolving 30 mg 5AS in lOOml hot distilled water and
adjusting to pH 6.0 with 1M NaOH prior to use. Nine volumes
of 5AS solution were then added to one volume of 0.05% HO
(30% w/v) to make the working substrate. With this substrate
the reaction was stopped after an hour by adding 0.025 ml
4M NaOH to each well and the absorbance of the solution was
measured at 449 nm on a SP 6 - 200 spectrophotometer (Pye
Unicam, Cambridge) using black walled microcells with a
lcm light path.
91.
The OPD substrate was prepared as follows:-
A buffer solution of O.IM citric acid and 0.2M Na„HPO
2 4
(pH 6.0), was made up, 35 mg OPD dissolved in 100 mi of the
buffer and 0.167 ml Ho0 (30% w/v) added. The trays con-
taining substrate solution were kept in the dark by wrapping
the container in aluminium foil. The reaction was stopped
after 30 minutes with 0.025 ml of 1M H^SO^ (Aristar). The
absorbance of the solution was measured at 460 nm on a Pye
Unicam spectrophotometer, using black walled microcells with
a 1 cm light path.
3.20. Absorption techniques
3 .20 ,1. Absorption of immune serum by direct contact
with adult flukes
Using sterile instruments in a laminar air-flow cabinet
(Microflow Ltd., Fleet, Hants.) 16 adult flukes were collected
from the bile ducts of infected rats and washed in sterile 199
o
tissue culture medium at 37 C. They were then placed in 160 ml
of immune bovine serum which had been sterilized by filtration
through 0.22 ^m membrane filter (Millipore U.K.) Ltd., London).
After 48 hours at 37°C, the flukes were removed and the serum
was refiltered as above and stored at -20°C.
3.20 .2. Absorption of immune serum by diffusible
antigens from encapsulated flukes
Adult flukes were encapsulated in diffusion chambers as
previously described. The procedure for absorption of immune
serum by direct contact was then repeated using these in place
of free flukes.
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3.20.3. Absorption of gamma-globulin from immune
serum by metabolic products
The metabolic products collected from adult flukes in
vitro (3.14.) were used to absorb gamma-globulin from immune
bovine serum. The concentration of metabolic antigen which
reacted completely with an equal volume of antibody in the
gamma-globulin was determined by the semi quantitative immuno¬
diffusion technique (Sewell, 1967b), (3.18 .)
*
CHAPTER 4
STUDIES ON THE STIMULATION OF RESISTANCE TO FASCIOLA HEPATICA
IN RATS AND RABBITS FOLLOWING PREVIOUS INFECTION AND TREATMENT
Introduction
In this chapter studies on the effect of previous immature
and mature infections, which had been eliminated by an
anthelmintic, on the resistance to challenge with F. hepatica
in rats and rabbits are described. Rats were chosen to
represent hosts that can give good resistance and rabbits to
represent those in which the development of resistance is
relatively inneffective. Immature and mature sensitising
infections were eliminated in rats and rabbits using
deacetylated diamphenethide and rafoxanide respectively.
The choice of the latter drug was based on the reports of
Bolbol (197S) and Coles (1975) that rafoxanide is an
effective fasciolicide in rabbits. However, the use of
deacetylated diamphenethide necessitated the following pre¬
liminary experiment:
4.1. The activity of deacetylated diamphenethide against
immature and mature F. hepatica in rats
Int roduction
The fasciolicidal activity of diamphenethide against all
stages of F. hepatica in sheep has been reported by Dickerson,
Harfenist and Kingsbury (1971) and Kingsbury and Rowland
(1972). Harfenist (1973) investigated its mode of action
and reported that diamphenethide is active by virtue of its
deacetylation in the liver to give an amino compound which is
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lethal to F. hepatica. However, Coles (1975) found that
the acetylated compound is inactive in the rat. He later
(.1976) reported that this lack of activity in the rat is
due to this animal's inability to deacetylate the drug to
the active moiety. This experiment was designed to confirm
the fasciolicidal activity of deacetylated diampnenethide
in rats.
Experimental design
Twelve rats were divided into 3 equal groups A, B and
C. They were all infected orally at day 0 with 20 meta-
cercariae of F. hepatica. Each rat in group A. was given an
oral dose of deacetylated diamphenethide at a rate of 150 mg/
kg body weight at the 4th and again at the 5th week after
infection. Group B was similarly treated at the 8th and 9th
week and group C was left untreated as a control for infection.
Peripheral eosinophil counts and serum glutamic dehydrogenase
levels were determined fortnightly and post-mortem examination
was carried out 10 weeks after infection.
Results
All rats survived until the end of the experiment. The
numbers of flukes recovered at post-mortem examination are
shown in Table 4.1., the peripheral eosinophil counts in
Appendix Table 4.1. and Fig. 4.1. and the serum glutamic
dehydrogenase assays in Appendix Table 4.2. and Fig. 4.2.
No flukes were recovered from groups A or B whereas some were
recovered from all the rats in the control group C.
Peripheral eosinophil counts and serum glutamic dehydro¬
genase levels in group C showed progressive elevation
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TABLE 4.1.
Post-mortem findings fron rats infected with 2C
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Fig.42. Serum Glutamic Dehydrogenase Assays.
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reaching peaks at the 4th week after infection. The levels
then fell steadily. A similar pattern was found in group
B which was treated at the 8th week wnen the levels of those
parameters were already fairly low. However, a sharp
somewhat premature drop in the levels for both parameters
was observed sifter treatment of the immature infection of
group A. The mean enzyme activities of group A were
significantly lower than those of group C from the second
to the 8th week after infection. (At the 2nd week, t =
2.55, PC0.05; at the 4th week, t = 3.40, P < 0.02; at the
6th week, t = 14.39, P< O.OOl, at the 8th week t = 4.75,
P< O.Ol) .
Discussion
Coles (1976) found that the free amine of diamphenethide
completely eliminated mature F. hepatica in rats but that
rat liver extracts failed to deacetylate diamphenethide.
The results of the present experiment confirmed that
deacetylated diamphenethide was entirely effective against
both immature and mature F. hepatica in rats. The
peripheral eosinophil counts and serum glutamic dehydro¬
genase assays were consistent with the post-mortem findings.
4.2. Stimulation of resistance to Fasciola hepatica
in rats by two previous immature infections and by
a mature infection eliminated in each case by an
anthelmintic
Introduction
There' is good evidence that rats can acquire the
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ability to resist superinfection (Ruther, 1963; Hayes,
Bailer and Mitrovic, 1972; 1973; 1974a; Goose and
Macgregor, 1973a; b; Doy, Hughes and Harness, 1978) and
that elimination of a mature sensitising infection by an
anthelmintic does not interfere with this resistance
(Goose and Macgregor, 1973a, b; Armour and Dargie, 1974).
However, the protective effect of sensitising immature in¬
fections, terminated by anthelmintics shortly before challenge
has not been investigated in rats. The following experiment
is designed to study such resistance and compare it with that
stimulated by mature infections terminated by anthelmintics.
Experimental design
Fortytwo rats were divided into the following groups:
A (14 rats), B (12 rats), C (8 rats), (4 rats) and
group (4' rats). Each rat in groups A and was
infected at xveek O with 20 metacercariae of F. hepatica. The
rats in group were the first infection controls and were
killed 8 weeks after infection. At the 4th week post¬
infection each rat in group A was treated with 150 mg/kg
body weight of deacetylated diamphenthide. This was repeated
at the 5th week, then at the 6th week the rats were reinfected
as at week O. Rats in group were used as controls for
this second infection and were killed 8 weeks later. At
week lO and 11 the rats in group A were treated with deacet¬
ylated diamphenethide as before and challenged with 20
metacercariae of F. hepatica at week 12. Post-mortem
examinations were carried out 8 weeks later.
lOO.
Group B received an infective dose equal to that of
group A at week 0, similar treatment with deacetylated
diamphenthide at weeks 10 and 11 (but not at weeks 4
and 5)j challenge at week 12 and necropsy 8 weeks later.
Group C was used as a control for the challenge infections
for groups A and B.
Peripheral eosinophil counts, serum glutamic dehydro¬
genase assays and antibody (ELISA) titres were determined every
two weeks until the end of the experiment.
Results
Fluke recovery
The mean number of flukes recovered from the first in¬
fection controls (group D^) was 2.5 - 0.5 and that from the
second infection controls (group D^) was 2.25 - 1.5.
The fluke burdens recovered from group A, B and C are
shown in Table 4.2. Statistical analysis revealed significant
reductions of 69% and 83% in groups A and B respectively as
compared with group C. However, no significant difference was
found between the numbers of flukes recovered from group A
as compared to those for group B.
Macroscopic lesions
The macroscopic lesions in the livers cf rats challenged
after treatment of 2 immature infections (group A, Plates 4.1.1.,
4.1.2.) were much more severe than those in the livers of
rats challenged after treatment of mature infections (group
B, Plates 4.2.1., 4.2.2.) or the livers of the challenge
controls (group C, Plates 4.3.1., 4.3.2.). Livers of
the rats in group A were generally congested and many
TABLE4.2.



























ByWilcoxon'stwo-sampletest: AvB,P>0.05,n.s. AvC,P<O.005 BvC,P<O.OOl
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Plates 4,1.1., 4.1.2. Macroscopic lesions in the
livers of rats challenged with 20 metacercariae of F. hepatlea
after treatment of 2 immature infections.
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Plates 4.2.1., 4.2.2. Macroscopic lesions in the livers
of rats challenged with 20 metacercariae of F. hepatica
after treatment of a mature infection.
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Plates 4.3,1., 4.3,2. Macroscopic lesions in the livers
of rats challenged with 20 raetacercariae of F. hepatica
for 8 weeks.
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had petechial or ecchymotic haemorrhages. They were hard
in consistency and fibrous adhesions were common between
adjacent lobes. Diffuse fatty changes as well as yellowish
necrotic foci gave many livers a mottled appearance. Necrotic
areas were commonly found at the edges of lobes. Some of the
necrotic areas protruded from the liver surface in a plaque¬
like or granular form. Also nodular growth was seen on the
visceral and parietal surfaces of many lobes. These nodules
were firm in consistency and were about 2-5mm in diameter.
The livers in group A were generally smaller than those in
group B and C. The nodularity was less marked in most
cases in the livers from group B while it was rarely seen in
the livers from group C.
The bile ducts containing flukes were generally thickened
and dilated. In many of the livers in group C this was the
only gross pathological change.
Eosinophil counts
The peripheral eosinophil counts are shown in Appendix
Table 4.3. and Fig. 4.3. Infection control groups C,
and showed progressive increases in eosinophil counts
until the 4th or 6th week. The eosinophil counts in groups
A and B increased after each infection and decreased after
each treatment but reached lower peaks softer challenge than
softer the initial infections.
Serum glutamic dehydrogenase assay
The serum glutamic dehydrogenase levels in the different
groups showed similar patterns to those of the eosinophil
counts. The data are given in Appendix Table 4.4. and Fig.
4.4. The enzyme levels reached a peak at the 6th week
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Fig.4-3. Peripheral Eosinophil Counts.
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Group A Rats infected
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Group C Rats challenged
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second infection controls.




























post-infection in all three infection control groups. The
enzyme levels in groups A and B were consistently elevated
after infections and reduced after treatments. The mean
enzyme levels in groups A and B were significantly lower
than those of the challenge control (group C) at the 4th and
6th weeks after challenge i.e. 16 and 18 weeks after the start
of the experiment (A v C at the 16th week, t = 4.2, P <0.001;
at the 18th week, t = 5.71, P <0.001; B v C at the 16th
week, t = 3.93, P<0.001; at the 18th week, t = 5.77,
P < O.OOl) .
Serology
ELISA values are shown in Appendix Table 4.5. and Fig.
4.5. Those for the control group C showed a progressive
elevation after infection up to the 8th week. The antibody
titres in groups A and B increased steadily after infection
despite the two treatments, to reach a plateau 14 weeks after
initial infection.
Discussion
The results show clearly that either immature or mature
infections which have been eliminated by anthelmintics can
stimulate resistance to challenge in rats. This resistance
was not only shown by a significant reduction in the number of
flukes recovered from previously infected and treated rats
but also by the less marked host response to challenge in¬
fection as indicated by lower eosinophil counts and lower
glutamic dehydrogenase levels. The level of resistance
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stimulated by the mature infection, as manifested by the
number of flukes recovered at necropsy may have been higher
than that initiated by two previous immature infections and
treatments but this difference was not significant.
Peripheral eosinophil counts
Although there was a consistently greater eosinophilic
response to primary infection than to subsequent infections
there was always some increase. Such an eosinophilia is a
characteristic feature of parasitic infections and Doy, Hughes
and Harness (1978) reported that eosinophils were prevalent
in the lamina propia of the small intestine of rats 3 weeks
after primary infection and increased markedly 48 hours
after challenge.
Serum glutamic dehydrogenase
Boyd (1962) observed a relationship between the increase
in serum glutamic dehydrogenase level and the extent of
hepatic necrosis due to carbon tetrachloride in sheep, cattle
and rats. However, he found that the increase in the serum
enzyme activity in the rat was comparatively lower than in
sheep and cattle despite the higher concentration of the
enzyme in the livers of rats. Accordingly, the author
suggested that a most sensitive indicator of hepatic necrosis
in the rat would be glutamic pyruvic transaminase (EC 2.6.1.2
Alanine aminotransferase).
The suitability of serum glutamic dehydrogenase as an
indicator of hepatic damage to fascioliasis was reported in
sheep by Sewell (1967 a) . This was confirmed by Hughes,
Treacher and Harness (1973) in goats and by Lehner (1977) in
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rats. The former authors attributed the surprising
results of Boyd (1962) to the fact that he used carbon
tetrachloride to produce the hepatic damage.
The present findings support those of Lehner (1977)
and also show the effect of repeated infections and treat¬
ments prior to challenge on the serum levels of this enzyme
in the rat. They indicate that the enzyme levels peaked
at the 6th week after infection. This is in agreement with
the findings of Thorpe (1965) that the maximum liver damage
is reached 6 weeks after infection in rats and that from
then on flukes enter the bile ducts and further marked
hepatic damage is unlikely to occur. Individual variation
in the period of hepatic migration may explain the difference
in the time of occurrance of maximum hepatic damage in
different rats.
Serum glutamic dehydrogenase levels recorded after
secondary infections were markedly lower than those following
initial infection, indicating less hepatic damage.
Campbell and Barry (1970) reported that serum glutamic -
oxalo-acetic transaminase (EC 2.6.1.1 Aspartate amino¬
transferase) levels in rats decreased after treatment and
suggested the use of assays for this enzyme in the selection
of compounds effective against liver flukes. However, it
would seem that serum glutamic dehydrogenase may be a
better alternative for this purpose since it is a liver
specific enzyme.
Serology
The enzyme-linked immunosorbent assay (ELISA) of
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Engvall and Perlmann (1971) was first used in the sero-
diagnosis of Trichenella spiralis by Ruitenberg, Steerenberg,
Brosi, Buys, Ljungstrom and Engvall (1974). The use of this
test in serological studies of many other parasitic diseases
has been reviewed by Voller, Bartlett and Bidwell (1976).
However, ELISA has only recently been used for the assay of
antibodies to F. hepatica by Lehner (1977) in rats, rabbits,
sheep and cattle sera and by Burden and Hammet (1978) in
bovine serum.
Lehner (1977) reported that metabolic products derived
from adult flukes iri vitro did not protect rats from challenge
with F. hepatica . Booster vaccine injections in such
vaccinated rats failed to produce an anamnastic response. He
found that after challenge the antibody titres of the
vaccinated groups did not rise in proportion to those of the
control groups. Sometimes the rise in the titres of the
vaccinated rats was even less than that of the controls.
However, the present results indicate that the rats which
acquired resistance to challenge by curtailed previous immature
or mature infections had a different serological response, as
measured by ELISA, from that of Lehner's rats vaccinated with
metabolic products. The ELISA values continued to rise
until 14 - 18 weeks after initial infection in all the groups.
4.3. Stimulation of resistance to Fasciola hepatica in
rabbits by two previous infections eliminated by
an anthelmintic
Introduc ticn
Bolbol (1975) reported that while a single previous in-
fection curtailed by treatment failed to stimulate resistance
to F. hepatica in rabbits, 2 previous infections and treatments
resulted in a significant reduction in the number of flukes
recovered after challenge. The following experiment was
designed to confirm these findings.
Experimental design
Seventeen rabbits were divided into 4 groups, A (6 rabbits),
B (7 rabbits), C (2 rabbits) and D (2 rabbits). Each rabbit in
groups A and C was infected with 10O metacercariae of F. heoatica
at day O. The rabbits in group A were then treated with rafox-
anide at 26 mg/kg body xveight at the 4th and again at the 5th
week after infection. At the 6th week the rabbits in this group
and those in group D were infected with 100 metacercariae. The
rabbits in group A were again treated with rafoxanide at the 10th
and 11th week, and challenged, together with the rabbits in group
B, with lOO metacercariae at the 12th week. The latter group
formed the control for the challenge infection. Peripheral
eosinophil counts, serum glutamic dehydrogenase levels and anti¬
body titres were determined fortnightly. Post-mortem examination
of all rabbits was carried out 8 weeks after their final infection.
Results
Fluke recovery
The numbers of flukes recovered from the previously in¬
fected rabbits (group A) and challenge controls (group B) are
recorded in Table 4.3. There was a reduction of 33% in the
number of flukes recovered from group A compared to group B
but this difference was not significant. The mean number of
"f* "f"
flukes recovered from groups C and D were 30-2 and 28-8
respectively.
TABLE4.3.





















The gross pathological changes found in the livers of
the three infection control groups are shown in plates
4.4., 4.5. and 4.6. They included congestion, enlarge¬
ment, fatty changes, fibrinous adhesions on the surfaces of
all lobes and yellowish or brownish debri in the dilated and
thickened bile ducts. Whitish necrotic foci and strands
of fibrous connective tissue gave the livers a characteristic
appearance. The pathological changes in the livers of
the repeatedly infected rabbits (group A) were more severe
(Plates 4.7.1., 4.7.2., 4.7.3., 4.7.4.). There were
more adhesions and some of the livers were hard to cut due to
fibrosis. Granulomas about 1 cm in diameter containing rem¬
nants of flukes as well as greenish caseated material protruded
from the surfaces of many lobes. The livers in this group
had a fleshy appearance.
Peripheral eosinophil counts
The peripheral eosinophil counts are shown in Appendix
Table 4.6. and Fig. 4.6. These were clearly influenced by
infection and treatment. The mean eosinophil counts of
group A progressively increased after infection up to the
4th week when the first treatment was administered. They
then dropped slightly but increased again after the second
infection. A steep decrease after the second treatment was
followed by a steady increase after challenge infection. The
challenge infection controls showed progressive increase in
mean eosinophil counts until they were killed after 8 weeks.
The eosinophil counts of the first and second infection
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Plates 4.4. and 4.5. Macroscopic lesions in the
livers of rabbits challenged with lOG metacercariae
of F. hepatica for 8 weeks.
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Plate 4.6. Macroscopic lesions in the livers of
rabbits challenged with lOO metacercariae of F. hepatica
for 8 weeks.
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Plates 4.7.1., 4.7.2. Macroscopic lesions in the livers of
rabbits challenged with lOO metacercariae of F. hepatica for
8 weeks after treatment of 2 immature previous infections.
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Plates 4.7.3., 4.7.4, Macroscopic lesions in the livers
of rabbits challenged with lOO metacercariae of F. hepatica
for 8 weeks after treatment of 2 immature previous infections.
120.
Fig.4 6. Peripheral Eosinophil Counts.
Group A. Rabbits infected at
weeks 0 and 8, treated at
weeks 4 and 10 and































Group C-tt First infection
controls.
Group Diai Second infection
controls.
I Infection with 100
metacecercaria or Fhepatica.
T Treatment with rafoxanide
(26mg/kg).
2 4 6 8 10 12 14
Weeks Post Infection.
controls both showed a progressive increase after infection
reaching a peak at the 6th week with a decrease afterwards.
Serum-qlutamic dehydrogenase assay
The enzyme assays axe recorded in Appendix Table 4.7.
and Fig. 4.7. Mean levels in all the infection controls
(groups B, C and D) showed progressive elevation up to the
6th week followed by a fall at the 8th week. Also, the
mean enzyme levels in the repeatedly infected rabbits
(group A) rose up to the 4th week, with a slight drop 2 weeks
after the first treatment. Mean levels rose again after
the second infection, followed by a considerable decrease 2
weeks after the second treatment. A much smaller rise was
observed after challenge infection, peaking at the 6th week
with a drop in the 8th week. The mean levels in group A were
significantly lower at the 4th week (t = 5.00, P<0.001) and
the 6th week (t = 5.50, P< O.OOl) after challenge infection
than those in the challenge infection controls (group B).
Serology
ELISA values are shown in Appendix Table 4.8. and Fig.
4.8. The mean values of the first infection controls rose
rapidly up to the 4th week and then remained constant until
the 8th week. However, the mean ELISA values of the second
infection controls and challenge controls shewed a slow but
progressive increase until the 8th week after infection. The
mean ELISA values of group A rose steadily despite treatment
and reinfection to reach a fairly constant plateau by the
lOth week, although the highest activity reached was
observed in the last week, 20 weeks after initial infection.


























































Fig. 4-8. ELISA Values.
Group A— Rabbits infected
at weeks 0 and 6. treated
at weeks 4 and 10 and
challenged at week 12.
Group B Challenged at
week 12.
Group C »»» First infection
controls.
Group D • a • Second
infection controls.
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The results of this experiment will be discussed with
those of the following experiment.
4.4. Resistance to Fasciola hepatica in rabbits after
treatment of a mature infection
Introduction
In the previous experiments it was found that whereas
two sensitising infections which had been treated while the
flukes were still immature in the parenchyma failed to
stimulate a significant resistance to challenge in rabbits,
a similar procedure in rats elicited significant resistance.
A slightly higher (though insignificant) level of resistance
appeared to have been found in rats when the sensitising in¬
fection was removed after maturity. An experiment was
therefore designed to find out whether the removal of a mature
sensitising infection has a similar effect in rabbits.
Experimental design
Sixteen rabbits were divided into 3 groups, A, B and C.
Each of the 6 rabbits in group A was infected with 100
metacercariae of F_. hepatica at week O together with the two
c
rabbits in group B. These latter were the infection controls
for group A. Eight weeks later group A was treated with
rafoxanide at 26 mg/kg body weight while group B was
necropsied. At week 10, the rabbits in group A were
challenged with ICO metacercariae each together with the 8
&
rabbits of group C. Necropsy was carried out 8 weeks after
challenge. - Peripheral eosinophil counts and serum glutamic
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The mean number of flukes recovered from the first
4-
infection controls (group C) was 44 - 2.8. The numbers
of flukes recovered from groups A and B are recorded in table
4.4. There was no significant difference between the numbers
of flukes recovered from these groups.
Macroscopic lesions
The gross lesions were similar in the livers of rabbits
in both groups A and B. These are shown in Plates 4.8 .1. ,
4.8.2. and Plates4.9.1., 4.9.2., and were similar to those seen
in the rabbits which had received single control infections
in the previous experiment. Adhesions were found over the
surface of the hepatic lobes. Fatty changes, necrotic areas
and fibrous networks were characteristic. Large granulomas
covered with adhesions were also observed. They had
yellowish thick fibrous capsules, containing greenish debri
and sometimes yellowish necrotic material resembling solid
fat as well as fluke remnants. The bile ducts were
enlarged and their walls were thickened.
Peripheral eosinophil counts
These are shown in Appendix Table 4.9. and Fig. 4.9.
Eosinophil counts of groups A and B rose steadily to reach
a peak at the 6th week after challenge. There was no clear
difference between the two groups.
TABLE4.4.


















Plates 4,8.1., 4.8.2. Macroscopic lesions in the livers
of rabbits challenged with 100 metacercariae of F. hepatica
for 8 weeks after treatment of a mature infection.
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Plates 4.9.1., 4.9.2. Macroscopic lesions in the livers
of rabbits challenged with lOO metacercariae of F. hepatica
for 8 weeks.
Fig 4-9. Peripheral Eosinophil Counts.
Weeks Post Infection.
Group A____ Rabbits challeged at week
0 after treatment of an 8- week
primary infection.
Group 8 Challenge controls.
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Serum glutamic dehydrogenase
The results of the enzyme assays are shown in Appendix
Table 4.10. and Fig. 4.10. Again the levels of the enzyme
in both groups A and B rose similarly and steadily to a
peak at week 6. There was no significant difference
between the mean enzyme levels in the two groups at any
time.
Discussion
Contrary to the findings in rats, neither two immature
nor one mature infection which had been eliminated by
anthelmintics were capable of stimulating a significant
resistance to challenge in rabbits. However, the two
previous immature infections did result in a reduction of
33% in the challenge infection. Taken together with
Bolbol's (1975) findings, this supports his suggestion
that such a reduction may be due directly to the structural
changes including the fibrosis caused by the repeated
immature infections. It i3 probable that such a reduction
did not occur in the rabbits challenged after treatment of
a single mature infection because of the lesser degree of
damage produced by the latter. Bolbol (1975) also found
that a single immature infection did not cause a reduction
in the number of flukes developing after challenge. It is
also possible that the hepatic parenchymal regeneration
after the localisation of the flukes in the bile ducts will
have further reduced any impediment to the development of
the invading flukes of the challenge infection.
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Weeks Post Infection.
Group A__ Rabbits challenged at
week 0 after treatment of an 8-
week primary infection.
Group B Challenge controls.
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Peripheral eosinophil counts
Furmaga, Gundlach and Sobieszewski (1975) reported
that the leucocytic changes in sheep ana rabbits infected
with Fasciola are similar and that the quantitative changes
in eosinophils during the different stages of the infection
are similar to those in the total leucocyte counts. They
reported that a marked eosinophilia occurs between the
third and the tenth weeks of infection but this is
followed by a fall. The present experiment confirms
these findings in rabbits as well as similar findings by
Bolbol (1975). The observation that eosinophil counts are
readily influenced by treatment has also been reported by
Sinclair (1973) in sheep and by Bolbol (1975) in rabbits.
However, previous immature or mature infections in rabbits
did not appear to influence the eosinophil response to
challenge infection; the response in the repeatedly in¬
fected animals and infection controls being similar.
Serum glutamic dehydrogenase
The suitability of serum glutamic dehydrogenase as a
measure of liver damage in rabbits was not only indicated
by the progressive elevation of the enzyme levels during
the parenchymal migration phase but also by the influence
of the level of infection. Even the insignificant re¬
duction in the number of flukes which developed from the
challenge infection in rabbits with 2 previous infections
was accompanied by a concomitant decrease in the enzyme
level•
Serum glutamic dehydrogenase levels generally peaked
6 weeks after infection. This probably coincides with
the period of maximum liver damage which is followed by
rapid repair after the localisation of the flukes in the
bile ducts. Such observations were also reported by
Sewell (1966a) .
Serology
Although the ELISA values were higher after challenge
in the repeatedly infected rabbits than in the controls, the
level of resistance obtained was not significant. Hence,
these antibodies do not appear to be protective. Sinclair
and Kendall (1969) also showed that while rabbits are
capable of producing precipitating antibodies in high con¬
centrations, these were also not protective.
It was perhaps surprising that ELISA values continued
to increase after treatment. However, a similar obser¬
vation has been made by Hillyer and Diaz (1976) studying
precipitins. They reported that in rabbits infected with
F, hepatica and treated with rafoxanide a further slight
rise in precipitin titres occurred but this was followed by
a rapid fall. Also Be'nex, Guilhon and Barnabe' (1973)
reported similar findings using a fluorescent antibody
technique in sheep treated with bithionol sulphoxide.
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CHAPTER 5
STUDIES ON RESISTANCE TO FASCIQUA HEPATICA IN RATS AND
RABBITS INDUCED BY IMPLANTED FLUKES
The experiments described in chapter 4 indicated that the
non-specific hepatic changes caused by previous infections may
not be the only factors responsible for the resistance to
challenge with F. hepatica in rats, although this may be
true in rabbits. The following experiments were carried out
to confirm this and to show that specific factors derived from
the flukes are involved in this resistance.
5.1. The immune response of rats to subcutaneous implantation
with mature F, hepatica
Introduction
In this experiment mature flukes were implanted sub-
cutaneously into rats to see whether resistance to oral
challenge can be stimulated in the absence of the hepatic in¬
flammation and fibrosis which follow primary oral infections,
Experimental design
Twenty rats were divided into 2 groups, A (12 rats) and
B (8 rats). Rats in group A were each implanted subcutaneously
with 1 or 2 mature flukes. Two weeks later each rat in both
groups was orally infected with 20 metacercariae of F. hepatica.
Peripheral eosinophil counts and serum glutamic dehydro¬
genase activities were determined fortnightly. Post-mortem
examination was carried out 8 weeks after challenge.
Results
At post-mortem examination all the implanted flukes were
found to be dead within a fibrous cyst.
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Fluke recovery
This is shown in Table 5.1. A highly significant re¬
duction was found in the numbers of flukes recovered from the
implanted rats compared with those from the non-implanted
controls.
Peripheral eosinophil counts
These are shown in Appendix Table 5.1. and Fig. 5.1. The
counts increased after infection in both groups, reaching a
peak in the non-implanted rats at the 6th week. In the im¬
planted rats a lower peak was reached 4 weeks after infection.
Serum glutamic dehydrogenase assay
The results are shown in Appendix Table 5.2. and Fig. 5.2.
In both groups the enzyme level increased, reaching a peak at
the 4th week. However, the increase was much reduced in the
implanted rats and the difference between the mean enzyme
levels in the two groups was significant at the 4th (t = 2.70,
PC 0.02) and 6th (t = 3.14, PcO.Ol) weeks.
Discussion
The results of this experiment will be discussed together
with those of the next experiment.
5.2. The immune response of rabbits to subcutaneous in-
plantation with mature F. hepatica.
Experimental design
Thirteen rabbits were divided into 2 groups, A (8 rabbits)
and B (5 rabbits). Rabbits in group A were each implanted
subcutaneously with 2, 3 or 5 mature flukes and were challenged
2 weeks later-, together with those in group B, with 100 meta-
cercariae each of F. hepatica. Peripheral eosinophil counts
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and serum glutamic dehydrogenase activities were determined
fortnightly. All rabbits were necropsied 8 weeks after
challenge.
Results
At necropsy there were no cysts, similar to those found
in rats, around the dead implanted flukes.
Fluke recovery
This is shown in Table 5.2. There was no significant
difference in the numbers of flukes recovered from the im¬
planted and non-implanted rabbits.
Peripheral eosinophil counts
These are recorded in Appendix Table 5.3. and Fig. 5.3.
Infection was followed by a progressive increase of eosinophil
counts reaching a peak at the 6th week in both groups with only
slightly higher counts in the non-implanted group, except at
six weeks after infection. Even then the difference was not
significant.
Serum glutamic dehydrogenase assays
These are shown in Appendix Table 5.4. and Fig. 5.4.
Infection was followed in both groups by a progressive
elevation of the enzyme level with maximum values at the 6th
week. There was no significant difference in the mean enzyme
levels in the two groups.
Discussion
Subcutaneous implantation of adult flukes stimulated a
significant resistance to oral challenge in rats. This was
shown by a significant reduction in the fluke burden and lower
glutamic dehydrogenase levels indicating little liver damage.
On the other hand, in rabbits there was no evidence of resistance.
137 c
TABLE 5.1.
The immune response of rats to subcutaneous implantation





Nos. of flukes recovered
at PM
Individual mean + s.d.
Implanted with 1 or 2
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By Wilcoxon's two-sample test:
A v B. P< O.OOl
TABLE 5.2.
The immune response of rabbits to subcutaneous implantation





Nos. of flukes recovered
at PM
Individual I mean - s.d.
Implanted with 2, 3 or
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By Wilcoxon's two-sample test:
A v B, P>0.05 n.s.
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Fia.5-1. Peripheral Eosinophil Counts.
Group A__ Rats implanted S/C
with living flukes before challenge.
Group B Infection control group.
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fig.-5A
Implantation Experiment in Rats - Glutamic Dehydrogenase Levels.
c
2
Group A __ Implanted s/c with living
flukes before challenge.
Group B Infection control.
2 3 4 5 6
Weeks after Infection.
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Fig. 5 3- Implantation Experiment in Rabbits-Peripheral Eosinophil Count.
A __ Group of rabbits implanted
s/c with living flukes.
































Group A _ Rabbits implanted s/c with
living flukes before challenge.
Group 6 Infection control.
2 3 4 5 6
Weeks after Infection.
♦
These findings confirm that resistance can be stimulated in
rats in the absence of hepatic inflammation and fibrosis
induced by primary infections. However, it is not possible
at this stage to tell whether this resistance is stimulated
by metabolic products, eggs from the mature flukes or by
factors in the tegument of the fluke. The fact that sub¬
cutaneous implantation fails to stimulate resistance to
challenge in rabbits supports the previous conclusion that the
mechanical barrier which follows primary infection is probably
responsible for any reduction in the number of flukes from
challenge, where this occurs.
5.3. The effect of intraperitoneal implantation of mature
flukes contained in diffusion chambers on the immune
response of rats
Introduction
This experiment was carried out to see whether the metabolic
products which are released from flukes will stimulate resistance
to challenge in the absence of direct contact between the im¬
planted flukes and the host tissues, thus excluding any effects
due to the fluke tegument. At the same time it was designed
to investigate the immune response due to direct intra¬
peritoneal implantation of mature flukes. Since rabbits had
shown no evidence of resistance due to subcutaneous implantation
in the previous experiment, subsequent implantation experiments
were undertaken only in rats.
A pilot experiment was first carried out to see whether
the flukes inside diffusion chambers survive up to the time of
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challenge i.e. 2 weeks after implantation. In this experi¬
ment diffusion chambers containing adult flukes were implanted
intraperitoneally into 8 rats. Two of these were selected
at random and killed at the 2nd, 5th, 7th and 14th day after
implantation. The diffusion chambers were then taken out
and examined. All the flukes were found to be alive. A
diffusion chamber in the peritoneal cavity of a rat is shown
in Plate 5.1.
Experimental design
Thirtynine rats were divided into 5 groups, A (12 rats),
B (8 rats), C (7 rats), D (6 rats) and E (6 rats). Group A was
implanted intraperitoneally with 1 or 2 living adult flukes in
diffusion chambers and group B was similarly implanted with
empty chambers. Group C was left as the unimplanted control
group, while group D was implanted intraperitoneally with 1 or
2 dead flukes in chambers. Finally group E was implanted intra¬
peritoneally with 1 or 2 un-encapsulated mature flukes. Serum
was collected at days 2, 5, 7, 9, 11 and 14 after implantation
to examine for precipitating antibodies. Rats in all groups
were each challenged with 20 metacercariae of F. hepatica 2
weeks after implantation. Serum glutamic dehydrogenase
activity was determined fortnightly and post-mortem examination
was carried out 8 weeks after challenge.
Results
At post-mortem examination both the directly implanted
flukes and the flukes in chambers were found to be dead and en¬
cysted.
Fluke recovery
This is shown in Table 5.3. A significant reduction in
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Plate 5.1. A diffusion chamber in the peritoneal
cavity of a rat.
TABLE5.3.
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the numbers of flukes recovered from rats implanted with adult
flukes in chambers was found compared to those from rats im¬
planted with empty chambers, those from rats implanted with
dead flukes in chambers, or those from non-implanted rats.
Similarly, a significant reduction was found in the numbers
of flukes recovered from rats directly implanted with adult
flukes in the peritoneal cavity compared with those from non-
implanted rats. However, no significant difference was
found between the numbers of flukes recovered from rats im¬
planted with flukes in chambers and from those implanted
directly without encapsulation. Also no significant differences
were found between the numbers of flukes recovered from rats
implanted with dead flukes in chambers, from those implanted
with empty chambers, or from non-implanted rats.
Serum glutamic dehydrogenase assays
These are recorded in Appendix Table 5.5. and Fig. 5.5.
The enzyme levels in all groups progressively increased after
infection reaching a peak at the 4th week. However, the peak
levels were significantly lower in the groups implanted
directly with living flukes or with living flukes in chambers
than in the other three groups. (A v B at the 4tn week, t = 3.41,
P<0.01; at the 6th week, t = 2.83, P<0.02. A v C at the 4th
week, t = 3.38 , P<0.01; at the 6 th week, t = 2.67, P < O .02.
A v D at the 4th week, t = 5.86, P<O.0Ol; at the 6th week, t
= 6.56, P<O.0Ol. E v C at the 4th week, t = 2.74, PdD.02; at
the 6th week, t = 3.13, PCO.Ol. There were no significant
differences in the mean enzyme levels of A v E, C v D, or
B v C at any time).
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The Effect of l/P Implantation of Mature Flukes in Diffusion Chambers
on the Immunity to F. hepatica in Rats. Serum Glutamic Dehydrogenase Levels.
Fia. 5.5.
Rats implanted l/P with 1 or 2 mature flukes in chambers.
a a Rats implanted l/P with empty chambers.
Non-implanted infection controls.
* * Rats implanted l/P with 1 or 2 dead flukes in chambers.
Rats implanted l/P with 1 or 2 mature flukes.




Precipitation lines in agar first appeared five days
after implantation with living flukes whether or not the
flukes were encapsulated in chambers. They did not appear
after implantation with dead flukes in chambers.
Discussion
It is clear that mature F. hepatica implanted intra-
peritoneally or subcutaneously will stimulate an immune re¬
sponse which is protective to rats against challenge infections.
The fact that this protective immunological response was
also found in rats implanted with living flukes in diffusion
chambers (but not with dead flukes) indicates that this
response can be stimulated by soluble metabolic products before
the death of the flukes within the chambers. It also indicates
that cellular contact between host and parasite is not necessary
for the stimulation of resistance. Furthermore only a
relatively small quantity of antigenic material is required,
since resistance was stimulated by metabolic products from one
or two flukes over a relatively short time.
5.4. The effect of subcutaneous implantation and removal
of mature flukes in diffusion chambers on the immune
response to F. hepatica by rats
Introduction
This experiment was carried out to confirm that the meta¬
bolic products from living flukes released into the subcutaneous




Fortytwo rats were divided into 6 groups, A (8 rats),
B (9 rats), C (5 rats), D (5 rats), E (8 rats) and F (7 rats).
Rats in group A were implanted subcutaneously with 2 mature
flukes in chambers and group B was similarly implanted with
empty chambers. Group C was implanted subcutaneously with
mature flukes in chambers and group D was similarly implanted
with empty chambers. Similarly group E was implanted intra-
peritoneally with mature flukes in chambers and group F was
implanted with empty chambers. Two weeks later the chambers
were removed from the rats in groups A and B. The rats in the
six groups were then each challenged with 20 metacercariae of
F. hepatica. Serum glutamic dehydrogenase activity was
determined fortnightly and post-mortem examination of all six
groups was cdrried out 8 weeks after challenge.
Results
At post-mortem examination the chambers in the sub¬
cutaneous tissues and intraperitoneal cavity were encysted and
all flukes inside them were dead. In contrast the flukes
present in the chambers removed from the rats in group A, 2
weeks after implantation, were all still alive.
Fluke recovery
The numbers of flukes recovered from the rats are shown
in Table 5.4. A significant reduction was found in the
numbers recovered from the rats in group A compared with those
from group B. Significant reductions were also found in the
fluke burdens in group C and E when compared with those
recovered in the control groups D and F respectively. In
TABLE5.4.
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contrast there were no significant differences between groups
A, C and E and between groups B, D and F respectively.
Serum glutamic dehydrogenase assays
These are recorded in Appendix Table 5.6. and Fig. 5.6.
The enzyme levels in all groups progressively increased after
infection to a peak at the 4th or 6th weeks. However the
peaks were significantly lower in the groups of rats implanted
with living flukes compared with the controls (A v B at the 4th
week after infection, t = 7.47, P < O.OOl; at the 6th \veek,
t = 5.56, P< O.OOl. C v D at the 4th week, t = 2.41, P < 0.05;
at the 6th week, n.s. E v F at the 4th week, t = 5.93, P <O.OOl;
at the 6th week, t = 5.39, P <0.001. There were no significant
differences between the enzyme levels ofAvC, AvE, B vD,
B v F or D v F at any time.
Discussion
The results of this experiment will be discussed with
those of the next experiment.
5.5. The effect of repeated intraperitoneal implantations
of mature flukes encapsulated in diffusion chambers
on the immune response to F. hepatica by rats
Introduction
This experiment was carried out to see whether the level of
resistance can be increased by repeating the immunogenic
stimulus.
Experimental design
Thirteen rats were divided into two groups A (7 rats) and B
(6 rats). Group A was implanted intraperitoneally with single



























set of S/C Implantation and Removal of Mature Flukes in Chambers
Immunity to F. hepatica in Rats. Serum Glutamic Dehydrogenase Levels.
Rats implanted S/C with 2 mature flukes in
chambers, removed before challenge.
a a a a Rats implanted S/C with 2 empty chambers,
removed before challenge.
a a a a Rats implanted S/C with 2 mature flukes in chambers.
Rats implanted S/C with 2 empty chambers.
o o ooo Rats implanted l/P with 2 mature flukes in chambers.
Rats implanted l/p with 2 empty chambers.
1 2 3 4 5 6 7 8
Weeks after Infection.
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previous experiment (5.4.). Group B was similarly implanted
with empty chambers. Similar chambers with or without living
flukes were implanted again in the respective group 12 weeks
later. Two weeks after these second implantations each rat
in both groups was infected with 20 metacercariae of
F. hepatica. Serum was examined weekly after the first and
second implantations for precipitating antibodies. Serum
glutamic dehydrogenase activity was determined fortnightly
after challenge and post-mortem examination was carried out
after 8 weeks.
Results
At post-mortem examination the chambers were found within
cysts and the flukes were dead.
Fluke recovery
This is shown in Table 5.5. A very highly significant
reduction was found in the numbers of flukes recovered from
the rats in group A compared with those in group B. The level
of resistance (91%) in group A was higher than that in group E
(67%) of the previous experiment (5.4) in which rats were im¬
planted on one occasion and challenged after 2 weeks.
Serum glutamic dehydrogenase assays
These are recorded in Appendix Table 5.7. and Fig. 5.7.
The level of the enzyme in the control group showed a
progressive elevation following infection reaching a peak at
the 6th week. However, in the implanted group there was
only a slight increase at the 6th week in one rat, the enzyme
levels in the others being within the normal range. There
TABLE5.5.

















Fig. 5 7. Serum Glutamic Dehydrogenase Assays.
Group A Rats implanted l/P with
2 mature flukes in chambers twice at
an interval of 12 weeks before chalieng<

















was a highly significant difference between the mean enzyme
levels of the implanted and control groups at the 4th and 6th
weeks after infection (A v B at the 4th week after infection,
t = 8.75, PcO.OOl; at the 6th week, t = 8.68, PcO.OOl).
Serology
Precipitating antibodies were detectable in all rats in
Group A by the week after the first implantation and continued
to be detected up to the 11th week. In the 12th week they
could be detected only in the serum of one rat. However, a
week after the second implantation the sera of all implanted
rats again contained precipitating antibodies.
Discussion
The fact that resistance could be induced by implanting
single flukes in diffusion chambers and removing them within
2 weeks confirms that only small amounts of metabolic products
are necessary to stimulate a significant resistance to challenge.
This resistance develops whether the antigens are released into
the subcutaneous tissues or into the peritoneal cavity. It has
also been shown that the serological response diminishes with
time and may no longer be detectable after 12 weeks. How¬
ever, it can be restored by restimulation with the antigen and
this also appears to result in a higher level of resistance
than that initiated by the initial stimulus. In this respect,
the experiment was not strictly controlled (as the challenge
infections were not given at the same time or from the sane
pool of metacercariae) but the level of resistance (91%)
obtained following the double implantation procedure was greater




STUDIES ON THE PASSIVE TRANSFER OF RESISTANCE TO FASCIOLA
HEPATICA IN RATS AND RABBITS
Introduction
It was concluded from the work described in the previous
chapters that soluble immunologically active factors play a role
in the resistance of rats to F, hepatica although no evidence
for this was found in rabbits. However, these factors could be
stimulating either a humoral or a cellular response, or perhaps,
both are involved. Experiments were therefore designed to
study the protective effect of circulating antibodies passively
transferred into rats and rabbits.
6.1. Passive transfer of resistance to F. hepatica in rats
by immune homologous serum
Experimental design
Twentysix rats were divided into 3 groups, A (12 rats),
B, (8 rats) and C (6 rats). Each rat was infected with 20
metacercariae of F. hepatica. Immediately after infection the
rats in group A were each injected intraperitoneally with 10 ml
of immune serum from rats which had been infected with 20 raeta-
cercariae 8 weeks previously. This was repeated 2 days later,
Group B was similarly twice injected with normal homologous
serum, while group C was left as the challenge control.
Peripheral eosinophil counts and serum glutamic dehydrogenase
activities were determined fortnightly and necropsy was carried




This is recorded in Table 6.1. A highly significant
difference was found befween the numbers of flukes recovered
from rats injected with immune serum compared with those from
rats injected with normal serum (P< O.Ol). Furthermore,
the difference between the numbers of flukes recovered from
the rats in the former group and those from the challenge
controls xvas even greater (P <0.001). However, the
numbers of flukes recovered from rats injected with normal
serum and those from challenge controls were also significantly
different at P< 0.05.
Peripheral eosinophil counts
These are shown in Appendix Table 6.1. and Fig. 6.1. The
eosinophil counts in rats injected with normal serum and these
in challenge controls showed similar progressive increases
peaking at the 6th week. However, the counts in rats injected
with immune serum showed little further increase after the
initial rise 2 weeks after infection.
Serum glutamic dehydrogenase assays
The results are shown in Appendix Table 6.2. and Fig. 6.2.
Infection was followed by similar elevations of the enzyme
levels in the group injected with normal serum and in the
challenge controls, with slightly higher levels in the former.
In contrast there was very little increase after infection
in the group injected with immune serum.
TABLE6.1.
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Fig. 6-1. Peripheral Eosinophil Counts.
Weeks after Infection.
Group A Rats injected l/P with
serum from infected rats.
Group 8 infection control.
Group C Rats injected l/P with
serum from normal rats.
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The mean enzyme levels of the rats in the group given
the immune serum were significantly lower than those of the
rats in either of the other two groups at 4 and 6 weeks
after infection (At 4 weeks, A v B, t = 4.60, P <0.001;
A v C, t = 4.27, P <0.001; at 6 weeks, A v B, t = 3.67,
P <0.01; A v C, t = 3.56, PcO.Ol). On the other hand, no
significant difference was found between the enzyme levels
of the two control groups B and C at any time.
Discussion
Although it is clear that homologous immune serum can
confer a significant resistance against F. hepatica in rats,
it appears from the apparent resistance conferred even by
normal serum that a 'flushing effect' of serum on the young
flukes in the peritoneum contributed to this resistance.
However, as. the normal serum did not confer a similar level
of resistance, this suggests that the reduction in the
flukes recovery was not simply due to this 'flushing effect'
and tends to confirm that circulating antibodies have a
protective effect.
6.2. Passive transfer of resistance to F. hepatica
in rabbits by immune homologous serum
Experimental design
Fourteen rabbits were divided into 3 groups, A (5 rabbits),
B (5 rabbits) and C (4 rabbits). The rabbits were each
infected with 100 metacercariae of F. hepatica. This was
immediately followed by intraperitoneal injection of each
rabbit in group A with 24 ml of immune serum obtained from
rabbits which had been infected with lOO metacercariae 3
163.
weeks previously. These injections were repeated 2 days
later. Group B was similarly injected with normal homo¬
logous serum and group C was left as the challenge control
group. Peripheral eosinophil counts and glutamic dehydro¬
genase assays were determined fortnightly and post-mortem
examination was carried out after 10 weeks.
Result s
Fluke recovery
This is recorded in Table 6.2. No significant
differences were found between the numbers of flukes re¬
covered from rabbits injected with immune serum compared to
those from rabbits injected with normal serum or from the
challenge controls.
Peripheral eosinophil counts
These are shown in Appendix Table 6.3. and Fig. 6.3.
The counts peaked at the 6th week after infection in the con¬
trol groups and at the 8th week in the group injected with
immune serum. Higher counts were observed in rabbits in¬
jected with normal or immune serum than in challenge controls.
Serum glutamic dehydrogenase assays
The results are recorded in Appendix Table 6.4. and Fig.
6.4. The enzyme levels were similar in all three groups
with no significant differences between the mean levels at
any time.
Discussion
In contrast to the findings in rats, immune homologous
serum failed to confer resistance in rabbits. This may have
been either because immune rabbit serum is not protective or
TABLE6.2.




































































Group of rabbits Injected
with serum from infected
rabbits.
Infection control group.
Group of rabbits injected
with serum from normal
rabbits.
• B











because the volume of serum was not sufficiently large to con¬
fer resistance. The ratio of the transferred serum to recepient
weight was aboy..t 1:50 in rabbits compared to about 1:15 in rats,
which may also account for the fact that the administration of
normal rabbit serum had no effect on the fluke burdens in the
rabbits similar to that seen in the rats.
6.3. The effect of intraperitoneal transfer of immune rat
serum on resistance to F. hepatica by rabbits
Introduction
This experiment was carried out to see whether immune rat
serum could protect rabbits against F. hepatica.
Experimental design
Immune serum was collected from 60 rats which had been in¬
fected 8-10 weeks earlier with 20 metacercariae of F. hepatica.
Three groups of rabbits (A, B and C) and 2 groups of rats
(D and E) were used. There were 7 rabbits in group A, 4
rabbits in group B, 8 rabbits in group C, 6 rats in group D
and 5 rats in group E. The rabbits were each infected with
10O metacercariae while the rats were each infected with 20
metacercariae. Each rabbit in group A was injected intra¬
peritoneal ly with 25 ml of immune rat serum immediately after
infection and this was repeated 2 days later. The rabbits in
group B were similarly injected with normal rat serum, while
those in group C were left as the challenge controls. The rats
in group D were each injected intraperitoneally immediately after
infection with 10 ml from the same pool of immune serum as was
used for the rabbits in group A and this was also repeated
after 2 days. This group was used as a control for the
168.
protective value of the immune rat serum. Group E was
similarly injected but with normal rat serum from the same
pool as was used in the rabbits in group B. Peripheral
eosinophil counts and serum glutamic dehydrogenase activities
were determined fortnightly and post-mortem examinations
were carried out 8 weeks after challenge infection.
Results
Fluke recovery
This is recorded in Table 6.3. A significant difference
was found between the numbers of flukes recovered from the
rabbits injected with immune rat serum compared with those
from the rabbits injected with normal rat serum or from the
challenge controls. A significant difference was also found
between the numbers of flukes recovered from the rats injected
with immune rat serum and those from the rats injected with
normal rat serum. Gn this occasion the administration of
normal rat serum appeared to reduce the number of flukes which
were recovered from the recepient rabbits compared with
challenge controls but this difference was not significant.
Peripheral eosinophil counts
These are recorded in Appendix Table 6.5., Fig. 6.5.1.
and Fig. 6.5.2. The counts showed similar trends in all
three groups of rabbits, peaking at the 6th week. However,
counts from rabbits injected with normal or immune serum
were higher than those from challenge controls, the highest
peak being shown by the rabbits injected with normal rat
serum.
TABLE6.3.
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Fig. 6-5-1. Peripheral Eosinophil Counts.
Weeks after Infection.
GroupA_ Rabbits injected with
immun rat serum.
Group B Rabbits injected with
normal rat serum.
















Fig.6-5-2. Peripheral Eosinophil Counts.
Group D__ Rats injected with
immune rat serum.
Group E_— Rats injected with
normal rat serum.
1 2 3 4 5 6 7 8
Weeks after Infection.
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Rats in the group injected with immune serum and those in
the group injected with normal rat serum showed increased counts
which peaked at the 4th week in the former and at the 6th week
in the latter.
Serum glutamic dehydrogenase assays
The results are shown in Appendix Table 6.6., Fig. 6.6.1.
and Fig. 6.6.2. The enzyme levels increased after infection
in all 3 groups of rabbits reaching a peak at the 6th week.
However, the challenge controls showed the highest peak while
the rabbits injected with immune rat serum showed the lowest
peak. The difference between the mean enzyme activity in the
rabbits injected with immune rat serum and that in the rabbits
injected with normal rat serum was significant at the 4th week
(t = 2.61, P<0.05) but not at the 6th week. Furthermore, the
differences between the mean enzyme activity of rabbits injected
with immune rat serum and the challenge controls were even
greater at the 4th week (t = 3.19, P<0.01) and the 6th week
(t = 3.44, P <0.01). There was no significant difference in the
mean enzyme activity of the rabbits injected with normal rabbit
serum and that of the challenge controls. On the other hand,
a highly significant difference was found between the mean
enzyme activity of rats injected with immune rat serum compared
to that of rats injected with normal rat serum at the 4th week
(t = 9.48, P < 0.001) but not at the 6th week after infection.
Discussion
Immune rat serum which conferred resistance on recepient
rats was found.-to be protective to rabbits as well. A similar
173.
Fig.6 61. Serum Glutamic Dehydrogenase Levels.
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Group A—_ Rabbits injected with
immune rat serum.
Group B Rabbits injected with
normal rat serum.
Group C Infection controls.
Weeks after Infection.
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Fia.6-6-2. Serum Glutamic Dehydrogenase Assays.
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volume of immune rabbit serum had previously failed to protect
rabbits against F. hepatica. This is probably due to a
greater protective capacity of immune rat serum. However,
the great individual variation which resulted in some of the
rabbits which had received the immune rat serum being very
resistant while others showed little or no resistance probably
indicates that this is rather a disparate ability in rabbits.
6.4, The effect of intraperitoneal transfer of immune
rabbit serum on resistance to F, hepatica by rats
Introduction
This experiment was carried out to see whether immune
rabbit serum cam confer resistance to recepient rats although
it fails to do so in recepient rabbits.
Experimental design
Donor rabbits had 8-week-old infections with 10O meta-
cercariae of F, hepatica.
Two groups (A and B) each of 5 rats were used. Each rat
was infected with 20 metacercariae. Immediately after in¬
fection the rats in group A were each injected intraperit-
oneally with 10 ml of immune rabbit serum and this was repeated
after 2 days. Group B was similarly injected with normal
rabbit serum. Peripheral eosinophil counts and serum glutamic
dehydrogenase activities were determined fortnightly and
necropsy was carried out 8 weeks after infection.
Results
Fluke recovery
This is r.ecorded in Table 6.4. A significant difference
was found between the numbers of flukes recovered from the
TABLE6.4.



















These are shown in Appendix Table 6.7. and Fig. 6.7.
Infection was followed by similar increased eosinophil counts
which reached a peak at the 6th week in both groups.
Serum glutamic dehydrogenase assays
The results are recorded in Appendix Table 6.8. and Fig.
6.8. The enzyme levels in the rats injected with normal
rabbit serum rose to a peak at the 6th week, but the elevation
in the rats injected with immune rabbit serum was less. There
was a highly significant difference between the enzyme levels
of the two groups at the 4th week (t = 5.66, P <0.0Q1) and the
6th week (t = 5.20, P<0.001) after infection.
Discuss ion
Although immune rabbit serum failed to confer protection
on rabbits (Experiment 6.2.), it did appear to protect
recepient rats. This may have been because the ratio of the
transferred serum to the body weight of the recepient was
about 1:15 in rats and 1:50 in rabbits. It is therefore
possible that a larger volume of immune rabbit serum is re¬
quired to confer protection in rabbits. If this is so, the
fact that in the earlier experiments immune rat serum was able
to confer resistance on rabbits while a similar volume of
immune rabbit serum had failed to do so, supports the previous
suggestion that the protective capacity of the former is
greater than that of the latter.
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Fig, 6-7. The Effect of l/P Transfer of Immune Rabbit Serum on the
Immunity to F.hepatica in Rats. Peripheral Eosinophil Counts.
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Rats injected l/P with
immune rabbit serum.
Rats injected l/P with
normal rabbit serum.
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6.5. The effect of intraperitoneal transfer of immune
bovine serum on resistance to F. hepatica in rats
Introduction
It has been suggested previously that infections with
F. hepatica in rats and rabbits can be used as models for the
similar infections in cattle and sheep respectively. The
protective effect of immune rat and rabbit sera have been in¬
vestigated and it therefore completes the comparisons to study
the protective value of bovine and ovine immune sera. Further¬
more, as much larger volumes of bovine or ovine sera can be
obtained, as compared with those from rats or rabbits, these
offer considerable advantages for further studies on the
passive transfer system.
Experimental design
The donors of immune bovine serum were two calves each in¬
fected with 750 metacercariae. Serum was collected at the 8th,
9th and lOth weeks after infection. The calves were reinfected
after 22 weeks and more serum was collected 8 weeks later.
Precipitating antibodies were detected against somatic fluke
antigen in every batch of serum collected.
Eighteen rats were divided into 2 groups, A (lO rats) and
B (8 rats) and each rat was infected with 20 metacercariae.
Immediately after infection the rats in group A were each in¬
jected intraperitoneally with 10 ml of immune bovine serum
and this was repeated after 2 days. Rats in group B were
similarly injected with normal bovine serum. Serum glutamic
dehydrogenase activity was determined fortnightly and post¬




This is recorded in Table 6.5. A highly significant
difference was found between the numbers of flukes recovered
from the two groups.
Serum glutamic dehydrogenase assays
The results are shown in Appendix Table 6.9. and Fig. 6.9.
The enzyme level increased after infection in both groups
reaching a peak at the 4th week in the rats injected with
immune bovine serum but not until the 6th week in the rats
injected with normal bovine serum. The enzyme activity in the
latter rats was higher than that in the former at both the 4th
and 6th weeks but the difference was significant only at the
latter time (t = 2.59, P<0.02).
Discussion
It is clear that immune bovine serum can confer resistance
on recepient rats. This serum was therefore used in several
subsequent passive-transfer experiments because large volumes
can easily be obtained.
6.6. The effect of intraperitoneal transfer of immune ovine
serum on the resistance to F. hepatica by rats
Introduction
This experiment was intended to complete the study on the
protective effects of immune sera from the four host species.
Experimental design
Donors of immune ovine serum had been infected with 1COO
metacercariaa 12 weeks previously. Precipitating antibodies
were detected in the sera against somatic fluke antigen.
TABLE6.5.
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Two groups (A and B) each of 5 rats were used. The rats
were each infected with 20 metacercariae. Immediately after
infection the rats in group A were each injected intra-
peritoneally with 10 ml immune ovine serum and this was repeated
after 2 days. Group B was similarly injected with normal
ovine serum. Serum glutamic dehydrogenase activity was
determined fortnightly and post-mortem examination was carried
out after 8 weeks.
Result s
Fluke recovery
This is recorded in Table 6.6. No significant difference
was found between the numbers of flukes recovered from the two
groups.
Serum glutamic dehydrogenase assays
The results are recorded in Appendix Table 6.10 and Fig.
6.10. The enzyme levels reached peaks at the 4th and 6th weeks
in rats injected with normal ovine serum and immune ovine serum
respectively. However, there was no significant difference
between the enzyme levels in the two groups at any time.
Discussion
Immune ovine serum apparently failed to confer any
protection on recepient rats although an equal volume of immune
rabbit serum had previously been shown to be protective. This
result was unexpected because of the previously mentioned
similarities between rabbits and sheep. It was therefore
decided to repeat this experiment with 7 rats in each group
instead of 5.
TABLE6.6.
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This is recorded in Table 6.7. Once again no significant
difference was found between the numbers of flukes recovered
from the two groups.
Serum glutamic dehydrogenase assays
The results are shown in Appendix Table 6.11. and Fig. 6.11.
Once again the enzyme levels reached similar peaks at the 4th
and 6th weeks in the rats injected with normal ovine serum and
the rats injected with immune ovine serum respectively, and
there was no significant difference between the mean enzyme
activities in the two groups at any time.
Discussion
Again, no resistance was conferred on recepient rats by
10 ml of the immune ovine serum. However it may be that a
larger volume of this serum would have confered protection or that
the immune ovine serum had lost its protective effect by 12
weeks after infection. It is therefore not possible to conclude
conclusively from these experiments that there is a distinct
qualitative difference in the ability of rabbit and ovine sera
from infected hosts to passively confer resistance to rats.
6.8. Passive transfer of resistance to F. bepatica in rats
by gamma-globulin from immune homologous serum-
Introduction
In this experiment the protective effect of gamma-globulin
precipitated from an immune rat serum, which was itself known
to be able to 'donfer resistance on recepient rats, was
TABLE
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investigated. This was envisaged as the first step in
determining the immunoglobulin class(es) responsible for this
resistance and also as a useful step in facilitating absorbtion
studies.
Experimental design
Twentythree rats were divided into 4 groups, A (8 rats),
B (5 rats), C (5 rats) and D (5 rats). The rats were each
injected with 20 metacercariae. Immediately after infection
each rat in group A was injected intraperitoneally with 10 ml
of precipitated gamma-globulin from an immune serum pool
obtained from 30 rats infected with 20 metacercariae for 3
weeks and this was repeated after 2 days. Group B was
similarly injected with gamma-globulin from normal rat serum.
As a control for the protective value of the pool of immune
serum from which the gamma-globulin had been precipitated, the
rats in group C were each injected intraperitoneally with 8 ml
of the original serum immediately after infection and again 2
days later. The rats in group B were similarly injected with
normal rat serum. Serum glutamic dehydrogenase activity xvas
determined fortnightly and post-mortem examination was carried
out 8 weeks after infection.
Fluke recovery
This is recorded in Table 6.8. A significant difference
was found in the numbers of flukes recovered from rats injected
with immune gamma-globulin as compared with those from rats
injected with normal gamma-globulin. A significant difference
was also found between the numbers of flukes recovered from
TABLE6.8.






































rats injected with immune rat serum and those from rats in¬
jected with normal rat serum. However, a comparison between
the numbers of flukes recovered from rats injected with
immune gamma-globulin and those from rats injected with
immune rat serum showed no significant difference.
Serum glutamic dehydrogenase assays
The results are recorded in Appendix Table 6.12. and Fig.
6.12. The enzyme level reached a peak at the 4th week in
three of the groups and at the sixth week in the group given
normal rat serum. However the elevation of the enzyme
levels in the rats injected with immune gamma-globulin or
immune rat serum was reduced. The difference between the
enzyme activities of the rats given the immune gamma-globulin
and those injected with normal gamma-globulin was found to be
significant at both the 4th (t = 2.41, P<0.05) and the 6th
(t = 2.59, P<0.05) weeks. Similarly, a significant
difference was found in the mean enzyme activity of the rats
injected with immune rat serum as compared with that of rats
injected with normal rat serum at the 4th (t = 2.96, P<0.02)
weeks.
and 6th (t = 3.03, P c 0.02) / No significant differences
were found at any time in the mean enzyme activities of the
rats injected with immune gamma-globulin as compared with rats
injected with immune serum or between the rats given normal
gamma-globulin as compared with those given normal serum at
any time.
6.9. Passive transfer of resistance to F. hepatica in
rats by gamma-globulin from immune bovine serum
Introduction
In this experiment the protective effect of gamma-
Fig.612. Serum Glutamic Dehydrogenase Levels.
aaa4 Rats injected with Rats injected with &-
Weeks after Infection.
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globulin precipitated from the same pool of immune bovine
serum as was used in experiment 6.5. was investigated.
Experimental design
A similar design to the previous experiment was adopted
using gamma-globulin from normal and immune bovine serum in two
groups (A and B) each containing 6 rats.
Results
Fluke recovery
This is recorded in Table 6.9. A significant difference
was found between the numbers of flukes recovered from the rats
injected with immune bovine gamma-globulin and that from the
rats injected with normal bovine gamma-globulin.
Serum glutamic dehydrogenase assays
The results are shown in Appendix Table 6.13. and Fig. 6.13.
In both groups the enzyme levels reached a peak at the 4th
week. However, the peak was significantly lower (t = 2.39,
P<0.05.)" in the rats injected with immune bovine gamma¬
globulin as was the level 6 weeks after infection (t = 3.27,
P < O.Ol) .
Discussion
The results of this and the previous experiment clearly
show that both immune bovine and rat gamma-globulin cam confer
resistance to recepient rats. The next step in this study
would be to fractionate the gamma-globulin to determine the
immunoglobulin class(es) involved in the resistance.
6.10. Passive transfer of resistance to F. hepatica
in rabbits by concentrated immune bovine serum
It had been intended to investigate the protective effect
TABLE6.9.
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of immune bovine serum in rabbits using a lower ratio of
serum volume to recepient weight as in rats (i.e. less than
1:15). Normal and immune bovine sera were therefore con¬
centrated to one third of the original volume. However it
was found that about 20 ml of such serum was the maximum
volume that could be given without risking the rabbits dying
of serum sickness. Accordingly, only a pilot study was
carried out to determine the efficacy of this concentrated
serum in passively transferring resistance.
Experimental design
Two groups (A and B) each comprising 3 rabbits were used
and each rabbit was injected with SO metacercariae. Immediately
after infection the rabbits in group A were each injected with
10 ml of concentrated immune bovine serum and this was re¬
peated after .2 days. Group B was similarly injected with con¬
centrated normal bovine serum. All the rabbits were necropsied
8 weeks after infection.
Results
Fluke recovery
This is recorded in Table 6.10. A significant difference
was found between the numbers of flukes recovered from the
two groups.
Discussion
A volume of 20 ml of concentrated immune bovine serum
(equivalent to 60 ml unconcentrated serum) conferred a
significant resistance in rabbits. The fact that a similar
effective volume (50 ml) of unconcentrated immune rat serum
also conferred significant protection in rabbits whereas a
TABLE6.10.


















similar volume of immune rabbit serum failed to do so indicates
that the immune rat and bovine sera have a higher protective
value against F. hepatica than immune rabbit serum. It was
unfortunately impossible in the time available to repeat the
experiment with a larger number of rabbits.
6.11. Passive transfer of resistance to F. hepatica in
rats by serum from rats implanted with mature flukes
encapsulated in diffusion chambers
Experimental design
Fifteen donor rats were implanted intraperitoneally with
adult flukes encapsulated in filtration-membrane diffusion
chambers and serum was collected after 2 weeks. Precipitating
antibodies were detected against somatic fluke antigen.
Fourteen rats were divided into two equal groups (A and B).
All the rats were infected with 20 metacercariae. Immediately
after infection, each rat in group A \vas injected intraperitoneally
with 7.5 ml of serum obtained from rats implanted with flukes
in diffusion chambers and this was repeated after 2 days. Group
B was similarly injected with serum from rats implanted with
empty chambers. Serum glutamic dehydrogenase activities
were determined fortnightly and post-mortem examination was
carried out 8 weeks after infection.
Results
Fluke recovery
This is recorded in Table 6.11. A significant difference
was found between the numbers of flukes recovered from the two
groups .
TABLE6.11.
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Serum glutamic dehydrogenase assays
The results are shown in Appendix Table 6.14. and Fig.
6.14. The enzyme levels in both groups reached a peak at
the 4th week. However, the peak was significantly lower
in the group injected with serum from rats implanted with
encapsulated flukes (t = 2.49, P <0.05).
Discussion
It has previously been shown that the metabolic products
which diffuse through filtration membrane diffusion chambers
containing mature flukes are antigenic and can stimulate
resistance to challenge. It is now clear that some humoral
agent(s) which are thus produced can passively transfer this
resistance.
6.12.1. Absorption of the protective component(s) from
immune bovine serum
Introduction
Attempts were made to determine whether the protective
component in immune serum can be absorbed by direct contact
with mature flukes or by metabolic products diffusing from
mature flukes encapsulated in chambers.
Experimental design
Twentythree rats were divided into three groups A (8 rats),
B (8 rats) and C (7 rats). Each rat was infected with 20
metacercariae. Immediately after infection rats in group A
were each injected intraperitoneally with 10 ml of immune
bovine serum in which mature flukes had been maintained for
48 hours at 37°C and this was repeated after 2 days. Group
B was similarly injected with immune bovine serum in which
202.
Fig. 6-14.
Passive Transfer of Resistance to F. hepatica in Rats by Serum from
Rats implanted with Mature Flukes Encapsulated in Diffusion Chambers.
Serum Glutamic Dehydrogenase Levels.
Rats injected l/P with
serum from rats implanted
Weeks after Infection.
203.
mature flukes encapsulated in diffusion chambers had been
maintained for 48 hours at 37°C and group C with normal bovine
serum. Serum glutamic dehydrogenase activity was determined




Both absorbed sera still showed precipitation lines against
somatic fluke antigen in agar.
Fluke recovery
This is recorded in Table 6.12. There were no significant
differences between the numbers of flukes recovered from any
of the groups.
Serum glutamic dehydrogenase assays
Results a.re shown in Appendix Table 6.15. and Fig. 6.15.
Again there were no significant differences between the mean
enzyme levels in any of the groups at any time, all reaching a
peak at the 4th week.
Discussion
This experiment appeared to show that directly or in¬
directly absorbed immune serum lost its protective effect. Hew-
ever, as there was no group of rats injected with un-absorbed
immune serum kept at 37°C from 48 hours it is possible that
the loss of protection was simply due to this incubation at
an elevated temperature. It was therefore decided to repeat
this experiment in a modified form.
6.12.
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6.12.2. Absorption of the protective components from
immune bovine serum
Experimental design
Eighteen rats were divided into 3 groups A (7 rats) ,
B (4 rats) and C (7 rats). Each rat was infected with 20
metacercariae. Immediately after infection the rats in group
A were each injected intraperitoneally with 10 ml of immune
bovine serum which had been kept at 37°C for 48 hours and this
was repeated after 2 days. Groups B and C were similarly in¬
jected with normal bovine serum and immune bovine serum absorbed
by direct contact with living flukes for 48 hours respectively.
All rats were necropsied 8 weeks after infection.
Results
Serology
The absorbed serum still showed precipitation lines against
somatic fluke antigen.
Fluke recovery
This is recorded in Table 6.13. A significant difference
was found between the numbers of flukes recovered from the group
injected with immune bovine serum kept at 37°C for 48 hours and
that from the group injected with normal bovine serum. However,
although there were 32% fewer flukes recovered from the group
injected with immune bovine serum kept at 37°C for 48 hours when
compared with that from the group injected with directly absorbed
serum, this difference was not statistically significant.
Discussion
The results of this experiment are again inconclusive,
although they tend to support the suggestion from the previous
TABLE6.13.




2x10mlim uneboviserum keptat37Cfor48h u s atd ysOnd2I/P(A) 2x10mlnormalbovineserum atd ysOand2I/P(B) 2xlOmlim uneboviserum inwhichmatureflukesr maintainedfor48h u st daysOnd2l/P(C)
20 20 20
1,23 5, 4,6 2,34 4,9
+
2.71- 1.71 5 .00- 1.15 4.00 2.38
ByWilcoxon'stwo-sampletest: AvB,P<0.05 BvC,P>0.05,n.s. AvC,P>0.05,n s.
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experiment that the protective components of immune serum can
be absorbed out by the presence of living flukes. It appears
probable that either the abscrbtion was incomplete or that
keeping serum at 37°C for 48 hours reduces its protective
ability. Indeed both factors may be involved. This
study was not repeated again partly because there was in¬
sufficient time available but also because its importance was
overtaken by events in the form of the results from other con¬
current absorption experiments.
6.12.3. Absorption of the protective factor(s) from
gamma-globulin precipitated from infected
bovine serum
Introduction
In this experiment gamma-globulins precipitated from in¬
fected bovine gerum with ammonium sulphate were absorbed with
the volume of metabolic products from adult flukes maintained
in vitro sufficient to just remove all immuno-precipitating
activity. These absorbed globulins were then injected into
rats to see whether they had lost their protective effect.
Experimental design
Eighteen rats were divided into 3 equal groups A, B and C.
Each rat was injected with 20 metacercariae. Immediately after
infection the rats in group A were each injected intraperitoneally
with 6 ml of gamma-globulin from infected bovine serum and this
was repeated 2 days later. Group B was similarly injected with
gamma-globulin from normal bovine serum and group C with the




This is recorded in Table 6.14. Tiiere"were significant
differences between the numbers of flukes recovered from the
rats injected with gamma-globulin from immune bovine serum as
compared with those from the rats injected with either gamma¬
globulin from normal bovine serum or absorbed gamma-globulin
from immune bovine serum. Furthermore, no significant
difference was found between the numbers of flukes recovered
from the rats in the latter two groups.
Discussion
It is clear that the absorbed immune gamma-globulin failed
to confer resistance to recepient rats. Hence it appears that
the protective 'antibodies' were inactivated by some component(s)
in the metabolic products obtained from the cultured flukes.
Lehner (1977) showed that such metabolic products collected
from flukes maintained in vitro do not induce an active re¬
sistance when used as a vaccine. It therefore seems possible
that such metabolic products contain a hapten which reacts with
and inactivates the protective antibody.
The results of this experiment also suggested that the
tentative but not conventionally significant results of the
previous two experiments are in fact valid.
6.14.





























It is clear that resistance to F. hepatica can be actively
stimulated in rats by immature or mature previous infections
which have been eliminated by anthelmintics. The involvement
of immunological factors in such resistance has been confirmed
by the finding that metabolic products diffusing from mature
flukes encapsulated in diffusion chambers, which had been
implanted subcutaneously or intraperitoneally in rats, can
stimulate a protective response. These findings support
previous reports by Eriksen and Flagstad (3.974b)and Anderson,
Hughes and Harness (1975). The former authors reported that
implantation of mature flukes subcutaneously in rats for 4
weeks resulted in a 50% decrease in the numbers of flukes re¬
covered from oral challenge as compared to non-implanted
controls. Anderson et al, (1975) also reported that
histological examination of the prefemoral lymph nodes of rats
implanted subcutaneously with one adult fluke for 12 days
showed evidence of cell-mediated immunity and concomittant
production of antibody. Furthermore, there was intradermal
hypersensitivity to fluke antigen and precipitating anti¬
bodies were formed.
The fact that diffusible antigens, from encapsulated
mature flukes which had been implanted in rats, stimulated
a protective immunological response excludes any essential
immunogenic role for the flukes' tegumental cells or eggs
since these-are too large to pass through the diffusion
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chambers with a pore size of 0.45 um.
On the other hand, the present findings conflict with
reports by Goose (1977) and Rajasekariah and Howell (1978).
The former author reported that mature flukes implanted
intraperitoneally in rats completely failed to stimulate
resistance to oral challenge. However, it is possible that
this failure was due to the fact that he challenged his
rats 13 weeks after implantation, by which time the implanted
flukes were dead.
Rajasekariah and Howell (1978) however reported the
failure of subcutaneous implantation of mature flukes to
stimulate resistance to oral challenge in rats 2 or 4 weeks
after implantation. However they found that 4-week-old
flukes, metacercariae or fluke eggs would all stimulate a
significant resistance to challenge 2 weeks after implant¬
ation. The implanted metacercariae reached the liver where
they caused damage. However no hepatic damage was found
in rats implanted with eggs or 4-week-old flukes. The
authors suggested that implanted eggs were disseminated more
widely than eggs produced by implanted mature flukes because
the latter were encapsulated within a nodule, while the
former "may be processed more effectively by the defence
mechanisms of the host". They thus suggested that such
immature
eggs and the/flukes are more immunogenic than adult flukes.
However, implanted adult flukes would be expected to produce
a lot of eggs before they were encysted. Therefore, a
more likely'explanation is perhaps the alternative one
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given by the same authors, that the discrepency between their
results and those of other authors about the immunogenicity
of implanted mature flukes may be attributed to differences
in the strains of rats in the different experiments.
While implantation of mature flukes usually stimulates
significant resistance to F. hepatica in rats, it fails to
do so in rabbits. Hughes and Harness (1973a) reported
that mature flukes implanted into rats were found from the
third day within cysts in the body cavity, liver or the
scrotal sac. It appears that the short period before cyst
formation is enough for the implanted rats to develop a
protective immunological response against F. hepatica, or
that the antigens can diffuse from such cysts in rats.
In rabbits it was found in the present work that the
flukes quickly die after subcutaneous implantation and do not
become encysted so that the quantity of antigenic stimulus
may not be sufficient to stimulate a protective immunological
response. Similarly Hughes and Harness (1972; 1973a) and
Eriksen and Flagstad (1974b) reported that adult flukes im¬
planted into rabbits body cavities do not satisfactorily
adapt and thrive, whereas in rats implanted mature flukes
can live within cysts up to 12 weeks, whereas no cysts were
formed around dead flukes or flukes which died shortly after
transfer. It is also possible that rabbits are incapable
of recognising and responding to those 'essential' antigens
which can stimulate a protective immune response, as suggested
by Hughes (1963).
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The involvement of immunological response in the re¬
sistance of F. hepatica was also demonstrated in the present
work by passive transfer of a humoral agent contained within
the gamma-globulin fraction of serum and hence probably an
antibody. However, the successful transfer of such resistance
appears to depend on many factors such as the volume of
immune serum transferred, the time of transfer, the duration
of the infection in the donor and the species of the re-
cepient and donor. Thus immune rat and bovine sera as well
as gamma-globulin precipitated from such sera were found to
protect recepient rats and rabbits against challenge with
F. hepatica. However immune rabbit serum was found not to
confer resistance on recepient rabbits although, perhaps
surprisingly it was protective to rats. This difference may
have been due to the larger ratio of serum to recepient live-
weight in the rats, but sheep serum failed to confer any
resistance on recepient rats in a volume similar to that at
which rat or bovine sera were effective.
The importance of the volume and time of immune serum
transfer was first shown by Armour and Dargie (1974), who
found a direct relationship between the volume of serum
transferred and the degree of resistance obtained. Thus the
mean fluke recoveries from a challenge infection of 20
metacercariae in rats which had received O, 5, lO or 20 ml
were 3.6, 2, 1.4 and 0.6 respectively and successful
protection was obtained only when sera was given at the time
of challenge. On the other hand, Hayes, Bailer and Mitrovic
(1974b) found no significant difference in protective effect
between 5, 2.5 and 1 ml of immune homologous serum transferred
into rats. However, these authors also emphasised the im¬
portance of the time of serum transfer as immune serum given
at the day of infection was protective, whereas when it was
given 2 or 4 days after infection there was only a slight
protective effect and when it was given 6 or 8 days after
challenge there was no effect. Such factors as an in¬
sufficient volume of serum transferred into recepients or
incorrect time of transfer may have been responsible for the
failure of earlier attempts to transfer immunity passively
(Wikerhauser, 1961b; Corba, Armour, Roberts and Urquhart, 1971).
In the present work immune serum was collected from
different donor species after about 8-weeks of infection except
from sheep which had 12-week-old infections. It was not ex¬
pected that this would affect the protective capacity of the
serum. However, an analogous situation in rats suggests that
this may be so. Howell, Sandeman and Rajasekariah (1977)
reported that serum from donor rats with 13-20 week-old in¬
fections was protective to recepients whereas Hayes, Bailer
and Mitrovic (1974b) found that serum from rats with a 25-
week-old infection was not protective. This might be related
to the decrease in the antibody titre in older infections
although it should be pointed out that high serological titres
are not necessarily associated with resistance, as was found in
the present work in rabbits and sheep. Alternatively,
Van Tiggele (-1975) proposed that since sheep are more efficient
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producers of antibody to antigenic stimulus than calves,
the former may produce excessive amounts of blocking anti¬
bodies, with a consequent poor immunity in terms of re¬
sistance .
It is therefore clear that humoral immunity can be
involved in the resistance to F. hepatica. This was further
confirmed by the finding that the protective effect can be
absorbed out of both immune serum and immune gamma-globulin.
Hov/ever, as has been mentioned in chapter 3, resistance can
also be passively transferred by lymphocytes. Dargie, Armour,
Rushton and Murray (1974) suggested that either these
lymphocytes are attracted to the sites of antigen deposition
and stimulate a cell-mediated reaction or that they them¬
selves produce antibodies against the flukes in the recepient.
Since rats protected by immune serum transfer usually have
normal livers while those protected by lymphocytes show
evidence of hepatic damage, cellular infiltrates and dead
immature flukes, these authors suggested that in the former
case only, the young flukes are killed prior to entry into the
liver, while both types of immunity are involved in natural
resistance to F. hepatica, the cellular response acting as a
second line of defence.
There are, however, several other hypotheses which attempt
to explain the mechanism of resistance to F. hepatica. These
are mainly divided into two major groups. One of these in¬
cludes views which consider non-specific factors such as
competitive inhibition in high level infections or environmental
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changes in the liver due to inflammation and fibrosis caused
by primary infections to be responsible for the resistance
against F. hepatica in repeatedly infected hosts. (Thorpe.
1965; Bolbol, 1975; Hughes, Harness and Doy, 1977a).
Such non-specific factors may account for the reduction
in the number of flukes recovered from rabbits with repeated
infections, (Bolbol, 1975) but, there is undoubtedly a
specific immunological mechanism in rats. Thus, in spite of
the fact that liver damage and fibrosis in the rats which
had experienced two immature infections and treatments
appeared greater than in the rats challenged after treatment
of a single mature infection, the level of resistance was
similar in the two groups. Hence, in rats, resistance to
F. hepatica does not seem to be directly related to the degree
of hepatic fibrosis. It would have been desirable to confirm
this point by histopathological evidence as well. However,
these findings are in agreement with Hayes, Bailer and
Mitrovic (1973) who reported that a primary infection with
one fluke was sufficient to confer a high degree of re¬
sistance to challenge after 7 weeks in rats, although such
livers showed little damage at the time of challenge. They
also showed (1974a)that long-standing infections, of 7 or 12
months duration, conferred a significant degree of resistance
to reinfection, even though regenerative and healing
processes had occurred. The present work has also clearly
shown that metabolic products from mature flukes stimulate
significant resistance in rats and this further refutes the
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view that non-specific inflammatory and fibrotic changes
are exclusively responsible for the resistance of re¬
peatedly infected rats.
Another group of hypotheses consider a pre-hepatic or
hepatic immune response associated with immature fluke anti¬
gens to be responsible for the resistance in repeatedly in¬
fected animals. Thus, Hayes and Mitrovic (1977),
Rajasekariah and Howell (1977b) and Doy, Hughes and Harness
(1978) maintained that the protective immunological response
occurs in the intestinal wall in rats; and Fortmeyer (1974)
suggested that a similar mechanism occurs in rabbits. Doy
et al. suggested that the invading immature flukes from the
challenge infection trigger off a local anaphylactic
reaction as they migrate through the intestine. This is
either "via antigen/sensitised mast cell combination or
directly through secretion of a degranulation substance"
which in turn "could recruit the eosinophils seen in the
intestine after challenge". However, these authors were
not able to resolve the question as to whether the role of
the eosinophils in the intestine is only to "damp down" an
anaphylactic reaction or whether they are involved in the
destruction of immature flukes. Hughes, Harness and Doy
(1977a) suggested both that resistance in rats is associated
with immature stages and that mature flukes are either in¬
capable of producing the right antigens or that their
situation in the bile ducts prevents the hosts' response to
such antigens.. The latter suggestion is perhaps a more
likely explanation of their observations since the present
investigation has shown that mature flukes implanted into rats
are capable of stimulating significant resistance against
oral challenge and that this is so even when the flukes are
encapsulated in a permeable membrane.
Recently a new variant of the hypothesis which implicates
immature flukes was suggested by Goose (1978). He found that
the excretory and secretory products (ESP) of mature F. hepatica
maintained in vitro were toxic to rat lymphocytes. There was
a considerable decrease in the viability of these cells when
o
they were incubated in the presence of ESP at 37 C. for 2 hours.
This phenomenon was employed in investigating the mechanism
by which F. hepatica evades the host defences using an in
vitro immunocytoadhesion system. When juvenile flukes were
incubated with serum and peritoneal cells from rats resistant
to F. hepatica, these flukes became heavily coated with cells
which included many eosinophils. No cellular adhesion
occurred when serum from un-infected rats was used. Inclusion
of ESP in a system containing immune rat serum significantly
reduced the number of flukes with adherent cells. Hence it
was suggested that cellular attachment is the first step in
the lethal immune reaction to F. hepatica and that, jLn vivo,
ESP may prevent this attachment.
Continuing this line of thought, the author suggested that
very young flukes would be expected to be the immunogenic
stage of infection because they may not produce effective
quantities of ESP while, in contrast, older, actively feeding
flukes would be non-immunogenic. The author also suggested
that this hypothesis would explain the "early development
of resistance after initial infection, the waning resistance
in long-standing infections, the lack of resistance after
implantation with adult flukes" and the importance of
transferring serum in passive immunity experiments very soon
after challenge before the production of effective quantities
of ESP.
However, this hypothesis does not explain why a single
primary infection which was allowed to mature appeared to
result in a similar degree of resistance to oral challenge
as two immature primary infections in rats in the present
work (Table 4.2.).
The fact that metabolic products from mature flukes
also appeared to be capable of stimulating resistance against
challenge in the present work clearly conflicts with Goose's
conclusion that mature flukes are non-immunogenic. How¬
ever, although both immature and mature flukes can stimulate
resistance, it is possible that different immunological
mechanisms are stimulated by these.
Another consideration is the importance of a 'time factor
in resistance to F, hepatica, which was emphasised by Thorpe
and Broome (1962). They reported that a period of 7 - 11
weeks after sensitisation with irradiated metacercariae was
necessary for resistance to develop in rats. This was not
associated with the maturity of flukes, since the irradiated
metacercariae died before maturity. Their deduction was
supported by the observation by Corba, Armour, Roberts and
Urquart (1971) that lymphoid cells from donor rats with a 4-
week-old infection were not protective whirl's these from donors
with a lO-week-old infection were protective against challenge.
Also Doyle (1973) found that whereas there was no significant
resistance to challenge in calves with a 7-week-old primary
infection, a significant resistance was obtained from a 12-
week-old primary infection. He excluded the possibility that
this resistance was due to the physical barrier of fibrosis or
cholangitis since it is known that there is already fibrosis
in the livers of calves infected with F. hepatica for 7 weeks
(Dow, Ross and Todd, 1967). Thus the level of resistance
increased with the increase in the duration of primary in¬
fection. Hence, Doyle also suggested that a 'time factor'
is involved-in the host's ability to develop a protective
immune response. It was for this reason that the sera used
in the passive transfer studies in the present work were
usually obtained from donors which had been infected for 8-12
weeks. However one of the observations in the present study
would seem to suggest that the time factor is not critical,
at least in relation to the humoral protection arising from
infection with adult flukes, as a significant level of re¬
sistance to challenge was obtained in rats which had been
implanted with mature flukes encapsulated in diffusion
chambers for 2 weeks.
As previously mentioned, the antigens from mature flukes
might be less effective immunogens in natural infection
because the flukes are in the bile ducts. In this respect
222.
it would be interesting to see whether the bile in infected
animals contains some of these antigens involved in resistance,
especially as Gajos (1968) demonstrated specific antibody
in bile against an antigen prepared from adult flukes, and
Lehner (1977) showed that precipitating antigens in a
Fasciola-metabolic-product and bile from infected rabbits
show reactions of identity in immunodiffusion tests against
infected rabbit serum.
The fact that serum gamma-globulin was found to be
protective against F. hepatica also invites further research
to determine the immunoglobulin class(es) involved in this
resistance. Armour and Dargie (1973) have already reported
that IgG but not IgM is involved in this resistance, whereas
Lang (1974a) suggested that in mice both IgG and IgM are in¬
volved and that IgM possibly combines with a cell membrane
antigen activating complement to produce immune lysis of
fluke cells.
The specific antigens which stimulate the protective re¬
sponse also remain to be determined. Furthermore, the
questions of why metabolic products collected from flukes
maintained in vitro stimulated only a non-protective sero¬
logically detectable response (Lehner, 1977) while metabolic
products released in vivo stimulated a protective response and
the reason why such protection is not developed actively in
rAbbits and sheep also need to be elucidated.
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The effect of varying the dilution of the enzyme-labelled anti-immunoglobulin













The effect of varying the dilution of the enzyme-labelled anti-immunoglobulin

































The effect of varying the concentration of the antigen in the assay of rat serum using a conjugate
dilution of 1:400, serum dilution of 1:25 and OPD in the substrate
Ag concentration Absorbance








The effect of varying the concentration of the antigen in the assay of rabbit serum using a
conjugate dilution of 1:400, serum dilution of 1:50 and OPD in the substrate
Ag concentration Absorbance








The effect of varying the serum dilution in the assay of rat serum using a conjugate
dilution of 1:40G, Ag concentration of 4.5 mg/ml and OPD in the substrate
Absorbance
Serum dilution






The effect of varying the serum dilution in the assay of rabbit serum using a conjugate
dilution of 1:400, Ag concentration of 4.5 mg/ml and OPD in the substrate
Absorbance









Peripheral eosinophil counts (cells per mm ) of rats treated with deacetylated diamphenethide
to eliminate immature (Group A), mature (Group B) F. hepatica and infection controls (Group C)
Rat No. 0 w 2 w.pri. 4 w.pri. 6 w.p.i. 8 w.p.i. 10 w.p.
A 1 94 897 2417 597 922 119
2 127 1395 1926 551 765 804
3 109 78 2817 1306 412 413
4 129 1803 2978 962 171 343
mean ± 115 1043 2535 854 568 420
s.d. ±16 ±743 ±469 ±353 ±340 ±285
B 1 68 1701 2754 914 858 120
2 226 1333 3018 3444 1057 160
3 147 1029 1180 1251 306 201
4 107 2316 2612 2890 1438 288
mean ± 137 1595 2391 2125 915 192
s.d. ±68 ±554 ±825 ±1232 ±472 ±72
C 1 109 1101 2813 2245 1060 1089
2 98 1734 4269 1529 1314 789
3 85 1291 3921 2945 2444 790
4 100 1202 2047 2030 1641 950
mean ± 98 1332 3263 2187 1615 905
s.d. ±10 ±279 ±1021 ±588 ±602 ±144
Appendix Table 4.2
Serum glutamic dehydrogenase assays (micromoles product per litre of serum per minute) of rats
treated with deacetylated diamphenethide to eliminate immature (Group A), mature (Group B)
F. hepatica and infection controls (Group C)
Rat No. Ow . 2 w.p.i. 4 w.p.i. 6 w.p.i. 8 w.p.i. 10 w.p.
A 1 4.83 14.49 28.98 6.04 2.42 6.04
2 5.33 9.66 24.15 8.70 4.24 4.83
3 4.83 7.25 28.98 7.25 3.63 2.42
4 4.83 8.70 21.79 4.83 4.83 4.83
mean ± 4.96 10.03 25.98 6.71 3.78 4.53
s.d. ±0.24 ±3.14 ±3.60 ±1.66 ±1.03 ±1.52
B 1 5.33 12.08 28.98 14.49 9.66 7.25
2 7.24 21.54 38.64 28.98 14.49 7.25
3 3.62 19.32 38.64 38.64 19.32 6.04
4 5.33 14.49 24.15 28.28 12.07 4.83
mean ± 5.38 16.86 32.60 27.60 13.89 6.34
s.d. ±1.48 ±4.34 ±7.24 ±9.94 ±4.13 ±1.16
C 1 2.42 12.08 38.64 28.98 14.66 9.66
2 9.66 19.32 28.98 24.15 12.07 4.83
3 7.25 20.48 38.64 28.98 24.15 9.66
4 7.25 7.18 38.64 28.98 8.45 9.66
mean ± 6.65 14.77 36.23 27.77 14.83 8.45




Peripheral eosinophil counts (cells per mm ) of rats challenged after 2 previous infections and treatments
Group a), challenged after treatment of a mature infection (Group B), challenge controls (Group C), first
infection controls (Group D^) and second infection controls (Group D^)
Rat No. 0 w * 2 w 4 w 6 w * 8 w 10 w 12 w* 14 w 16 w 18 v/ 20 w
A 1 104* 716 1943 1475* 245 562 217* 1170 858 1693 1547
2 118* 786 2110 274* 202 681 112* 464 526 1928 618
3 00* 1047 2710 433* 725 1238 112* 420 401 722 848
4 00* 2323 2536 256* 622 1147 254* 246 1252 832 734
5 124* 484 2103 1635* 383 874 190* 564 1411 2611 2396
6 102* 788 4754 306* 239 683 214* 293 100 1415 1070
7 00* 1557 3447 304* 715 842 559* 1123 2360 3012 1215
8 395* 2039 1873 1130* 2666 1594 296* 446 617 1603 1307
9 255* 1887 2436 1228* 2610 1446 127* 126 763 1617 1428
10 171* 929 3646 753* 992 933 325* 1242 1072 990 840
11 354* 1156 2074 379* 1123 1716 128* 365 1532 2332 1354
12 138* 1040 1494 262* 248 754 535* 860 1328 2605 951
13 149* 3388 3030 2516* 350 825 248* 1349 2640 3705 1610
14 152* 402 399 247* 699 1001 124* 694 587 1111 1492
mean ± 147* 1324 2468 799* 844 1021 246* 668 1103 1870 1243
s.d. ±119 ±831 ±1046 ±699 ±813 ±358 ±145 ±407 ±723 ±881 ±460
B 1 228* 462 268 924 665 496 408* 1610 824 840 954
2 226* 3366 2548 4592 765 380 460* 249 800 388 1118
3 633* 4180 3960 3916 2220 2142 1091* 1283 464 1508 2033
4 130* 1368 1664 1210 595 648 819* 999 920 1175 2261
5 232* 2226 3150 2472 1738 1467 980* 1080 1785 1235 1746
6 00* 1824 2754 1944 600 444 288* 340 1089 987 803
7 184* 1308 2860 2261 931 1404 864* 1552 776 712 364
8 00* 2125 2408 1112 1529 1664 00 * 380 1014 946 1248
9 99* 2736 3042 2958 840 204 91* 540 288 760 690
10 113* 246 450 555 568 198 97* 742 2280 4380 1845
11 264* 1800 2864 2002 1008 77 255* 680 1026 1584 861
12 135* 2880 4212 3979 1815 1526 610* 2235 3888 5616 2235
mean ± 186* 2043 2515 2327 1106 887 496* 974 1262 1677 1388
s.d. ±164 ±1143 ±1205 ±1310 ±568 ±704 ±371 ±606 ±986 ±1608 ±594
C 1 387 264
. 250 324 198 460 242* 1088 1464 2205 1443
2 248 238 472 452 868 324 339* 1988 2130 2465 2850
3 278 420 264 426 588 274 387* 1386 2160 2844 2037
4 495 234 212 291 336 220 345* 1332 1443 1017 739
5 125 242 234 285 188 201 297* 900 2086 2669 2599
6 268 396 216 198 356 440 363* 2898 2304 4212 5454
7 360 252 366 488 436 254 270* 2535 3792 4806 1496
8 196 198 202 111 00 214 357* 3475 2256 1840 1488
mean ± 294 280 277 321 371 298 325* 1950 2204 2757 2263
s.d. ±116 ±81 ±94 ±129 ±267 ±101 ±50 ±934 ±725 ±1230 ±1457
D 1 135* 696 1584 1848 2961
2 465* 548 1326 1395 802
3 00* 525 1332 2431 432
4 162* 966 2562 1395 1140
mean ± 190* 683 1701 1767 667
s.d. ±196 ±202 ±586 ±491 ±380
D2 1 89* 1529 1953 1980 300
2 96* 1632 1589 2058 304
3 110* 1368 1323 2856 455
4 196» 1683 2445 1200 106
mean ± 122* 1553 1827 2023 291
s.d. ±49* ±139 ±486 ±676 ±143
* Administration of infection
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Appendix Table 4.4
Serum glutamic dehydrogenase assays (micrcmoles product per litre of serum per minute)
of rats challenged after 2 previous infections and treatments (Group A), challenged after treatment
of a mature infection (Group B), challenge controls (Group C), first infection controls (Group Dj)
and second infection controls (Group D2)
Rat No. 0 w* 2 w 4 w 6 8 w 10 w 12 w* 14 w 16 w 18 w 20 w
A 1 2.42* 9.66 48.30 14.49* 14.49 16.91 10.87* 14.49 16.91 16.91 9.66
2 4.83* 14.49 38.70 9.66* 14.49 14.49 7.25* 7.25 9.66 9.66 9.66
3 4.83* 9.66 24.15 14.49* 12.08 14.49 7.25* 7.25 7.25 4.83 4.83
4 2.42* 9.66 33.81 16.91 * 19.32 24.15 14.49* 14.49 24.15 24.15 9.66
5 2.42* 14.49 48.30 18.98* 19.32 19.32 14.49* 14.49 19.32 16.91 14.49
6 4.83* 14.49 30.19 14.49* 16.49 24.15 12.08* 14.49 14.49 14.49 9.66
7 3.14* 11.59 57.96 24.15* 24.15 19.32 16.91* 16.91 19.49 19.49 9.66
8 3.38* 9.66 33.81 9.66* 14.49 19.32 7.24* 9.66 9.66 12.08 9.66
9 4.83* 16.91 48.30 14.49* 14.49 38.81 7.24* 12.08 16.91 24.16 14.49
10 4.83* 9.66 48.30 14.49* 14.49 24.15 9.66* 14.49 16.91 14.49 4.83
11 3.38* 9.66 28.98 8.46* 16.91 16.91 9.66* 10.87 12.08 16.91 9.66
12 4.83* 14.49 33.81 14.49* 16.91 33.81 12.08* 14.49 17.87 12.08 9.66
13 4.83* 9.66 48.30 13.52* 9.66 9.66 9.66* 12.08 24.16 24.15 16.91
14 2.42* 14.49 48.30 16.91* 24.15 33.81 14.49* 14.49 14.49 9.66 4.83
mean ± 3.81* 12.04 48.80 14.66* 16.75 21.74 10.96* 12.68 15.95 15.71 9.83
s.d. ±1.10 ±2.68 ±10.05 ±4.01 ±4.19 ±7.69 ±3.23 ±2.95 ±5.11 ±5.91 ±3.60
B 1 2.42* 9.66 24.15 33.81 14.49 9.66 7.25* 12.07 16.90 14.49 9.66
2 4.83* 12.07 53.15 44.26 38.64 21.74 9.66* 14.49 24.15 24.15 14.49
3 4.83* 9.66 66.91 62.79 24.15 9.66 9.66* 12.08 14.49 21.74 9.66
4 2.42* 7.24 24.15 24.15 9.66 9.66 7.25* 12.08 14.49 16.91 9.66
5 4.83* 9.66 53.13 50.71 26.56 12.08 12.08* 14.49 24.15 16.91 9.66
6 2.42* 12.07 33.81 26.56 7.25 7.25 4.83* 7.25 12.08 14.49 9.66
7 4.83* 9.66 24.15 15.70 7.25 7.25 4.83* 7.25 9.66 14.49 4.83
8 2.42* 18.11 53.13 50.71 21.74 14.49 9.66* 12.08 21.74 24.15 14.49
9 4.83* 16.90 43.47 26.56 7.25 4.8.3 4.83* 9.66 14.49 14.49 9.66
10 4.83* 4.83 14.49 16.91 12.07 3.62 4.83* 14.49 14.49 16.91 9.66
11 3.62* 14.49 43.47 43.47 14.49 14.49 4.83* 9.66 14.49 16.91 14.49
12 4.83* 7.24 33.81 30.19 24.15 9.66 9.66* 14.49 16.91 24.15 16.91
mean ± 3.93* 10.97 38.98 35.49 17.31 10.37 7.45* 11.67 16.50 18.32 11.07
s.d. ±1.16 ±3.97 ±15.77 ±14.79 ±9.81 ±4.90 ±2.62 ±2.69 ±4.59 ±4.05 ±3.33
C 1 4.83 4.83' 4.83 4.83 4.83 4.83 4.83* 1.66 24.15 33.81 9.66
2 2.42 3.61 3.61 4.83 3.61 3.61 4.83* 4.83 19.32 26.57 19.32
3 2.42 3.61 3.61 4.83 3.61 3.61 3.61 * 14.49 33.81 33.81 14.49
4 3.61 3.61 3.61 4.83 4.83 4.83 4.83 * 9.66 19.32 24.15 14.49
5 4.83 4.83 4.83 4.83 4.83 4.33 4.83 * 9.66 26.57 33.81 9.66
6 2.42 4.83 2.42 2.42 2.42 2.42 2.42 * 14.49 26.57 33.81 9.66
7 4.83 3.61 3.61 3.61 4.83 3.61 3.61 * 14.49 48.30 26.57 14.49
8 4.83 4.83 3.61 3.61 4.83 4.83 4.83 * 12.08 33.81 24.15 14.49
mean ± 3.77 4.22 3.77 4.22 4.22 4.07 4.22 * 11.17 28.98 29.59 13.28
s.d. ±1.20 ±0.65 ±0.77 ±0.92 ±0.92 ±0.90 ±0.92 ±3.14 ±9.57 ±4.61 ±3.42
D1 1 4.83* 12.08 24.15 28.98 9.66
2 2.42* 9.66 28.98 33.81 14.49
3 2.42* 9.66 33.81 48.30 19.32
4 4.83* 9.66 19.32 24.15 9.66
mean ± 3.63* 10.27 26.57 33.81 13.28
s.d. ±1.39 ±1.21 ±6.24 ±10.43 ±4.62
D7 1 4.83* 14.49 33.81 33.81 14.49
2 2.42* 7.25 28.98 24.15 9.66
3 2.42* 9.66 24.15 26.56 9.66
4 2.42* 14.49 33.81 48.30 14.49
mean ± 3.02* 11.47 30.19 33.21 12.08




ELISA values (units of absorbance) of rats challenged after two previous infections, and treatments (Group A),
challenged after treatment of a mature infection (Group B) and challenge controls (Group C)
Rat No. 0 w* 2 w 4 w 6 w * 8 w 10 w 12 w* 14 w 16 w 18 w 20 w
A 1 0.12* 0.20 0.24 0.40* 0.52 0.56 0.78* 0.80 0.80 0.86 0.74
2 0.18* 0.24 0.21 0.46* 0.58 0.62 0.68* 0.84 0.74 0.75 0.72
3 0.15* 0.23 0.33 0.54* 0.58 0.80 0.72* 0.72 0.72 0.65 0.64
4 0.22* 0.28 0.34 0.40* 0.48 0.57 0.61 0.63 0.68 0.74 0.90
5 0.20* 0.36 0.37 0.48* 0.58 0.43 0.56* 0.64 0.70 0.70 0.68
6 0.15* 0.23 0.29 0.53* 0.66 0.62 0.68* 0.70 0.66 0.59 0.61
7 0.20* 0.31 0.33 0.35* 0.42 0.52 0.64* 0.68 0.69 0.68 0.55
8 0.22* 0.40 0.42 0.49* 0.53 0.56 0.62* 0.72 0.74 0.76 0.72
9 0.12* 0.41 0.47 0.56* 0.60 0.53 0.64* 0.70 0.71 0.72 0.76
10 0.08* 0.12 0.34 0.41* 0.54 0.56 0.68* 0.72 0.74 0.80 0.78
11 0.09* 0.18 0.30 0.48* 0.55 0.58 0.82* 0.90 0.90 0-92 0.78
12 0.10* 0.29 0.40 0.46* 0.56 0.56 0.76* 0.64 0.70 0.72 0.68
13 0.16* 0.23 0.30 0.41* 0.60 0.62 0.62* 0.52 0.60 0.90 0.80
14 0.04* 0.20 0.24 0.56* 0.54 0.58 0.64* 0.66 0.74 0.76 0.72
mean ± 0.07* 0.26 0.33 0.47* 0.55 0.58 0.68* 0.71 0.72 0.75" 0.72
s.d. +0.08 ±0.08 ±0.07 ±0.07 ±0.06 ±0.08 +0.07 ±0.09 ±0.07 ±0.09 +0.09
B 1 0.08* 0.11 0.34 0.52 0.58 0.58 0.60* 0.68 0.72 0.78 0.74
2 0.06* 0.19 0.36 0.39 0.56 0.54 0.62* 0.60 0.64 0.70 0.70
3 0.10* 0.23 0.30 0.46 0.55 0.48 0.60* 0.70 0.72 0.76 0.74
4 0.09* 0.19 0.32 0.42 0.52 0.62 0.58* 0.72 0.68 0.72 0.64
5 0.10* 0.20 0.28 0.42 0.48 0.54 0.68* 0.74 0.78 0.80 0.74
6 0.08* 0.17 0.24 0.38 0.48 0.42 0.42* 0.60 0.72 0.74 0.68
7 0.15* 0.23 0.34 0.44 0.52 0.48 0.56* 0.68 0.74 0.68 0.63
8 0.12* 0.21 0.32 0.43 0.62 0.54 0.58* 0.72 0.70 0.78 0.78
9 0.09* 0.18 0.30 0.40 0.56 0.52 0.62* 0.74 0.68 0.72 0.78
10 0.09* 0.20 0.26 0.45 0.51 0.52 0.64* 0.76 0.78 0.74 0.70
11 0.10* 0.23 0.39 0.44 0.54 0.48 0.56* 0.60 0.74 0.70 0.64
12 0.11* 0.24 0.38 0.43 0.54 0.46 0.58* 0.69 0.70 0.72 0.70
mean ± 0.10* 0.20 0.32 0.43 0.54 0.52 0.59* 0.69 0.72 0.74 0.71
s.d. +0.02 ±0.04 ±0.05 ±0.04 ±0.04 ±0.05 ±0.06 ±0.06 ±0.04 ±0.04 ±0.05
C 1 0.12* 0.41 0.47 0.42 0.60
2 0.19* 0.20 0.44 0.54 0.50
3 0.09* 0.21 0.24 0.42 0.48
4 0.16* 0.33 0.45 0.60 0.52
5 0.10* 0.21 0.34 0.48 0.56
6 0.14* 0.32 0.34 0.52 0.54
7 0.08* 0.16 0.29 0.38 0.48
8 0.08* 0.14 0.38 0.53 0.44
mean ± 0.12* 0.25 0.37 0.49 0.52
s.d. +0.04 +0.09 ±0.08 ±0.07 ±0.05




Peripheral eosinophil counts (cells per mm ) of rabbits with 2 previous infections and treatments




0 w* 2 w 4w 6 w * 8 w 10 w 12 w* 14 w 16 w 18 w 20 w
A 1 170* 875 2234 563* 3307 1316 794* 405 1716 2194 2149
2 204* 2667 4416 6271* 3893 11046 748* 2143 3387 4909 4904
3 81* 685 1709 922* 4832 3262 1126* 1619 1944 2595 1087
4 256* 1418 2221 1815* 4041 5423 2030* 810 1725 2308 1959
5 78* 1016 3028 667* 4345 2787 1484* 824 1779 1979 2985
6 245* 1461 1534 1096* 5701 4341 1412* 1297 2163 2550 6764
mean ± 172* 1354 2524 1889* 4353 4696 1266* 1183 2119 2756 3308
s.d. ±78 ±711 ±1063 ±2192 ±831 ±3409 ±482 ±632 ±644 ±1079 ±2130
B 1 00 188 00 00 292 155 290* 141 1708 2204 3787
2 145 00 00 119 146 248 250* 433 843 2175 2411
3 85 218 00 105 00 00 296* 326 3294 5946 5304
4 268 344 151 190 352 148 324* 473 3002 1742 3091
5 254 157 318 446 308 260 270* 00 934 2081 2421
6 210 324 330 180 578 531 338* 364 4500 3737 2192
7 105 353 00 00 107 290 214* 486 166 1773 1819
mean ± 152 226 114 149 255 233 283* 318 2291 2808 3004
s.d. ±98 ±127 ±154 ±152 ±190 ±164 ±43 ±183 ±1371 ±1539 ±1202
C 1 194* 527 1843 3763 2772
2 110* 697 2673 5840 3772
mean ± 152* 612 2258 4802 3272
s.d. ±59 ±120 ±587 ±1469 ±707
D 1 00* 430 2388 1966 1274
2 148* 89 1636 2242 1321
mean ± 74* 260 2012 2104 1297
s.d. ±105 ±241 ±532 ±195 ±33
* Administration of infection
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Appendix Table 4.7
Serum glutamic dehydrogenase assays (micromoles product per litre of serum per minute) of rabbits
with 2 previous infections and treatments (Group A), challenge controls (Group B), first infection
controls (Group C) and second infection controls (Group D)
Rabbit
No. 0 w* 2 w 4 w 6 w * 8 w 10 w 12 w* 14 w 16 w 18 w 20 w
A 1 3.62* 9.66 19.32 24.15* 36.23 28.98 12.08* 8.45 12.08 9.66
2 4.83* 12.08 19.32 16.91* 14.49 16.91 7.25* 12.08 12.08 8.45 7.25
3 7.25* 15.70 15.70 24.15* 14.49 14.49 4.83* 9.66 12.08 14.49 9.66
4 8.45* 19.32 21.44 9.66* 24.15 24.15 14.49* 9.66 12.08 14.49 7.25
S 4.83* 7.25 16.91 14.49* 14.49 28.98 4.83* — - 7.25 4.83
6 2.42* 14.49 16.91 16.91* 28.98 28.98 14.49* 19.32 - 19.32 16.91
mean ± 5.23* 13.08 18.27 17.71* 22,14 23.75 9.66* 11.83 12.08 12.80 9.26
s.d. ±2.25 ±4.35 ±2.12 ±5.65 ±9.22 ±6.55 ±4.58 ±4.39 ±00 ±4.95 ±4.16
B 1 2.42 2.42 2.42 2.42 2.42 2.42 3.63* 9.66 19.32 25.36 14.49
2 2.42 2.42 ■2.42 2.42 2.42 2.42 2.42* 4.83 25.36 25.36 19.32
3 2.42 2.42 2.42 2.42 2.42 2.42 2.42* 6.04 25.36 25.36 9.66
4 2.42 2.42 2.42 2.42 1.21 2.42 3.63* 9.66 16.91 24.15 7.25
5 1.21 1.21 1.21 2.42 1.21 2.42 4.83* 4.83 16.91 24.15 21.74
6 1.21 1.21 1.21 2.42 . 1.21 2.42 4.83* 9.66 16.91 19.32 19.32
7 1.21 2.42 1.21 2.42 1.21 2.42 3.63* 9.66 25.36 25.36 7.25
mean ± 1.90 2.07 1.90 2.42 1.73 2.42 3.63* 7.76 20.38 24.15 14.15
s.d. ±0.42 ±0.59 ±0.65 ±00 ±0.65 ±00 ±0.98 ±2.40 ±4.28 ±2.20 ±6.14
C 1 *oo 4.83 19.32 19.32 12.08
O 2.42 6.04 19.32 25.36 21.72
mean ± 1.21 * 5.44 19.32 22.34 16.90
s.d. ±1.71 ±0.85 ±00 ±4.27 ±6.82
D 1 3.63* 6.04 25.36 18.12 14.49
2 2.42* 3.63 13.29 32.61 19.32
mean ± 3.03* 4.84 19.33 25.37 16.91
s.d. ±0.86 ±1.70 ±8.53 ±10.25 ±3.41
* Administration of infection
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Appendix Table 4.8
ELISA values (units of absorbance) of rabbits with 2 previous infections and treatments (Group A),
challenge controls (Group B), first infection controls (Group C) and second infection controls (Group D)
Rabbit
No. 0 w* 2 w 4 w 6 w* 8 w 10 w 12 w* 14 w 16 w 18 w 20 w
A 1 0.39* 0.74 1.48 1.60* 2.68 2.78 2.82* 2.70 2.82 2.80 2.80
2 0.34* 0.75 1.36 2.04* 2.40 2.52 2.96* 2.60 2.74 2.60 2.60
3 0.33* 1.01 1.18 1.64* 2.30 2.50 2.80* 3.60 2.98 2.68 2.88
4 0.44* 0.90 1.01 1.70* 2.10 2.36 2.84* 2.76 2.82 2.8S 3.60
5 0.50* 0.98 1.48 1.76* 2.84 3.20 3.60* 2.88 2.86 2.73 3.60
6 0.35* . 0.96 1.68 2.52* 2.84 2.90 2.92* 2.60 2.66 3.60 3.60
mean ± 0.39* 0.89 1.37 1.88* 2.53 2.71 2.99* 2.69 2.81 2.88 3.18
s.d. ±0.07 ±0.12 ±0.24 ±0.35 ±0.31 ±0.31 ±0.31 ±0.11 ±0.11 ±0.36 ±0.47
B 1 0.15 0.20 0.10 0.15 0.20 0.20 0.25* 0.60 2.25 1.75 2.20
2 0.15 0.15 0.20 0.15 0.25 0.20 0.20* 0.60 1.40 1.85 1.25
3 0.50 0.50 0.40 0.45 0.35 0.35 0.35* 1.05 1.15 1.20 1.25
4 0.50 0.30 0.35 0.35 0.35 0.35 0.40* 0.65 0.90 1.50 2.30
5 0.10 0.20 0.25 0.25 0.20 0.25 0.25* 0.65 0.95 1.15 1.80
6 0.16 0.15 0.20 0.25 0.25 0.20 0.25* 0.60 0.90 1.55 1.95
7 0.15 0.15 0.21 0.15 0.20 0.20 0.15* 0.65:-' 0.95 1.35 1.50
mean ± 0.24 0.24 0.24 0.25 0.26 0.25 0.26* 0.69 1.21 1.48 1.75
s.d. ±0.17 ±0.14 ±0.10 ±0.11 ±0.07 ±0.07 ±0.09 ±0.17 ±0.49 ±0.26 ±0.42
C 1 0.42* 0.88 2.24 1.78 1.88
2 0.44* 0.98 1.84 2.18 2.06
mean ± 0.43* 0.93 2.04 1.98 1.97
s.d. ±0.01 ±0.07 ±0.28 ±0.28 ±0.13
D 1 0.43* 0.96 1.01 1.36 1.72
2 0.30* 0.86 1.28 1.80 1.88
mean ± 0.37* 0.91 1.15 1.58 1.80
s.d. ±0.09 ±0.07 ±0.19 ±0.31 ±0.11
* Administration of infection
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Appendix Table 4.9
Peripheral eosinophil counts (cell per mm ) of rabbits which were challenged after treatment
of a mature infection (Group A) and challenge controls (Group B)
Rabbit No. 0 w 2 w.p.i. 4 w.p.i. 6 w.p.i. 8 W.p.i.
A 1 00 974 535 2670 2040
2 625 1536 2331 2128 2772
3 404 1330 1365 744 1734
4 00 546 1212 2016 1717
5 216 360 786 2299 1717
6 00 976 1375 2928 2052
mean 1 s.d. 207±261 9531447 12671620 21301760 20051407
B 1 116 525 819 894 1113
2 00 736 336 795 1155
3 476 960 2448 2224 868
4 00 520 714 3640 1833
5 00 1287 1456 3480 2355
6 00 873 1019 2904 1768
7 00 510 468 1912 1326
8 00 438 720 424 2256
mean ±s.d. 741167 7311293 997+678 203411248 1584+551
Appendix Table 4.10
Serum glutamic dehydrogenase assays (micromoies product per litre of serum per minute) of
rabbits which were challenged after treatment of a mature infection (Group A) and challenge
controls (Group B)
Rabbit No. 0 w 2 w.p.i. 4 w.p.i. 6 w.p.i. 8 w.p.i.
A 1 4.83 9.66 24.15 24.15 9.66
2 4.83 14.49 28.98 48.30 9.66
3 2.42 14.49 14.49 24.15 19.32
4 2.42 9.66 33.81 48.30 9.66
5 00 4.83 24.15 28.98 7.25
5 4.83 9.66 33.81 24.15 00
mean 1 s.d. 3.22H.97 10.4713.64 26.5717.33 33.01111.99 9.2616.19
B 1 2.42 9.66 19.32 33.81 19.32
2 2.42 9.66 19.32 33.81 9.66
3 2.42 7.25 28.98 33.81 16.91
4 00 4.83 19.32 24.15 2.42
5 2.42 7.25 19.32 48.30 9.66
6 2.42 14.49 19.49 19.32 19.32
7 4.83 9.66 14.49 24.15 7.25
8 4.83 14.49 30.64 63.29 19.32




Peripheral eosinophil counts (cells per mm ) of rats implanted s/c with
living flukes before challenge (Group A) and infection controls (Group B)
Rat No. 0 w 2 w.a.i. 4 w.a.i. 6 w.a.i. 8 w.a.i.
A 1 1040 178 302 00 816
2 1298 380 1368 129 284
3 490 355 2736 1072 475
4 152 292 570 122 678
5 1647 477 1062 314 920
6 576 783 96 00 1364
7 1120 1725 324 121 520
8 430 336 1380 1536 1932
9 96 1164 1834 1859 1740
10 94 380 1224 396 776
11 91 1397 1727 2405 762
12 99 246 1261 2414 1802
mean ± s.d. 594±548 642±510 11571756 8641949 10051561
B* 1 00 816 1525 1419 1704
2 186 981 229 2145 685
3 90 208 600 678 172
4 231 608 2832 3270 2814
5 198 848 1464 1392 642
6 68 737 2717 1134 972
7 00 1062 1169 3195 1200
8 79 405 1680 630 2044
mean ± s.d. 106±89 708+288 15271911 1732+1040 12791862
*Also used as an infection control group in experiment (6.1) carried out at the same time.
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Appendix Table 5.2
Serum glutamic dehydrogenase assays (inicromoles per litre of serum per minute)
of rats implanted s/c with living flukes before challenge (Group A) and infection controls (Group B)
Rat No. 0 w 2 w.a.i. 4 w.a.i. 6 w.a.i. 8 w.a.i.
A 1 2.42 2.42 00 2.42 00
2 4.83 00 4.83 4.83 4.83
3 4.83 2.42 28.98 9.66 9.66
4 2.42 2.42 4.83 9.66 2.42
5 2.42 4.33 4.83 4.83 4.83
6 4.83 4.83 4.83 4.83 4.83
7 4.83 4.83 7.25 2.42 2.42
8 2.42 2.42 2.42 7.25 2.42
9 4.83 4.83 24.15 24.15 28.98
10 2.42 2.42 2.42 2.42 2.42
11 4.83 2.42 28.98 19.32 9.66
12 00 2.42 9.66 9.66 00
mean ± s.d. 3.42±1.61 3.02±1.50 10.27±10.66 8.45±6.87 6.04±7.88
B* 1 4.83 7.25 19.32 19.32 9.66
2 00 7.25 19.32 19.32 9.66
3 2.42 9.66 14.49 19.32 4.83
4 2.42 9.66 43.47 14.49 9.66
5 2.42 9.66 19.32 9.66 9.66
6 4.83 9.66 43.47 4830 9.66
7 4.83 14.49 19.32 28.98 9.66
8 2.42 7.25 14.49 14.49 4.83
mean ± s.d. 3.02±1.71 9.36±2.39 24.15+12.11 21.74+12.11 8.4512.24
* Also used as an infection control group in experiment (6.1) carried out at the same time.
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Appendix Table 5.3
Peripheral eosinophil counts (cells per mm ) of rabbits implanted s/c with living
flukes before challenge (Group A) and infection controls (Group B)
Rabbit No. Ow 2 w.a.i. 4 v.a.i. 6 w.a.i. 8 w.ai.
A 1 428 1785 570 1428 714
2 424 945 3591 3318 1677
3 792 1074 274 3759 1794
4 987 1148 3381 2366 732
5 605 966 2310 2112 1476
6 408 980 2535 1824 1890
7 292 808 2028 2197 1548
8 715 1690 1885 2282 1375
mean ± s.d. 581±235 1174+362 2071±1184 2410±765 1400±450
B 1 497 869 2288 5096 2352
2 260 776 1563 3388 2360
3 575 1182 1409 3232 1932
4 100 2166 2506 2669 2340
5 1072 882 1200 2768 1710
mean ± s.d. 500±370 1175±574 1793+571 3430±979 2138±300
Appendix 5.4
Serum glutamic dehydrogenase (micromoles product per litre of serum per minute) of
rabbits implanted s/c with living flukes before challenge (Group A) and infection controls (Group B)
Rabbit No. 0 W 2 w.a.i. 4 w.a.i. 6 w.a.i. 8 w.a.i.
A 1 4.83 19.32 19.32 33.81 9.66
2 4.83 14.49 19.32 24.15 14.49
3 00 24.15 24.15 19.32 9.66
4 2.42 14.49 19.32 28.98 14.49
5 2.42 19.32 24.15 19.32 9.66
6 00 9.66 14.49 19.32 9.66
7 2.42 9.66 14.49 19.32 9.66
8 2.42 9.66 19.32 14.49 9.66
mean ± s.d. 1.81±1.71 15.09±5.44 19.32±3.65 22.34±6.29 10.87+2.24
B 1 4.83 24.15 24.15 14.49 9.66
2 00 9.66 19.32 33.81 14.49
3 00 9.66 14.49 19.32 9.66
4 00 9.66 14.49 19.32 9.66
5 00 9.66 14.49 14.49 9.66
mean ± s.d. 0.97±2.16 12.56+6.48 17.39±4.32 20.29±7.94 10.63±2.16
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Appendix Table 5.5.
Serum glutamic dehydrogenase assays (micromoles product per litre of serum per minute) of
rats implanted i/p with 1 or 2 mature flukes in chambers (Group A), rats implanted with empty
chambers (Group B), non-implanted infection controls (Group C), rats implanted i/p with 1 or 2
dead flukes in chambers (Group D) and rats implanted i/p with 1 or 2 in mature flukes (Group E)
Rat No. 0 w. 2 w.a.i. 4 w.a.i. 6 w.a.i. S w.a.i.
A 1 4.83 4.83 9.66 14.49 4.83
2 4.83 9.66 24.15 24.15 9.66
3 4.83 9.66 14.49 19.32 14.49
4 00 4.83 14.49 14.49 9.66
5 4.83 19.32 24.15 19.32 9.66
6 4.83 9.66 14.49 14.49 4.83
7 - 4.83 14.49 28.98 14.49 00
8 4.83 9.66 9.66 9.66 4.83
9 9.66 14.49 25.81 19.32 9.66
10 2.42 9.66 38.64 19.32 2.42
11 4.83 9.66 14.49 14.49 4.83
12 4.83 9.66 38.64 38.64 9.66
mean ± s.d. 4.63±2.17 10.47±4.03 21.47+10.24 18.52±7.38 7.04±4.05
B 1 4.83 14.49 38.64 48.30 28.98
2 4.83 9.66 38.64 19.32 9.66
3 4.83 9.66 13.32 19.32 9.66
4 4.83 14.49 43.47 38.64 19.32
5 4.83 9.66 43.47 14.49 19.32
6 4.83 19.32 38.64 38.64 9.66
7 4.83 19.32 38.64 38.64 9.66
8 4.83 9.66 28.98 28.98 19.32
mean ±s.d. 4.83±00 13.28±4.28 36.23+8.16 30.79±12.09 15.70±7.19
C 1 4.83 19.32 48.30 48.30 19.32
2 4.83 9.66 33.81 33.81 14.49
3 4.83 19.32 53.13 19.32 19.32
4 4.83 9.66 19.32 28.98 14.49
5 4.83 14.49 33.81 14.49 9.66
6 4.83 19.32 57.84 28.98 14.49
7 00 4.83 33.81 33.81 9.66
mean ± s.d. 4.14±1.82 13.80±5.87 40.00±13.55 29.67±10.95 14.49+3.94
D 1 4.83 19.32 48.30 48.30 19.32
2 4.83 19.32 38.64 28.98 9.66
3 9.66 14.49 48.30 48.30 19.32
4 00 9.66 48.30 38.64 9.66
5 4.83 9.66 48.30 48.30 19.32
6 4.83 14.49 57.84 48.30 19.32
mean ± s.d. 4.83±3.05 14.49±4.32 48.28+6.07 43.47±8.08 16.10±4.99
E 1 4.83 4.83 28.98 19.32 9.66
2 4.83 9.66 33.81 19.32 9.66
3 4.83 9.66 19.32 9.66 9.66
4 4.83 4.83 19.32 4.83 4.83
5 4.83 9.66 19.32 19.32 9.66
6 4.83 19.32 19.32 9.66 4.83
mean ± s.d. 4.83±00 9.66±5.29 23.35+6.42 13.69±6.42 8.05±2.49
Appendix Table 5.6
Serum glutamic dehydrogenase assays (micromoles product per litre of serum per minute) of
rats implanted s/c with 2 mature flukes in chambers which were removed before challenge
(Group A)ji"ats implanted s/c with 2 empty chambers which were removed before challenge
(Group B), rats implanted with 2 mature flukes in chambers (Group C), rats implanted s/c
with 2 empty chambers (Group D), rats implanted i/p with 2 mature flukes in chambers
(Group E) and rats implanted i/p with empty chambers (Group F)
Rat No 0 W 2 w.a..i. 4 w.a.i. 6 w.a.i. 8 w.ai.
A 1 4.83 4.83 4.83 4.83 4.83
2 4.83 9.66 9.66 14.49 4.83
3 4.83 4.83 4.83 14.49 9.66
4 2.42 4.83 9.66 9.66 9.66
5 4.83 4.83 9.66 9.66 9.66
6 9.66 9.66 9.66 9.66 4.83
7 4.83 14.49 14.49 28.98 9.66
8 4.83 4.83 4.83 4.83 4.83
mean ±s.d. 5.13±2.01 7.25+3.65 8.45±3.42 12.08±7.75 7.25±2.58
B 1 9.66 14.49 33.81 38.64 9.66
2 4.83 14.49 38.64 48.30 9.66
3 4.83 9.66 38.64 38.64 14.49
4 4.83 9.66 48.30 48.30 14.49
5 4.83 14.49 24.15 19.32 9.66
6 4.83 9.66 24.15 24.15 9.66
7 9.66 9.66 48.30 38.64 9.66
8 4.83 9.66 24.15 33.81 9.66
9 4.83 14.49 38.64 33.81 14.49
mean ± s.d. 5.90±2.13 ll.81i2.55 35.42±9.66 35.96+9.69 11.27±2.41
C 1 4.83 9.66 14.49 24.15 9.66
2 4.83 9.66 28.98 28.98 9.66
3 4.83 9.66 14.49 28.98 9.66
4 4.83 14.49 14.49 14.49 9.66
5 4.83 4.83 4.83 9.66 00
mean ± s.d. 4.83±00 9.66±3.42 15.46±8.64 21.25+8.77 7.73+4.32
D 1 9.66 9.66 24.15 24.15 4.83
2 9.66 9.66 19.32 33.81 4.83
3 4.83 9.66 24.15 24.15 9.66
4 4.83 9.66 33.81 48.30 9.66
5 4.83 9.66 48.30 48.30 9.66
mean ± s.d. 6.76±2.65 9.66±00 29.95±10.31 35.74±12.12 7.73±2.65
E 1 4.83 4.83 9.66 14.49 9.66
2 4.83 9.66 14.49 14.49 9.66
3 4.83 4.83 4.83 9.66 4.83
4 4.83 9.66 14.49 14.49 9.66
5 4.83 9.66 24.15 24.15 14.49
6 2.42 2.42 4.83 2.42 4.83
7 4.83 9.66 14.49 14.49 4.83
8 4.83 4.83 4.83 9.66 9.66
mean ± s.d. 4.53±0.85 6.94±3.01 11.47+6.80 12.98±6.18 8.45±3.42
F 1 9.66 9.66 33.81 33.81 4.83
2 4.83 9.66 33.81 33.81 9.66
3 9.66 14.49 48.30 38.64 14.49
4 4.83 9.66 19.32 19.32 4.83
5 4.83 9.66 33.81 24.15 4.83
6 4.83 9.66 38.81 38.64 9.66
7 4.83 9.66 38.81 33.81 9.66
mean ± s.d. 6.21+2.36 10.35±1.83 35.24±8.71 31.74±7.3 8.28±3.65
Appendix Table 5.7
Serum glutamtic dehydrogenase assays (micromoles product per litre of serum per minute)
of rats implanted i/p with 2 mature flukes in chambers twice at an interval of 12 weeks
before challenge (Group A) and controls similarly implanted with empty chambers (Group B)
Rat No. 0 w. 2 w.a.i. 4 w a.i. 6 w.a.i. 8 w.a.i.
A 1 4.83 4.83 4.83 9.66 4.83
2 4.83 4.83 4.83 4.83 4.83
3 2.42 00 4.83 4.83 4.83
4 2.42 4.83 2.42 4.83 9.66
5 9.66 9.66 4.83 14.49 14.49
6 4.83 4.83 4.83 9.66 4.83
7 4.83 4.83 4.83 4.83 4.83
mean ± s.d. 4.83±2.41 4.83+2.79 4.4910.91 7.5913.80 6.90+3.80
B 1 4.83 9.66 19.32 24.15 4.83
2 4.83 14.49 33.81 48.30 9.66
3 9.66 14.49 28.98 38.64 14.49
4 4.83 14.49 38.64 38.64 14.49
5 4.83 9.66 24.15 48.30 14.49
6 4.83 9.66 38.64 38.64 9.66
mean 1 s.d. 5.64±1.97 12.0812.65 30.5917.89 39.4518.86 11.27+3.94
Appendix Table 6.1
Peripheral eosinophil counts (cells per mm ) of rats injected with immune rat serum (Group A),
challenge controls (Group B) and rats injected with normal rat serum (Group C)
Rat No. 0 w 2 w.a.i. 4 w.ai. 6 w.ai. 8 w.a.i.
A 1 00 588 515 510 297
2 00 917 928 832 186
3 00 714 636 101 640
4 260 1075 444 340 700
5 292 776 430 525 156
6 00 623 801 1248 525
7 356 1573 840 1601 744
8 00 864 695 1554 5712
9 00 900 854 424 264
10 80 384 1140 1815 744
11 94 384 882 490 225
12 243 898 720 1964 1133
mean ± s.d. 110±137 808±321 740+211 9501648 94311530
B* 1 00 816 1525 1419 1704
2 186 981 229 2145 685
3 90 208 600 678 172
4 231 608 2832 3270 2814
5 198 848 1464 1392 642
. 6 68 737 2717 1134 972
7 CO 1062 1169 3195 1200
8 79 405 1680 630 2044
mean ± s.d. 106±89 708±288 1527±911 173211040 12791862
* Also used as an infection control group in experiment (5.1) carried out at the same time
C 1 00 610 465 564 520
It 122 540 910 1080 1032
3 00 372 848 1056 380
4 97 1736 1736 1768 267
5 84 873 2540 3097 783
6 80 1056 1414 1530 984
mean 1 s.d. 63±51 864±491 13181747 15151879 66H319
Appendix Table 6.2
Serum glutamic dehydrogenase assays (micromoles product per litre of serum per minute)
of rats injected with immune rat serum (Group A), challenge controls (Group B) and rats
injected with normal rat serum (Group C)
Rat No. 0 w. 2 w.a.i. 4 w.a.i. 6 w.a.i. 8 w.ai.
A 1 4.83 2.42 2.42 2.42 2.42
2 2.42 2.42 4.83 4.83 00
3 2.42 00 2.42 4.83 2.42
4 2.42 2.42 4.83 4.83 00
5 00 2.42 2.42 2.42 00
6 2.42 00 4.83 4.83 4.83
7 4.83 9.66 14.49 1932 9.66
8 00 9.66 14.49 14.49 4.83
9 00 4.83 14.49 14.49 9.66
10 2.42 4.83 2.42 4.83 4.83
11 2.42 2.42 2.42 2.42 2.42
12 4.83 4.83 4.83 4.83 4.83
mean ± s.d. 2.42±1.78 3.83±3.17 6.24±5.09 7.05+5.68 3.83±3.33
B* 1 4.83 7.25 19.32 1932 9.66
i
£ 00 7.25 19.32 19.32 9.66
3 2.42 9.66 14.49 19.32 4.83
4 2.42 9.66 43.47 14.49 9.66
5 2.42 9.66 19.32 9.66 9.66
6 4.83 9.66 43.47 4830 9.66
7 4.83 14.49 19.32 28.98 9.66
8 2.42 7.25 14.49 14.49 4.83
mean ± s.d. 3.02±1.71 9.36±2.39 24.15±12.11 21.74+12.11 8.45±2.24
* Also used as a infection control group in experiment (5.1) carried out at the same time
C 1 4.83 9.66 9.66 9.66 4.83
■L 2.42 4.83 36.23 48.30 19.32
3 4.83 4.83 9.66 9.66 9.66
4 4.83 9.66 38.64 19.32 9.66
5 4.83 4.83 33.81 33.81 19.32
6 4.83 9.66 19.32 24.15 1932
mean ± s.d. 4.83±0.98 7.25±2.65 24.55±1335 24.15±14.97 13.69±6.42
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Appendix Table 6.3
Peripheral eosinophil counts (cells per mm^) of rabbits injected with immune rabbit serum (Group A),
rabbits injected with normal rabbit serum (Group B) and challenge controls (Group C)
Rabbit No. 0 w 2 w.a.i. 4 w.a.i. 6 w.a.i. 8 w a.i. 10 w.a.i.
A 1 128 338 3255 886 5482 1033
2 00 668 1724 2688 4763 1639
3 00 1404 3158 2448 1003 357
4 00 202 2250 1231 2859 1046
5 210 327 2219 3740 1571 1065
mean ± 67 587 2521 2198 3135 1028
s.d. ±97 ±487 ±660 ±1155 ±1951 ±454
B 1 442 328 2944 6188 1736 1784
2 298 175 691 3191 1273 1328
3 00 202 1558 4014 2095 785
4 369 119 2655 3522 1237 1615
5 99 509 3771 2519 583 2736
mean ± 241 266 2323 3886 1384 1649
s.d. ±185 ±155 ±1208 ±1396 ±571 ±715
C 1 00 140 1162 2217 999 508
2 165 547 3211 2943 1468 558
3 187 93 778 2553 929 446
4 291 390 654 1304 664 253
mean ± 160 292 1451 2254 1015 441
s.d. ±120 ±213 ±1192 ±699 ±334 ±133
Appendix Table 6.4
Serum glutamic dehydrogenase assays (micromoles product per litre of serum per minute) of rabbits
injected with immune rabbit serum (Group A), rabbits injected with normal rabbit serum (Group B)
and challenge controls (Group C)
Rat No. 0 w 2 w.a.i. 4 w.a.i. 6 w.a.i. 8 w.a.i. 10 w.a.i.
A 1 2.42 14.49 35.47 19.32 4.83 2.42
2 4.83 12.08 31.40 33.81 14.49 2.42
3 4.83 14.49 21.74 24.15 9.66 2.42
4 4.83 14.49 21.74 24.15 9.66 2.42
5 4.83 9.66 21.74 19.32 9.66 3.63
mean ± 4.35 13.04 26.42 24.15 9.66 2.66
s.d. ±1.08 ±2.16 ±6.57 ±5.92 ±3.42 ±0.55
B 1 4.83 9.66 24.15 24.15 9.66 2.42
2 2.42 9.66 38.64 38.64 9.66 4.83
3 4.83 9.66 28.98 33.81 9.66 2.42
4 2.42 9.66 38.64 38.64 4.83 2.42
5 2.42 7.25 19.32 19.32 9.66 2.42
mean ± 3.38 9.18 29.95 30.91 8.69 2.90
s.d. ±1.32 ±1.08 ±8.64 ±8.77 ±2.16 ±1.08
C 1 2.42 14.49 24.15 33.81 9.66 2.42
2 2.42 14.49 33.81 24.15 9.66 4.83
3 2.42 7.25 28.98 33.81 9.66 2.42
4 2.42 9.66 14.49 19.32 9.66 2.42
mean ± 2.42 11.47 25.36 27.77 9.66 3.02




Peripheral eosinophil counts (cell per mrn^) of rabbits injected with immune rat seru (Group A),
rabbits injected with normal rat serum (Group B), challenge controls (Group C), rats injected with
immune rat serum (Group D) and rats injected with normal rat serum (Group E)
Animal No. 0 w. 2 w.a.i. 4 w.a.i. 6 w.a.i. 8 w.a.i.
A 1 115 00 1458 882 1062
2 81 00 440 2224 4950
3 00 124 444 1196 581
4 00 535 3360 4080 1648
5 71 492 660 1341 3900
6 85 450 475 2142 1320
7 00 312 606 3401 1573
mean ± s.d. 50±48 273±231 106311073 218011187 214711623
B 1 279 354 432 3570 976
2 142 385 1526 4077 1234
3 00 410 896 2864 1806
4 89 546 1344 3297 1764
mean ± s.d. 128±117 424185 10501489 34521508 14451407
C* 1 116 525 819 894 1113
2 00 736 336 795 1155
3 476 960 2448 2224 868
4 00 520 714 3640 1833
5 00 1287 1456 3480 2355
6 00 873 1019 2904 1768
7 00 510 468 1912 1326
8 00 438 720 424 2256
mean ± s.d. 74+167 7311293 9971678 203411248 15841551
D 1 00 00 752 763 420
2 128 130 855 651 93
3 00 00 783 1792 79
4 00 00 2599 984 308
5 00 99 1183 1218 00
6 00 115 2227 616 384
mean 1 s.d. 21+52 57163 13991808 10041447 2141178
E 1 00 531 1445 1078 798
2 00 1074 1960 1914 705
3 88 400 1955 1356 896
4 00 749 1111 913 666
5 00 484 882 2142 968
mean 1 s.d. 17±39 6471271 14701487 14801530 8061126
* Also used as an infection control in experiment (4.4) carried out at the same time
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Appendix Table 6.6
Serum glutamic dehydrogenase assays (micromoles product per litre of serum per minute)
of rabbits injected with immune rat serum (Group A), rabbits injected with normal rat
serum (Group B), challenge controls (Group C), rats injected with immune rat serum
(Group D) and rats injected with normal rat serum (Group E)
Animal No. 0 W 2 w.a.i. 4 w.a.i. 6 w.a.i. 8 w.a.i.
A 1 2.42 4.83 9.66 14.49 24.15
2 2.42 4.83 14.49 14.49 14.49
3 4.83 2.42 7.25 9.66 00
4 00 2.42 19.32 9.66 4.83
5 2.42 2.42 14.49 24.15 4.83
6 4.83 4.83 9.66 19.32 9.66
7 4.83 4.83 9.66 14.49 4.83
mean Is.d. 3.11±1.82 3.80±1.29 12.08±4.18 15.18±S.16 8.9718.10
B 1 2.42 4.83 19.32 14.49 9.66
2 00 4.83 14.49 14.49 9.66
3 2.42 4.83 19.32 33.81 9.66
4 2.42 9.66 19.32 33.81. 9.66
mean ± s.d. 1.82±1.21 6.04±2.41 18.11+2.41 24.15+11.15 9.66100
C 1 2.42 9.66 19.32 33.81 19.32
2 2.42 9.66 19.32 33.81 9.66
3 2.42 7.25 28.98 33.81 16.91
4 00 4.83 19.32 24.15 2.42
5 2.42 7.25 19.32 48.30 9.66
6 2.42 14.49 14.49 19.32 19.32
7 4.83 9.66 14.49 24.15 7.25
8 4.83 14.49 30.64 63.29 19.32
mean ± s.d. 2.72±1.55 9.66±3.41 20.74+6.00 35.08±14.46 12.9816.57
D 1 4.83 4.83 9.66 9.66 2.42
2 4.83 19.32 9.66 24.15 00
3 2.42 2.42 9.66 9.66 00
4 00 4.83 9.66 19.32 2.42
5 2.42 4.83 9.66 966 00
6 2.42 4.83 9.66 9.66 2.42
mean 1 s.d. 2.8211.82 6.84±6.19 9.66±00 13.6916.42 1.2111.33
E 1 2.42 9.66 24.15 19.32 4.83
2 2.42 9.66 28.98 14.49 00
3 00 9.66 24.15 19.32 2.42
4 4.83 9.66 28.98 24.15 2.42
5 00 9.66 19.32 24.15 2.42
mean 1 s.d. 1.93±2.02 9.66100 25.1214.04 20.2914.04 2.4211.71
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Appendix Table 6.7
Peripheral eosinophil counts (cells per mm^) of rats injected with
immune rabbit serum (Group A) and rats injected with normal rabbit
semm (Group B)
Rat No. 0 w 2 w.a..i. 4 w.a.i. 6 w.ai. 8 w.a.i.
A 1 00 856 3007 3313 2351
2 113 498 2115 1925 1233
3 191 825 2849 2371 1766
4 98 123 329 742 632
5 109 121 143 339 320
mean ± s.d. 102+68 485+359 1689±1370 1738±1211 1260+S25
B 1 410 727 2338 1420 2349
2 224 891 2153 3427 3338
3 80 430 1015 1205 890
4 00 830 1325 1644 719
5 00 524 737 927 449
mean ± s.d. 143+175 680±198 1514+703 1725±988 1551±1241
Appendix Table 6.8
Serum glutamic dehydrogenase assays (micromoles product per litre of serum per minute) of
rats injected with immune rabbit serum (Group A) and rats injected with normal rabbit serum (Group B)
Rat No. 0 W. 2 w.a.i. 4 w.a.i. 6 w.a.i 8 w.a.i.
A 1 4.83 9.66 9.66 9.66 9.66
2 4.83 9.66 14.49 19.32 9.66
3 4.83 9.66 14.49 14.49 4.83
4 4.83 4.83 4.83 4.83 4.83
5 4.8'3 4.83 4.83 4.83 4.83
mean ± s.d. 4.83+00 7.73±2.65 9.66±4.83 10.63±6.30 6.76±2.65
B 1 4.83 9.66 38.64 38.64 19.32
2 4.83 9.66 24.15 33.81 9.66
3 9.66 19.32 38.64 48.30 19.32
4 4.83 9.66 24.15 24.15 9.66
5 4.83 9.66 33.81 33.81 19.32
mean ± s.d. 5.80±2.16 11.59±4.32 31.88±7.33 35.74+8.77 15.46±5.29
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Appendix Table 6.9
Serum glutamic dehydrogenase assays (micromoles product per litre of serum per minute)
of rats injected with immune bovine serum (Group A) and ratsinjected with normal
bovine serum (Group B)
Rat No. 0 W. 2 w.a.i. 4 w.a.i. 6 w.a.i. 8 w.a.i.
A 1 4.83 9.66 14.49 14.49 4.83
2 00 00 4.83 4.83 4.83
3 4.83 9.66 38.64 14.49 4.83
4 4.83 9.66 14.49 14.49 4.83
5 4.83 9.66 33.81 14.49 9.66
6 9.66 9.66 33.81 24.15 4.83
7 9.66 9.66 28.98 28.98 4.83
8 4.83 9.66 33.81 33.81 9.66
9 4.83 9.66 9.66 4.83 4.83
10 4.83 4.83 24.15 24.15 4.83
mean ± s.d. 5.31±2.74 8.21±3.26 23.67±11.93 17.87±9.67 5.80±2.04
B 1 4.83 4.83 28.98 28.98 9.66
2 4.83 9.66 24.15 28.98 9.66
3 9.66 9.66 24.15 43.17 9.66
4 4.83 9.66 38.64 48.30 9.66
5 4.83 9.66 43.47 38.64 9.66
6 4.83 9.66 19.32 19.32 4.83
1 4.83 9.66 19.32 19.32 4.83
8 4.83 9.66 38.64 19.32 9.66
mean ± s.d. 5.43±1.71 9.06±1.71 29.58±9.46 30.79±11.53 8.45±2.24
Appendix Table 6.10
Serum glutamic dehydrogenase assasy (micromoles product per litre of serum per minute)
of rats injected with immune ovine serum (Group A) and normal ovine serum (Group B)
Rat Group 0 w. 2 w.a.i. 4 w.a.i. 6 w.a.i. 8 w.a.i.
A 1 9.66 9.66 19.32 67.72 9.66
2 4.83 9.66 38.64 48.30 4.33
3 4.83 9.66 38.64 28.98 4.83
4 00 9.66 28.98 57.96 9.66
5 4.83 9.66 38.64 28.98 19.32
mean ±s.d. 4.33±3.42 9.66±00 32.84±8.64 46.37±17.28 9.66±5.92
B 1 9.66 14.49 38.64 24.50 9.66
2 9.66 9.66 19-32 28.98 9.66
3 4.83 9.66 33.81 19.32 4.83
4 4.83 9.66 38.64 38.64 4.83
5 4.83 9.66 48.30 38.64 9.66
mean ± s.d. 6.76±2.65 10.63+2.16 35.74±10.58 30.02±8.58 7.73±2.65
Appendix Table 6.11
Serum glutamic dehydrogenase assays (micromoles product per litre of serum per minute)
of rats injected with immune ovine serum (Group A) and normal ovine semm (Group B)
Rat group 0 W 2 w.a.i. 4 w.a.i. 6 w.a.i. 8 w.ai.
A 1 4.83 19.32 48.30 48.30 9.66
2 9.66 9.66 28.90 48.30 9.66
3 9.66 9.66 38.64 28.98 4.83
4 9.66 9.66 28.98 28.98 4.83
5 4.83 9.66 38.64 38.64 9.66
6 9.66 9.66 38.64 38.64 9.66
7 4.83 9.66 38.64 38.64 9.66
mean ± s.d. 7.5912.58 11.04±3.65 37.26±6.67 38.64+7.89 8.28±2.36
B 1 9.66 19.32 38.64 48.30 19.32
2 9.66 19.32 38.64 28.98 9.66
3 4.83 9.66 48.30 28.98 9.66
4 4.83 9.66 48.30 28.98 9.66
5 4.83 9.66 28.98 48.30 9.66
6 9.66 9.66 48.30 38.64 19.32
7 4.83 4.83 28.98 28.98 9.66
mean ± s.d. 6.90±2.5S 11.73±5.48 40.02+8.69 35.88±9.19 12.42+4.71
Appendix Table 6.12
Serum glutamic dehydrogenase assays (micromoles product per litre of serum per minute) of rats
injected with 7-globulin from immune rat serum (Group A), rats injected with 7-globulin from
normal rat serum (Group B),rats injected with immune rat serum (Group C) and rats injected
with normal rat serum (Group D)
Rat No. 0 w 2 w.a.i. 4 w.a.i. 6 w.a.i. 8 w.ai.
A 1 4.83 9.66 28.98 14.49 4.83
2 4.83 9.66 14.49 14.49 9.66
3 4.83 9.66 14.49 28.98 14.49
4 4.83 4.83 4.83 4.83 4.S3
5 4.83 9.66 28.98 28.98 9.66
6 00 9.66 38.64 28.98 9.66
7 00 9.66 14.49 9.66 4.83
8 00 4.83 4.83 4.83 4.83
mean 1 s.d. 3.02±2.5 8.45+2.24 18.72±12.23 16.91±10.64 7.8513.59
B 1 4.83 9.66 28.98 19.32 4.83
2 4.83 14.49 48.30 38.64 19.32
3 00 9.66 33.81 28.98 9.66
4 4.83 9.66 48.30 48.30 19.32
5 9.66 9.66 19.32 28.98 9.66
mean ± s.d. 4.83±3.42 10.63±2.16 35.74±12.60 32.84111.01 12.56+6.48
C 1 00 9.66 28.98 _ 9.66
2 9.66 9.66 14.49 14.49 4.83
3 4.83 4.83 4.83 4.83 4.83
4 4.83 4.83 9.66 9.66 4.83
5 4.83 4.83 19.32 19.32 4.83
mean ± s.d. 4.83±3.42 6.76±2.65 15.46±9.29 12.0816.24 5.8012.16
D 1 00 9.66 28.98 48.30 14.49
2 4.83 9.66 28.98 33.81 14.49
3 4.83 14.49 24.15 48.30 14,49
4 9.66 14.49 48.30 19.32 9.66
5 9.66 9.66 33.81 19.32 9.66
mean Is.d. 5.80+4.04 11.59+2.65 32.84+9.29 33.8U14.49 12.5612.65
Appendix Table 6.13
Serum glutmatic dehydrogenase assays (micromoles product per litre of serum per minute)
of rats injected with 7-globulin from immune bovine serum and 7-globulin from normal bovine serum
Rat No. 0 W. 2 w a.i. 4 w.a.i. 6 w.a.i. 8 w.a.i.
A 1 4.83 9.66 19.32 19.32 9.66
2 9.66 19.32 38.64 28.98 9.66
3 9.66 9.66 28.98 19.32 9.66
4 9.66 9.66 9.66 9.66 9.66
5 9.66 9.66 9.66 9.66 9.66
6 4.83 4.83 19.32 19.32 9.66
mean ±s.d. 8.05±2.49 10.47±4.75 20.93±11.29 17.71iT7.27 9.66±00
B 1 4.83 9.66 24.15 24.15 9.66
2 9.66 9.66 33.81 38.64 19.32
3 4.83 9.66 38.64 19.32 19.32
4 4.83 9.66 24.15 38.64 4.83
5 9.66 19.32 48.30 41.87 9.66
6 4.83 19.32 48.30 38.64 9.66
mean ± s.d. 6.44±2.49 12.88±4.99 36.23±10.91 33.54±9.36 12.08+5.
Appendix Table 6.14
Serum glutamic dehydrogenase assasy (micromoles product per litre of serum per minute)
of rats injected with serum from rats implanted with living flukes in chambers (Group A)
and rats injected with serum from rats implanted with empty chambers
Rat No. 0 W. 2 w.a.i. 4 w.a.i. 6 w.a.i. 8 w.a.i.
A 1 4.83 4.83 4.83 4.83 4.83
2 4.83 9.66 9,66 9.66 4.83
3 4.83 4.83 9.66 9.66 4.83
4 4.83 9.66 28.98 24.15 24.15
5 9.66 9.66 9.66 4.83 4.83
6 4.83 14.49 33.81 24.15 4.83
7 4.83 9.66 33.81 38.64 4.83
mean ± s.d. 5.5 2±1.83 8.97±3.33 18.63±12.91 16.56±12.74 7.59±7.30
B 1 4.83 9.66 19.32 19.32 9.66
2 4.83 14.49 43.47 48.30 9.66
3 4.83 14.49 43.47 33.81 9.66
4 9.66 9.66 48.30 14.49 14.49
5 4.83 9.66 19.32 19.32 4.83
6 4.83 14.49 48.30 48.30 4.83
7 9.66 14.49 28.98 38.64 9.66
mean ± s.d. 6.21±2.36 12.42+2.58 35.88±13.04 31.74±14.18 8.97±3.33
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Appendix Table 6.15
Serum glutamic dehydrogenase assays of rats injected with directly absorbed immune bovine
serum (Group A), rats injected with indirectly absorbent immune bovine serum (Group B)
and rats injected with normal bovine serum (Group C)
Rat No. 0 w.a.i. 2 w.a.i. 4 w.a.i. 6 w.a.i. 8 w.a.i.
A 1 4.83 28.98 33.31 38.64 19.32
2 4.83 14.49 38.64 19.32 9.66
3 4.83 9.66 38.64 33.81 24.15
4 9.66 14.49 57.96 28.98 24.15
5 9.66 28.98 38.64 38.64 14.49
6 4.83 9.66 38.64 38.64 19.32
7 4.83 9.66 28.98 14.49 14.49
8 4.83 9.66 33.81 28.98 14.49
mean 1 s.d. 6.04±2.24 15.70±8.45 38.6418.55 30.1919.20 17.5115.1
B 1 4.83 14.49 24.15 38.64 24.15
2 4.83 14.49 38.64 38.64 14.49
3 4.83 14.49 33.81 33.81 9.66
4 2.42 9.66 33.81 28.98 4.83
5 4.83 19.32 38.64 28.98 14.49
6 9.66 24.15 38.64 28.98 24.15
7 4.83 14.49 38.64 33.81 14.49
8 4.83 9.66 28.92 24.15 19.32
mean ± s.d. 5.13±2.02 15.09±4.79 34.4115.41 32.0015.11 15.7016.6'
C 1 4.83 9.66 48.30 38.64 9.66
2 2.42 4.83 24.15 19.32 9.66
3 4.83 9.66 33.81 48.30 9.66
4 4.83 14.49 38.64 43.47 14.49
5 4.83 14.49 43.47 48.30 9.66
6 4.83 14.49 28.98 28.98 9.66
7 4.83. 14.49 28.98 19.32 9.66
mean 1 s.d. 4.49±0.88 11.73±3.81 35.19+8.70 35.19H2.69 10.3511.8:
